<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Poly(Alkyl‐Terphenyl Piperidinium) Ionomers and Membranes with an Outstanding Alkaline‐Membrane Fuel‐Cell Performance of 2.58 W cm<sup>−2</sup>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033733555-d076eb34-8bbb-4753-ac55-027ae82edc81/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013395</link>
            <description><![CDATA[<p class="para" id="N65541">Aryl‐ether‐free anion‐exchange ionomers (AEIs) and membranes (AEMs) have become an important benchmark to address the insufficient durability and power‐density issues associated with AEM fuel cells (AEMFCs). Here, we present aliphatic chain‐containing poly(diphenyl‐terphenyl piperidinium) (PDTP) copolymers to reduce the phenyl content and adsorption of AEIs and to increase the mechanical properties of AEMs. Specifically, PDTP AEMs possess excellent mechanical properties (storage modulus&gt;1800 MPa, tensile strength&gt;70 MPa), H<sub>2</sub> fuel‐barrier properties (&lt;10 Barrer), good ion conductivity, and ex‐situ stability. Meanwhile, PDTP AEIs with low phenyl content and high‐water permeability display excellent peak power densities (PPDs). The present AEMFCs reach outstanding PPDs of 2.58 W cm<sup>−2</sup> (&gt;7.6 A cm<sup>−2</sup> current density) and 1.38 W cm<sup>−2</sup> at 80 °C in H<sub>2</sub>/O<sub>2</sub> and H<sub>2</sub>/air, respectively, along with a specific power (PPD/catalyst loading) over 8 W mg<sup>−1</sup>, which is the highest record for Pt‐based AEMFCs so far.</p><p class="para" id="N65540">Poly(alkyl‐terphenyl piperidinium) membranes and ionomers display outstanding hydrogen‐barrier properties and mechanical properties as well as excellent hydroxide‐ion conductivity that results in an excellent power density of 2.58 W cm<sup>−2</sup> and 1.38 W cm<sup>−2</sup> at 80 °C in H<sub>2</sub>/O<sub>2</sub> and H<sub>2</sub>/air, respectively, along with a new, outstanding specific power in alkaline‐exchange‐membrane fuel cells.<div class="section"><div class="box" id="N65557"><div class="imageVideo"><img src="/dataresources/secured/content-1766033733555-d076eb34-8bbb-4753-ac55-027ae82edc81/assets/ANIE-60-7710-g001.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Quantifying the Likelihood of Structural Models through a Dynamically Enhanced Powder X‐Ray Diffraction Protocol]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033724066-7ff9d91d-4ebc-49e3-b7df-38e2b7a0b035/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202017153</link>
            <description><![CDATA[<p class="para" id="N65541">Structurally characterizing new materials is tremendously challenging, especially when single crystal structures are hardly available which is often the case for covalent organic frameworks. Yet, knowledge of the atomic structure is key to establish structure‐function relations and enable functional material design. Herein, a new protocol is proposed to unambiguously predict the structure of poorly crystalline materials through a likelihood ordering based on the X‐ray diffraction (XRD) pattern. Key of the procedure is the broad set of structures generated from a limited number of building blocks and topologies, which is submitted to operando structural characterization. The dynamic averaging in the latter accounts for the operando conditions and inherent temporal character of experimental measurements, yielding unparalleled agreement with experimental powder XRD patterns. The proposed concept can hence unquestionably identify the structure of experimentally synthesized materials, a crucial step to design next generation functional materials.</p><p class="para" id="N65540">Structurally characterizing new and poorly crystalline materials such as covalent organic frameworks is highly challenging. The dynamic protocol of this work overcomes this challenge through a systematic likelihood ordering based on intuitive heuristics and X‐ray diffraction patterns. It succeeds in unambiguously identifying a material's atomic‐level structure, accounting for the operando conditions and inherent temporal character of experiments.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033724066-7ff9d91d-4ebc-49e3-b7df-38e2b7a0b035/assets/ANIE-60-8913-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fluorescent and Water Dispersible Single‐Chain Nanoparticles: Core–Shell Structured Compartmentation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033654795-22ef42e2-fd31-46e7-8822-2421f1e8cc30/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015179</link>
            <description><![CDATA[<p class="para" id="N65541">Single‐chain nanoparticles (SCNPs) are highly versatile structures resembling proteins, able to function as catalysts or biomedical delivery systems. Based on their synthesis by single‐chain collapse into nanoparticular systems, their internal structure is complex, resulting in nanosized domains preformed during the crosslinking process. In this study we present proof of such nanocompartments within SCNPs via a combination of electron paramagnetic resonance (EPR) and fluorescence spectroscopy. A novel strategy to encapsulate labels within these water dispersible SCNPs with hydrodynamic radii of ≈5 nm is presented, based on amphiphilic polymers with additional covalently bound labels, attached via the copper catalyzed azide/alkyne “click” reaction (CuAAC). A detailed profile of the interior of the SCNPs and the labels’ microenvironment was obtained via electron paramagnetic resonance (EPR) experiments, followed by an assessment of their photophysical properties.</p><p class="para" id="N65540">The internal structure of single‐chain nanoparticles (SCNPs) has been investigated, forming nanosized domains preformed during the crosslinking process. We present proof for the presence of nano‐compartments within SCNPs via a combination of electron paramagnetic resonance (EPR) and fluorescence spectroscopy. A novel strategy to encapsulate labels within such water dispersible SCNPs is presented.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033654795-22ef42e2-fd31-46e7-8822-2421f1e8cc30/assets/ANIE-60-7820-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Iron Oxidation in <i>Escherichia coli</i> Bacterioferritin Ferroxidase Centre, a Site Designed to React Rapidly with H<sub>2</sub>O<sub>2</sub> but Slowly with O<sub>2</sub>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033639237-e11e98dd-d922-4d36-9248-6554bb60546b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015964</link>
            <description><![CDATA[<p class="para" id="N65541">Both O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> can oxidize iron at the ferroxidase center (FC) of <i>Escherichia coli</i> bacterioferritin (EcBfr) but mechanistic details of the two reactions need clarification. UV/Vis, EPR, and Mössbauer spectroscopies have been used to follow the reactions when apo‐EcBfr, pre‐loaded anaerobically with Fe<sup>2+</sup>, was exposed to O<sub>2</sub> or H<sub>2</sub>O<sub>2</sub>. We show that O<sub>2</sub> binds di‐Fe<sup>2+</sup> FC reversibly, two Fe<sup>2+</sup> ions are oxidized in concert and a H<sub>2</sub>O<sub>2</sub> molecule is formed and released to the solution. This peroxide molecule further oxidizes another di‐Fe<sup>2+</sup> FC, at a rate circa 1000 faster than O<sub>2</sub>, ensuring an overall 1:4 stoichiometry of iron oxidation by O<sub>2</sub>. Initially formed Fe<sup>3+</sup> can further react with H<sub>2</sub>O<sub>2</sub> (producing protein bound radicals) but relaxes within seconds to an H<sub>2</sub>O<sub>2</sub>‐unreactive di‐Fe<sup>3+</sup> form. The data obtained suggest that the primary role of EcBfr in vivo may be to detoxify H<sub>2</sub>O<sub>2</sub> rather than sequester iron.</p><p class="para" id="N65540">The kinetics of <i>E. coli</i> bacterioferritin di‐ferrous ferroxidase centre reacting with O<sub>2</sub> and H<sub>2</sub>O<sub>2</sub> shows that H<sub>2</sub>O<sub>2</sub> reacts circa 1000 times faster than O<sub>2</sub> implying that the primary in vivo role of the protein is ROS detoxification rather than iron sequestering.<div class="section"><div class="box" id="N65563"><div class="imageVideo"><img src="/dataresources/secured/content-1766033639237-e11e98dd-d922-4d36-9248-6554bb60546b/assets/ANIE-60-8361-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Effect of Metal–Organic Framework (MOF) Database Selection on the Assessment of Gas Storage and Separation Potentials of MOFs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033632957-d0487ed4-24d3-4763-a697-23c884b08696/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015250</link>
            <description><![CDATA[<p class="para" id="N65541">Development of computation‐ready metal–organic framework databases (MOF DBs) has accelerated high‐throughput computational screening (HTCS) of materials to identify the best candidates for gas storage and separation. These DBs were constructed using structural curations to make MOFs directly usable for molecular simulations, which caused the same MOF to be reported with different structural features in different DBs. We examined thousands of common materials of the two recently updated, very widely used MOF DBs to reveal how structural discrepancies affect simulated CH<sub>4</sub>, H<sub>2</sub>, CO<sub>2</sub> uptakes and CH<sub>4</sub>/H<sub>2</sub> separation performances of MOFs. Results showed that DB selection has a significant effect on the calculated gas uptakes and ideal selectivities of materials at low pressure. A detailed analysis on the curated structures was provided to isolate the critical elements of MOFs determining the gas uptakes. Identification of the top‐performing materials for gas separation was shown to strongly depend on the DB used in simulations.</p><p class="para" id="N65540">We examined thousands of common materials in two widely used computation‐ready metal–organic framework databases (MOF DBs) to reveal how structural discrepancies affect simulated CH<sub>4</sub>, H<sub>2</sub>, CO<sub>2</sub> uptakes and CH<sub>4</sub>/H<sub>2</sub> separation performances of MOFs. Identification of the top‐performing materials for gas separation was shown to strongly depend on the DB used in simulations.<div class="section"><div class="box" id="N65557"><div class="imageVideo"><img src="/dataresources/secured/content-1766033632957-d0487ed4-24d3-4763-a697-23c884b08696/assets/ANIE-60-7828-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[High‐Silica CHA Zeolite Membrane with Ultra‐High Selectivity and Irradiation Stability for Krypton/Xenon Separation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033614759-ae87c1ff-5370-40c5-9141-a3a9d54aaa1b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202100172</link>
            <description><![CDATA[<p class="para" id="N65541">Capture and storage of the long‐lived <sup>85</sup>Kr is an efficient approach to mitigate the emission of volatile radionuclides from the spent nuclear fuel reprocessing facilities. However, it is challenging to separate krypton (Kr) from xenon (Xe) because of the chemical inertness and similar physical properties. Herein we prepared high‐silica CHA zeolite membranes with ultra‐high selectivity and irradiation stability for Kr/Xe separation. The suitable aperture size and rigid framework endures the membrane a strong size‐exclusion effect. The ultrahigh selectivity of 51–152 together with the Kr permeance of 0.7–1.3×10<sup>−8</sup> mol m<sup>−2</sup> s<sup>−1</sup> Pa<sup>−1</sup> of high‐silica CHA zeolite membranes far surpass the state‐of‐the‐art polymeric membranes. The membrane is among the most stable polycrystalline membranes for separation of humid Kr/Xe mixtures. Together with the excellent irradiation stability, high‐silica CHA zeolite membranes pave the way to separate radioactive Kr from Xe for a notable reduction of the volatile nuclear waste storage volume.</p><p class="para" id="N65540">High‐silica CHA zeolite membranes show ultra‐high Kr/Xe selectivity and superior hydrothermal stability. Together with their irradiation stability, high‐silica CHA zeolite membranes can pave the way to enrich radioactive <sup>85</sup>Kr from xenon for a notable decrease in the volatile nuclear waste volume.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766033614759-ae87c1ff-5370-40c5-9141-a3a9d54aaa1b/assets/ANIE-60-9032-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fe‐Catalyzed Anaerobic Mukaiyama‐Type Hydration of Alkenes using Nitroarenes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033573965-23b4d1b8-60ab-4ec4-8a72-f049a77a1cee/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015740</link>
            <description><![CDATA[<p class="para" id="N65541">Hydration of alkenes using first row transition metals (Fe, Co, Mn) under oxygen atmosphere (Mukaiyama‐type hydration) is highly practical for alkene functionalization in complex synthesis. Different hydration protocols have been developed, however, control of the stereoselectivity remains a challenge. Herein, highly diastereoselective Fe‐catalyzed anaerobic Markovnikov‐selective hydration of alkenes using nitroarenes as oxygenation reagents is reported. The nitro moiety is not well explored in radical chemistry and nitroarenes are known to suppress free radical processes. Our findings show the potential of cheap nitroarenes as oxygen donors in radical transformations. Secondary and tertiary alcohols were prepared with excellent Markovnikov‐selectivity. The method features large functional group tolerance and is also applicable for late‐stage chemical functionalization. The anaerobic protocol outperforms existing hydration methodology in terms of reaction efficiency and selectivity.</p><p class="para" id="N65540">The highly diastereoselective Fe‐catalyzed anaerobic Markovnikov‐selective hydration of alkenes using nitroarenes as oxygenation reagents is reported.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033573965-23b4d1b8-60ab-4ec4-8a72-f049a77a1cee/assets/ANIE-60-8313-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Non‐Carbohydrate Glycomimetics as Inhibitors of Calcium(II)‐Binding Lectins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033537574-51ce8ce7-e663-48a7-9fb7-6cf1ccbd99f8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013217</link>
            <description><![CDATA[<p class="para" id="N65541">Because of the antimicrobial resistance crisis, lectins are considered novel drug targets. <i>Pseudomonas aeruginosa</i> utilizes LecA and LecB in the infection process. Inhibition of both lectins with carbohydrate‐derived molecules can reduce biofilm formation to restore antimicrobial susceptibility. Here, we focused on non‐carbohydrate inhibitors for LecA to explore new avenues for lectin inhibition. From a screening cascade we obtained one experimentally confirmed hit, a catechol, belonging to the well‐known PAINS compounds. Rigorous analyses validated electron‐deficient catechols as millimolar LecA inhibitors. The first co‐crystal structure of a non‐carbohydrate inhibitor in complex with a bacterial lectin clearly demonstrates the catechol mimicking the binding of natural glycosides with LecA. Importantly, catechol <b>3</b> is the first non‐carbohydrate lectin ligand that binds bacterial and mammalian calcium(II)‐binding lectins, giving rise to this fundamentally new class of glycomimetics.</p><p class="para" id="N65540">A screening yields the first non‐carbohydrate small molecules mimicking the interaction of carbohydrates in the binding sites of bacterial lectins. The catechols, known as PAINS, were carefully validated in numerous biophysical assays. A crystal structure in complex with <i>Pseudomonas aeruginosa</i> LecA and NMR analyses with mammalian C‐type lectin Langerin prove the catechol moiety as a general replacement motif for carbohydrates in calcium(II)‐binding lectins.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766033537574-51ce8ce7-e663-48a7-9fb7-6cf1ccbd99f8/assets/ANIE-60-8104-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Axon‐Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033457547-52789528-6555-49f6-ba1f-c7357f231569/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.26014</link>
            <description><![CDATA[<div class="section" id="ana26014-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative disease of unknown etiology. Although the prevalent view regards a CD4<sup>+</sup>‐lymphocyte autoimmune reaction against myelin at the root of the disease, recent studies propose autoimmunity as a secondary reaction to idiopathic brain damage. To gain knowledge about this possibility we investigated the presence of axonal and myelinic morphological alterations, which could implicate imbalance of axon‐myelin units as primary event in MS pathogenesis.</p></div><div class="section" id="ana26014-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65552">Using high resolution imaging histological brain specimens from patients with MS and non‐neurological/non‐MS controls, we explored molecular changes underpinning imbalanced interaction between axon and myelin in normal appearing white matter (NAWM), a region characterized by normal myelination and absent inflammatory activity.</p></div><div class="section" id="ana26014-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65558">In MS brains, we detected blister‐like swellings formed by myelin detachment from axons, which were substantially less frequently retrieved in non‐neurological/non‐MS controls. Swellings in MS NAWM presented altered glutamate receptor expression, myelin associated glycoprotein (MAG) distribution, and lipid biochemical composition of myelin sheaths. Changes in tethering protein expression, widening of nodes of Ranvier and altered distribution of sodium channels in nodal regions of otherwise normally myelinated axons were also present in MS NAWM. Finally, we demonstrate a significant increase, compared with controls, in citrullinated proteins in myelin of MS cases, pointing toward biochemical modifications that may amplify the immunogenicity of MS myelin.</p></div><div class="section" id="ana26014-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65564">Collectively, the impaired interaction of myelin and axons potentially leads to myelin disintegration. Conceptually, the ensuing release of (post‐translationally modified) myelin antigens may elicit a subsequent immune attack in MS. ANN NEUROL 2021;89:711–725</p></div>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Development of High‐Performance Pyrimidine Nucleoside and Oligonucleotide Diarylethene Photoswitches]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033409807-eb70970b-ef32-4b82-89aa-a3540e39a22c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014878</link>
            <description><![CDATA[<p class="para" id="N65541">Nucleosidic and oligonucleotidic diarylethenes (DAEs) are an emerging class of photochromes with high application potential. However, their further development is hampered by the poor understanding of how the chemical structure modulates the photochromic properties. Here we synthesized 26 systematically varied deoxyuridine‐ and deoxycytidine‐derived DAEs and analyzed reaction quantum yields, composition of the photostationary states, thermal and photochemical stability, and reversibility. This analysis identified two high‐performance photoswitches with near‐quantitative, fully reversible back‐and‐forth switching and no detectable thermal or photochemical deterioration. When incorporated into an oligonucleotide with the sequence of a promotor, the nucleotides maintained their photochromism and allowed the modulation of the transcription activity of T7 RNA polymerase with an up to 2.4‐fold turn‐off factor, demonstrating the potential for optochemical control of biological processes.</p><p class="para" id="N65540">From a library of 26 deoxyuridine‐ and deoxycytidine‐derived diarylethenes we identified two high‐performance photoswitches with near‐quantitative, fully reversible back‐and‐forth switching, high reaction quantum yields and no detectable thermal or photochemical deterioration. Incorporated into an oligonucleotide, these nucleotides allowed the optochemical modulation of the activity of T7 RNA polymerase.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033409807-eb70970b-ef32-4b82-89aa-a3540e39a22c/assets/ANIE-60-8164-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Sandarazols are Cryptic and Structurally Unique Plasmid‐Encoded Toxins from a Rare Myxobacterium<a href="#anie202014671-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033374343-5ddaabb5-7f72-4f91-b904-7f446c2ccc2a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014671</link>
            <description><![CDATA[<p class="para" id="N65541">Herein, we describe a new plasmid found in Sandaracinus sp. MSr10575 named pSa001 spanning 209.7 kbp that harbors a cryptic secondary metabolite biosynthesis gene cluster (BGC). Activation of this BGC by homologous‐recombination‐mediated exchange of the native promoter sequence against a vanillate inducible system led to the production and subsequent isolation and structure elucidation of novel secondary metabolites, the sandarazols A–G. The sandarazols contain intriguing structural features and very reactive functional groups such as an α‐chlorinated ketone, an epoxyketone, and a (2R)‐2‐amino‐3‐(N,N‐dimethylamino)‐propionic acid building block. In‐depth investigation of the underlying biosynthetic machinery led to a concise biosynthetic model for the new compound family, including several uncommon biosynthetic steps. The chlorinated congener sandarazol C shows an IC<sub>50</sub> value of 0.5 μ<span style="font-variant: all-small-caps">m</span> against HCT 116 cells and a MIC of 14 μ<span style="font-variant: all-small-caps">m</span> against Mycobacterium smegmatis, which points at the sandarazols’ potential function as defensive secondary metabolites or toxins.</p><p class="para" id="N65540">Genetic activation artificially induced a plasmid‐encoded natural product biosynthetic gene cluster and activated the complex biosynthesis of a previously unknown cytotoxin named sandarazol. Its biosynthesis is unique in featuring the genetic blueprint for the formation of intriguing structural features such as an α‐chlorinated ketone, an epoxyketone, and a rare (<i>2R</i>)‐2‐amino‐3‐(<i>N</i>,<i>N</i>‐dimethylamino)‐propionic acid building block.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1766033374343-5ddaabb5-7f72-4f91-b904-7f446c2ccc2a/assets/ANIE-60-8081-g002.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Benzo‐Fused Perylene Oligomers with up to 13 Linearly Annulated Rings]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033361128-b49753db-eee0-4fe3-97a6-785d35a93a73/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202017062</link>
            <description><![CDATA[<p class="para" id="N65541">The longer acenes with more than six linearly fused six‐membered rings are still fascinating chemists and physicists because of their unique photophysical properties and their high potential for organic electronics applications. Unfortunately, with increasing size (seven and more rings) these compounds rapidly lose chemical stability. Besides kinetic and chemical stabilization approaches introducing either bulky or electron‐withdrawing groups or both, such systems also have been stabilized by peri‐annulation. Although strictly spoken, these peri‐annulated compounds are no longer real acenes, they have fascinating properties as well. Herein, we describe the first synthesis of a new series of peri‐annulated acenes with up to 13 linearly fused rings, which is unprecedented till date. Furthermore, this new series contains perylene units connected through benzene rings along their [<i>b,k</i>]edges, responsible for unique absorption and emission properties.</p><p class="para" id="N65540">A new series of discrete oligomeric linearly fused polycyclic aromatic hydrocarbons (PAHs) stabilized by peri‐annulation in described. The intrinsic perylene units of the novel PAHs with up to 13(!) linearly fused rings are responsible for colorful and bright photophysical properties.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033361128-b49753db-eee0-4fe3-97a6-785d35a93a73/assets/ANIE-60-7941-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Gain‐of‐Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033264491-445918a8-5627-487d-9e35-806523e1fd24/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28385</link>
            <description><![CDATA[<div class="section" id="mds28385-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">We describe a 4‐generation Dutch pedigree with a unique dominantly inherited clinical phenotype of a combined progressive chorea and cervical dystonia carrying a novel heterozygous dopamine D2 receptor (<i>DRD2</i>) variant.</p></div><div class="section" id="mds28385-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65554">The objective of this study was to identify the genetic cause of the disease and to further investigate the functional consequences of the genetic variant.</p></div><div class="section" id="mds28385-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65560">After detailed clinical and neurological examination, whole‐exome sequencing was performed. Because a novel variant in the <i>DRD2</i> gene was found as the likely causative gene defect in our pedigree, we sequenced the <i>DRD2</i> gene in a cohort of 121 Huntington‐like cases with unknown genetic cause (Germany). Moreover, functional characterization of the <i>DRD2</i> variant included arrestin recruitment, G protein activation, and G protein‐mediated inhibition of adenylyl cyclase determined in a cell model, and G protein‐regulated inward‐rectifying potassium channels measured in midbrain slices of mice.</p></div><div class="section" id="mds28385-sec-0004"><h3 class="BHead" id="nov000-4">Result</h3><p class="para" id="N65575">We identified a novel heterozygous variant c.634A &gt; T, p.Ile212Phe in exon 5 of <i>DRD2</i> that cosegregated with the clinical phenotype. Screening of the German cohort did not reveal additional putative disease‐causing variants. We demonstrated that the D2<sub>S/L</sub>‐I<sup>212</sup>F receptor exhibited increased agonist potency and constitutive activation of G proteins in human embryonic kidney 239 cells as well as significantly reduced arrestin3 recruitment. We further showed that the D2<sub>S</sub>‐I<sup>212</sup>F receptor exhibited aberrant receptor function in mouse midbrain slices.</p></div><div class="section" id="mds28385-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65596">Our results support an association between the novel p.Ile212Phe variant in <i>DRD2</i>, its modified D2 receptor activity, and the hyperkinetic movement disorder reported in the 4‐generation pedigree. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p></div>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cys–Cys and Cys–Lys Stapling of Unprotected Peptides Enabled by Hypervalent Iodine Reagents]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033223445-bf0bbdfc-1e9b-4f90-a7a7-5b1e7d693eef/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014511</link>
            <description><![CDATA[<p class="para" id="N65541">Easy access to a wide range of structurally diverse stapled peptides is crucial for the development of inhibitors of protein‐protein interactions. Herein, we report bis‐functional hypervalent iodine reagents for two‐component cysteine‐cysteine and cysteine‐lysine stapling yielding structurally diverse thioalkyne linkers. This stapling method works with unprotected natural amino acid residues and does not require pre‐functionalization or metal catalysis. The products are stable to purification and isolation. Post‐stapling modification can be accessed via amidation of an activated ester, or via cycloaddition onto the formed thioalkyne group. Increased helicity and binding affinity to MDM2 was obtained for a <i>i,i+</i>7 stapled peptide.</p><p class="para" id="N65540">Bifunctional hypervalent iodine reagents for two‐component cysteine‐cysteine and cysteine‐lysine stapling are reported. Efficient and selective stapling on non‐protected peptides was observed, and post‐stapling modification could be easily achieved using reactive esters or cycloaddition on the thioalkynes formed on the cysteine residue. One stapled peptide displayed both enhanced helicity and binding to the MDM2 protein.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033223445-bf0bbdfc-1e9b-4f90-a7a7-5b1e7d693eef/assets/ANIE-60-9022-g019.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Enhanced Live‐Cell Delivery of Synthetic Proteins Assisted by Cell‐Penetrating Peptides Fused to DABCYL]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033214437-d73a1cc8-b7db-46eb-97c8-64c72adbd58a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016208</link>
            <description><![CDATA[<p class="para" id="N65541">Live‐cell delivery of a fully synthetic protein having selectivity towards a particular target is a promising approach with potential applications for basic research and therapeutics. Cell‐penetrating peptides (CPPs) allow the cellular delivery of proteins but mostly result in endosomal entrapment, leading to lack of bioavailability. Herein, we report the design and synthesis of a CPP fused to 4‐((4‐(dimethylamino)phenyl)azo)benzoic acid (DABCYL) to enhance cellular uptake of fluorescently labelled synthetic protein analogues in low micromolar concentration. The attachment of cyclic deca‐arginine (cR10) modified with a single lysine linked to DABCYL to synthetic ubiquitin (Ub) and small ubiquitin‐like modifier‐2 (SUMO‐2) scaffolds resulted in a threefold higher uptake efficacy in live cells compared to the unmodified cR10. We could also achieve cR10DABCYL‐assisted delivery of Ub and a Ub variant (Ubv) based activity‐based probes for functional studies of deubiquitinases in live cells.</p><p class="para" id="N65540">Efficient intracellular delivery of synthetic native proteins is a challenge due to endosomal entrapment and subsequent degradation. We report the enhanced cellular uptake of fluorescently labelled synthetic proteins by attaching a newly developed cell‐penetrating peptide (CPP) composed of cyclic deca‐arginine linked to DABCYL.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033214437-d73a1cc8-b7db-46eb-97c8-64c72adbd58a/assets/ANIE-60-7333-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Total Synthesis of Mycinolide IV and Path‐Scouting for Aldgamycin N]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033169927-cc4b6364-bd41-45e0-b817-1e581f5ccb2f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016475</link>
            <description><![CDATA[<p class="para" id="N65541">Proof‐of‐concept is provided that a large estate of 16‐membered macrolide antibiotics can be reached by a “unified” approach. The key building block was formed on scale by an asymmetric vinylogous Mukaiyama aldol reaction; its alkene terminus was then converted either into the corresponding methyl ketone by Wacker oxidation or into a chain‐extended aldehyde by catalyst‐controlled branch‐selective asymmetric hydroformylation. These transformations ultimately opened access to two structurally distinct series of macrolide targets. Notable late‐stage maneuvers comprise a rare example of a ruthenium‐catalyzed redox isomerization of an 1,3‐enyne‐5‐ol into a 1,3‐diene‐5‐one derivative, as well as the elaboration of a tertiary propargylic alcohol into an acyloin by <i>trans</i>‐hydrostannation/Chan‐Lam‐type coupling. Moreover, this case study illustrates the underutilized possibility of forging complex macrolactone rings by transesterification under essentially neutral conditions.</p><p class="para" id="N65540">Dozens of macrolide antibiotics are known that differ from each other only in the decoration of an otherwise highly conserved 16‐membered lactone core and in the lateral glycosylation pattern. A unified approach was explored that holds the promise of bringing numerous members of this type into reach from a single “eastern” building block.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033169927-cc4b6364-bd41-45e0-b817-1e581f5ccb2f/assets/ANIE-60-7893-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[B‐Cu‐Zn Gas Diffusion Electrodes for CO<sub>2</sub> Electroreduction to C<sub>2+</sub> Products at High Current Densities]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033163153-6a13d623-dc7d-4a8d-9e02-e55f948fe1e5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016898</link>
            <description><![CDATA[<p class="para" id="N65541">Electroreduction of CO<sub>2</sub> to multi‐carbon products has attracted considerable attention as it provides an avenue to high‐density renewable energy storage. However, the selectivity and stability under high current densities are rarely reported. Herein, B‐doped Cu (B‐Cu) and B‐Cu‐Zn gas diffusion electrodes (GDE) were developed for highly selective and stable CO<sub>2</sub> conversion to C<sub>2+</sub> products at industrially relevant current densities. The B‐Cu GDE exhibited a high Faradaic efficiency of 79 % for C<sub>2+</sub> products formation at a current density of −200 mA cm<sup>−2</sup> and a potential of −0.45 V vs. RHE. The long‐term stability for C<sub>2+</sub> formation was substantially improved by incorporating an optimal amount of Zn. Operando Raman spectra confirm the retained Cu<sup>+</sup> species under CO<sub>2</sub> reduction conditions and the lower overpotential for *OCO formation upon incorporation of Zn, which lead to the excellent conversion of CO<sub>2</sub> to C<sub>2+</sub> products on B‐Cu‐Zn GDEs.</p><p class="para" id="N65540">A B‐Cu gas diffusion electrode (GDE) system was developed for highly selective CO<sub>2</sub> conversion to C<sub>2+</sub> products at high relevant current densities by mitigating the flooding problem and tuning the three‐phase boundary. Anodic protection by sacrificial Zn nanosheets remarkably improved the long‐term stability for CO<sub>2</sub> electroreduction at high current densities.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1766033163153-6a13d623-dc7d-4a8d-9e02-e55f948fe1e5/assets/ANIE-60-9135-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Operando Investigation of Ag‐Decorated Cu<sub>2</sub>O Nanocube Catalysts with Enhanced CO<sub>2</sub> Electroreduction toward Liquid Products]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033142571-160d0b95-d5ba-41fb-937f-61a371958da0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202017070</link>
            <description><![CDATA[<p class="para" id="N65541">Direct conversion of carbon dioxide into multicarbon liquid fuels by the CO<sub>2</sub> electrochemical reduction reaction (CO<sub>2</sub>RR) can contribute to the decarbonization of the global economy. Here, well‐defined Cu<sub>2</sub>O nanocubes (NCs, 35 nm) uniformly covered with Ag nanoparticles (5 nm) were synthesized. When compared to bare Cu<sub>2</sub>O NCs, the catalyst with 5 at % Ag on Cu<sub>2</sub>O NCs displayed a two‐fold increase in the Faradaic efficiency for C<sub>2+</sub> liquid products (30 % at −1.0 V<sub>RHE</sub>), including ethanol, 1‐propanol, and acetaldehyde, while formate and hydrogen were suppressed. Operando X‐ray absorption spectroscopy revealed the partial reduction of Cu<sub>2</sub>O during CO<sub>2</sub>RR, accompanied by a reaction‐driven redispersion of Ag on the CuO<sub>x</sub> NCs. Data from operando surface‐enhanced Raman spectroscopy further uncovered significant variations in the CO binding to Cu, which were assigned to Ag−Cu sites formed during CO<sub>2</sub>RR that appear crucial for the C−C coupling and the enhanced yield of liquid products.</p><p class="para" id="N65540">Cu<sub>2</sub>O nanocubes showed a remarkable increase (30 %) in the Faradaic efficiency for C<sub>2+</sub> liquid products after the decoration with Ag nanoparticles. Operando spectroscopy revealed a reaction‐driven redispersion of Ag on CuO<sub><i>x</i></sub> as well as a certain Cu–Ag miscibility. These changes were coupled with significant variations in the binding of CO to Cu that favored the enhancement of the liquid product yields.<div class="section"><div class="box" id="N65552"><div class="imageVideo"><img src="/dataresources/secured/content-1766033142571-160d0b95-d5ba-41fb-937f-61a371958da0/assets/ANIE-60-7426-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Scalable De Novo Synthesis of Aldgarose and Total Synthesis of Aldgamycin N]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033079280-7137e61e-f1bd-4535-9d61-eb93401e607c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016477</link>
            <description><![CDATA[<p class="para" id="N65541">Since the accompanying study had shown that the introduction of the eponymous aldgarose sugar to the C5‐OH group of the macrocyclic aglycone of aldgamycin N is most difficult, if not even impossible, the synthesis route was revised and the glycosidation performed at an earlier stage. To mitigate the “cost” of this strategic amendment, a practical and scalable de novo synthesis of this branched octose was developed. The glycoside formation required mild conditions; it commenced with the reaction of the aglycone with the trichloroacetimidate donor to give a transient orthoester, which slowly rearranged to the desired aldgaropyranoside. The presence of the polar peripheral groups in the product did not impede the selective late‐stage functionalization of the macrolide ring itself: the contained propargylic alcohol entity was readily transformed into the characteristic acyloin motif of the target by a ruthenium‐catalyzed <i>trans</i>‐hydrostannation followed by a modified Chan‐Lam‐type coupling.</p><p class="para" id="N65540">One sugar has to be attached before the transannular ketone is revealed from an alkyne precursor to render the first successful total synthesis ever of a member of the aldgamycin family of antibiotics. Although this phasing of events implies that the precious branched monosaccharide must be carried through several steps, a practical and scalable synthesis of the required aldgarose fragment greatly mitigates the “cost” of this strategy.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033079280-7137e61e-f1bd-4535-9d61-eb93401e607c/assets/ANIE-60-7900-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033054201-7efbabc4-cc26-418b-9b1d-6a2bfb68a440/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28389</link>
            <description><![CDATA[<div class="section" id="mds28389-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Nilotinib is US Food and Drug Administration–approved for leukemia, and this open‐label study investigated the safety, tolerability, and potential clinical effects of nilotinib in medically optimized patients with Parkinson's disease.</p></div><div class="section" id="mds28389-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65551">Safety and tolerability were the primary objectives, and clinical outcomes were exploratory.</p></div><div class="section" id="mds28389-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">A total of 63 patients completed a 15‐month phase 2, double‐blind, placebo‐controlled study and were rerandomized 1:1 into an open‐label study of nilotinib 150 mg versus 300 mg for 12 months.</p></div><div class="section" id="mds28389-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">Nilotinib was safe and tolerated, and no adverse effects seemed to be related to the drug, and no differences in adverse events were observed between groups. Exploratory clinical outcomes showed that nilotinib 300 mg was remarkably stable from baseline to 27 months using partial and total Unified Parkinson's Disease Scale (UPDRS). Nilotinib 150 mg versus 300 mg, significantly declined using partial or the sum of UPDRS Parts I and II. There was no significant difference in nilotinib 150 mg versus 300 mg using UPDRS Part III (<i>on</i> levodopa) and total UPDRS Parts I to III. Subgroup analysis showed that late‐start nilotinib 150 mg significantly worsened using the sum of UPDRS Parts II + III and total UPDRS Parts I to III compared with late‐start nilotinib 300 mg. Quality of life using the Parkinson's Disease Questionnaire in nilotinib 150 mg significantly declined between 15 and 27 months compared with nilotinib 300 mg, and there was no change in cognition using the Montreal Cognitive Assessment between groups.</p></div><div class="section" id="mds28389-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65572">This study provides evidence that nilotinib is safe and tolerated in Parkinson's disease. The exploratory clinical data will inform an adequately powered larger study to evaluate the efficacy of nilotinib 300 mg in Parkinson's disease. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-11-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Effect of <i>SMN</i> Gene Dosage on ALS Risk and Disease Severity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033013886-ba37b3b2-5c97-4682-bf07-d5361a81503a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.26009</link>
            <description><![CDATA[<div class="section" id="ana26009-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">The role of the survival of motor neuron (<i>SMN</i>) gene in amyotrophic lateral sclerosis (ALS) is unclear, with several conflicting reports. A decisive result on this topic is needed, given that treatment options are available now for <i>SMN</i> deficiency.</p></div><div class="section" id="ana26009-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65555">In this largest multicenter case control study to evaluate the effect of <i>SMN1</i> and <i>SMN2</i> copy numbers in ALS, we used whole genome sequencing data from Project MinE data freeze 2. <i>SMN</i> copy numbers of 6,375 patients with ALS and 2,412 controls were called from whole genome sequencing data, and the reliability of the calls was tested with multiplex ligation‐dependent probe amplification data.</p></div><div class="section" id="ana26009-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65570">The copy number distribution of <i>SMN1</i> and <i>SMN2</i> between cases and controls did not show any statistical differences (binomial multivariate logistic regression <i>SMN1 p</i> = 0.54 and <i>SMN2 p</i> = 0.49). In addition, the copy number of <i>SMN</i> did not associate with patient survival (Royston‐Parmar; <i>SMN1 p</i> = 0.78 and <i>SMN2 p</i> = 0.23) or age at onset (Royston‐Parmar; <i>SMN1 p</i> = 0.75 and <i>SMN2 p</i> = 0.63).</p></div><div class="section" id="ana26009-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65603">In our well‐powered study, there was no association of SMN1 or SMN2 copy numbers with the risk of ALS or ALS disease severity. This suggests that changing SMN protein levels in the physiological range may not modify ALS disease course. This is an important finding in the light of emerging therapies targeted at SMN deficiencies. ANN NEUROL 2021;89:686–697</p></div>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Large‐Peptide Permeation Through a Membrane Channel: Understanding Protamine Translocation Through CymA from <i>Klebsiella Oxytoca</i>
<a href="#anie202016943-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033007710-a880b1a9-b974-4272-864c-d2bf8072e3a3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016943</link>
            <description><![CDATA[<p class="para" id="N65541">Quantifying the passage of the large peptide protamine (Ptm) across CymA, a passive channel for cyclodextrin uptake, is in the focus of this study. Using a reporter‐pair‐based fluorescence membrane assay we detected the entry of Ptm into liposomes containing CymA. The kinetics of the Ptm entry was independent of its concentration suggesting that the permeation through CymA is the rate‐limiting factor. Furthermore, we reconstituted single CymA channels into planar lipid bilayers and recorded the ion current fluctuations in the presence of Ptm. To this end, we were able to resolve the voltage‐dependent entry of single Ptm peptide molecules into the channel. Extrapolation to zero voltage revealed about 1–2 events per second and long dwell times, in agreement with the liposome study. Applied‐field and steered molecular dynamics simulations added an atomistic view of the permeation events. It can be concluded that a concentration gradient of 1 μ<span style="font-variant: all-small-caps">m</span> Ptm leads to a translocation rate of about one molecule per second and per channel.</p><p class="para" id="N65540">Surprisingly, large peptides (Protamine, 5.1 kDa) can permeate through bacterial outer membrane channels. The use of fluorescence, electrophysiology, and all‐atom modeling allows to quantify the flux. This approach can be transferred to related problems.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033007710-a880b1a9-b974-4272-864c-d2bf8072e3a3/assets/ANIE-60-8089-g001.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[An Unexpected Cubic Symmetry in Group IV Alloys Prepared Using Pressure and Temperature]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766033001311-611a4522-2052-4dbf-89c8-bf6780cd4eae/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016179</link>
            <description><![CDATA[<p class="para" id="N65541">The cubic diamond (<i>Fd</i>
3‾
<i>m</i>) group IVA element Si has been the material driver of the electronics industry since its inception. We report synthesis of a new cubic (<i>Im</i>
3‾
<i>m</i>) group IVA material, a GeSn solid solution, upon heating Ge and Sn at pressures from 13 to 28 GPa using double‐sided diamond anvil laser‐heating and large volume press methods. Both methods were coupled with in situ angle dispersive X‐ray diffraction characterization. The new material substantially enriches the seminal group IVA alloy materials landscape by introducing an eightfold coordinated cubic symmetry, which markedly expands on the conventional tetrahedrally coordinated cubic one. This cubic solid solution is formed, despite Ge never adopting the <i>Im</i>
3‾
<i>m</i> symmetry, melting inhibiting subsequent <i>Im</i>
3‾
<i>m</i> formation and reactant Ge and Sn having unlike crystal structures and atomic radii at all these pressures. This is hence achieved without adherence to conventional formation criteria and routes to synthesis. This advance creates fertile avenues for new materials development.</p><p class="para" id="N65540">New materials can be created without the need to follow conventional criteria and routes to synthesis. We demonstrate this for Ge–Sn, a system actively investigated for optoelectronic applications to overcome conventional cubic Si's deficiencies. Ge and Sn are however unreactive in the bulk, but we remove reactivity barriers and form a different structure, a simple new cubic solid solution.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766033001311-611a4522-2052-4dbf-89c8-bf6780cd4eae/assets/ANIE-60-9009-g001.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Liquid Phase Peptide Synthesis via One‐Pot Nanostar Sieving (PEPSTAR)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766032975902-211aee86-c318-4ddc-a09b-9b4ad6de5e3a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014445</link>
            <description><![CDATA[<p class="para" id="N65541">Herein, a one‐pot liquid phase peptide synthesis featuring iterative addition of amino acids to a “nanostar” support, with organic solvent nanofiltration (OSN) for isolation of the growing peptide after each synthesis cycle is reported. A cycle consists of coupling, Fmoc removal, then sieving out of the reaction by‐products via nanofiltration in a reactor‐separator, or synthesizer apparatus where no phase or material transfers are required between cycles. The three‐armed and monodisperse nanostar facilitates both efficient nanofiltration and real‐time reaction monitoring of each process cycle. This enabled the synthesis of peptides more efficiently while retaining the full benefits of liquid phase synthesis. PEPSTAR was validated initially with the synthesis of enkephalin‐like model penta‐ and decapeptides, then octreotate amide and finally octreotate. The crude purities compared favorably to vendor produced samples from solid phase synthesis.</p><p class="para" id="N65540">PEPSTAR, a “rising star” in peptide synthesis, features a “nanostar” support to grow peptides with organic solvent nanofiltration for isolation. The three‐armed and monodisperse nanostar enables efficient nanofiltration and real‐time reaction monitoring. A cycle consists of coupling, Fmoc removal and nanofiltration, which all performed continuously in a synthesizer to produce high purity peptide crudes through a one‐pot approach.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766032975902-211aee86-c318-4ddc-a09b-9b4ad6de5e3a/assets/ANIE-60-7786-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766032970034-d55a4466-94bf-49a1-8e6a-15ec89620469/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28382</link>
            <description><![CDATA[<div class="section" id="mds28382-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">No clinical trials have been specifically designed to compare medical treatments after surgery in Parkinson's disease (PD).</p></div><div class="section" id="mds28382-sec-0002"><h3 class="BHead" id="nov000-2">Objective</h3><p class="para" id="N65551">Study's objective was to compare the efficacy and safety of levodopa versus dopamine agonist monotherapy after deep brain stimulation (DBS) in PD.</p></div><div class="section" id="mds28382-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">Thirty‐five surgical candidates were randomly assigned to receive postoperative monotherapy with either levodopa or dopamine agonist in a randomized, single‐blind study. All patients were reevaluated in short‐ (3 months), mid‐ (6 months), and long‐term (2.5 years) follow‐up after surgery. The primary outcome measure was the change in the Non‐Motor Symptoms Scale (NMSS) 3 months after surgery. Secondary outcome measures were the percentage of patients maintaining monotherapy, change in motor symptoms, and specific non‐motor symptoms (NMS). Analysis was performed primarily in the intention‐to‐treat population.</p></div><div class="section" id="mds28382-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">Randomization did not significantly affect the primary outcome (difference in NMSS between treatment groups was 4.88 [95% confidence interval: −11.78–21.53, <i>P</i> = 0.566]). In short‐ and mid‐term follow‐up, monotherapy was safe and feasible in more than half of patients (60% in short‐ and 51.5% in mid‐term follow‐up), but it was more often possible for patients on levodopa. The ability to maintain dopamine agonist monotherapy was related to optimal contact location. In the long term, levodopa monotherapy was feasible only in a minority of patients (34.2%), whereas dopamine agonist monotherapy was not tolerated due to worsening of motor conditions or occurrence of impulse control disorders.</p></div><div class="section" id="mds28382-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65572">This trial provides evidence for simplifying pharmacological treatment after functional neurosurgery for PD. The reduction in dopamine receptor agonists should be attempted while monitoring for occurrence of NMSs, such as apathy and sleep disturbances. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fungal Dioxygenase AsqJ Is Promiscuous and Bimodal: Substrate‐Directed Formation of Quinolones versus Quinazolinones]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766032928437-5e6f3339-9725-4ed6-966b-6c917975903b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202017086</link>
            <description><![CDATA[<p class="para" id="N65541">Previous studies showed that the Fe<sup>II</sup>/α‐ketoglutarate dependent dioxygenase AsqJ induces a skeletal rearrangement in viridicatin biosynthesis in <i>Aspergillus nidulans</i>, generating a quinolone scaffold from benzo[1,4]diazepine‐2,5‐dione substrates. We report that AsqJ catalyzes an additional, entirely different reaction, simply by a change in substituent in the benzodiazepinedione substrate. This new mechanism is established by substrate screening, application of functional probes, and computational analysis. AsqJ excises H<sub>2</sub>CO from the heterocyclic ring structure of suitable benzo[1,4]diazepine‐2,5‐dione substrates to generate quinazolinones. This novel AsqJ catalysis pathway is governed by a single substituent within the complex substrate. This unique substrate‐directed reactivity of AsqJ enables the targeted biocatalytic generation of either quinolones or quinazolinones, two alkaloid frameworks of exceptional biomedical relevance.</p><p class="para" id="N65540">AsqJ catalyzes a complex rearrangement sequence in quinolone biosynthesis. We show the AsqJ biocatalytic potential to significantly exceed this natural function. An unprecedented reaction pathway leading to quinazolinones is uncovered, functionally and mechanistically characterized in detail, revealing a unique substrate‐dependent product selectivity in enzyme catalysis.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766032928437-5e6f3339-9725-4ed6-966b-6c917975903b/assets/ANIE-60-8297-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Chiral Self‐sorting of Giant Cubic [8+12] Salicylimine Cage Compounds]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766032917350-573bdd2f-780d-4451-a905-41d2ca52ffdf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016592</link>
            <description><![CDATA[<p class="para" id="N65541">Chiral self‐sorting is intricately connected to the complicated chiral processes observed in nature and no artificial systems of comparably complexity have been generated by chemists. However, only a few examples of purely organic molecules have been reported so far, where the self‐sorting process could be controlled. Herein, we describe the chiral self‐sorting of large cubic [8+12] salicylimine cage compounds based on a chiral TBTQ precursor. Out of 23 possible cage isomers only the enantiopure and a <i>meso</i> cage were observed to be formed, which have been unambiguously characterized by single crystal X‐ray diffraction. Furthermore, by careful choice of solvent the formation of <i>meso</i> cage could be controlled. With internal diameters of <i>d</i>
<sub>in</sub>=3.3–3.5 nm these cages are among the largest organic cage compounds characterized and show very high specific surface areas up to approx. 1500 m<sup>2</sup> g<sup>−1</sup> after desolvation.</p><p class="para" id="N65540">Highly selective chiral self‐sorting. The chiral self‐sorting behavior of large cubic [8+12] salicylimine cage compounds was investigated, revealing a high selectivity for the most symmetric cage compounds, for which an explanation is presented. The properties of the isolated enantiopure and <i>meso</i> cage compounds were investigated by single crystal X‐ray diffraction and gas sorption measurements showing high porosities and selectivities.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766032917350-573bdd2f-780d-4451-a905-41d2ca52ffdf/assets/ANIE-60-8896-g011.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[“NAD‐display”: Ultrahigh‐Throughput in Vitro Screening of NAD(H) Dehydrogenases Using Bead Display and Flow Cytometry]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766031764909-e0a38677-2666-4720-b340-a3b21abdc111/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013486</link>
            <description><![CDATA[<p class="para" id="N65541">NAD(H)‐utiliing enzymes have been the subject of directed evolution campaigns to improve their function. To enable access to a larger swath of sequence space, we demonstrate the utility of a cell‐free, ultrahigh‐throughput directed evolution platform for dehydrogenases. Microbeads (1.5 million per sample) carrying both variant DNA and an immobilised analogue of NAD<sup>+</sup> were compartmentalised in water‐in‐oil emulsion droplets, together with cell‐free expression mixture and enzyme substrate, resulting in the recording of the phenotype on each bead. The beads’ phenotype could be read out and sorted for on a flow cytometer by using a highly sensitive fluorescent protein‐based sensor of the NAD<sup>+</sup>:NADH ratio. Integration of this “NAD‐display” approach with our previously described Split &amp; Mix (SpliMLiB) method for generating large site‐saturation libraries allowed straightforward screening of fully balanced site saturation libraries of formate dehydrogenase, with diversities of 2×10<sup>4</sup>. Based on modular design principles of synthetic biology NAD‐display offers access to sophisticated in vitro selections, avoiding complex technology platforms.</p><p class="para" id="N65540">A detection system was devised to screen dehydrogenase enzymes (DH) at ultrahigh‐throughput in in vitro droplet compartments. An NAD(H) analogue and a DH DNA library were co‐immobilised on beads. Water‐in‐oil emulsion droplets containing cell‐free expression mix and substrate allow compartmentalised protein production and catalysis. A fluorescent sensor of NAD(H) redox state was loaded onto beads, allowing bulk sorting of 2×10<sup>4</sup> DH variants in a day by flow cytometry.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766031764909-e0a38677-2666-4720-b340-a3b21abdc111/assets/ANIE-60-9015-g002.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Practical and Selective sp<sup>3</sup> C−H Bond Chlorination via Aminium Radicals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030392622-b885b226-1848-46ba-8b19-906bbe78551d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202100030</link>
            <description><![CDATA[<p class="para" id="N65541">The introduction of chlorine atoms into organic molecules is fundamental to the manufacture of industrial chemicals, the elaboration of advanced synthetic intermediates and also the fine‐tuning of physicochemical and biological properties of drugs, agrochemicals and polymers. We report here a general and practical photochemical strategy enabling the site‐selective chlorination of sp<sup>3</sup> C−H bonds. This process exploits the ability of protonated <i>N</i>‐chloroamines to serve as aminium radical precursors and also radical chlorinating agents. Upon photochemical initiation, an efficient radical‐chain propagation is established allowing the functionalization of a broad range of substrates due to the large number of compatible functionalities. The ability to synergistically maximize both polar and steric effects in the H‐atom transfer transition state through appropriate selection of the aminium radical has provided the highest known selectivity in radical sp<sup>3</sup> C−H chlorination.</p><p class="para" id="N65540">Direct and selective sp<sup>3</sup> C−H chlorination has been achieved using a photoinduced strategy. This approach is based on a radical‐chain propagation that exploits the ability of aminium radicals to undergo site‐selective H‐atom transfer (HAT).<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766030392622-b885b226-1848-46ba-8b19-906bbe78551d/assets/ANIE-60-7132-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Tuning the H‐Atom Transfer Reactivity of Iron(IV)‐Oxo Complexes as Probed by Infrared Photodissociation Spectroscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030378989-553d5e2d-ad48-435d-add7-39f99bebc723/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016695</link>
            <description><![CDATA[<p class="para" id="N65541">Reactivities of non‐heme iron(IV)‐oxo complexes are mostly controlled by the ligands. Complexes with tetradentate ligands such as [(TPA)FeO]<sup>2+</sup> (TPA=tris(2‐pyridylmethyl)amine) belong to the most reactive ones. Here, we show a fine‐tuning of the reactivity of [(TPA)FeO]<sup>2+</sup> by an additional ligand X (X=CH<sub>3</sub>CN, CF<sub>3</sub>SO<sub>3</sub>
<sup>−</sup>, ArI, and ArIO; ArI=2‐(<sup><i>t</i></sup>BuSO<sub>2</sub>)C<sub>6</sub>H<sub>4</sub>I) attached in solution and reveal a thus far unknown role of the ArIO oxidant. The HAT reactivity of [(TPA)FeO(X)]<sup>+/2+</sup> decreases in the order of X: ArIO &gt; MeCN &gt; ArI ≈ TfO<sup>−</sup>. Hence, ArIO is not just a mere oxidant of the iron(II) complex, but it can also increase the reactivity of the iron(IV)‐oxo complex as a labile ligand. The detected HAT reactivities of the [(TPA)FeO(X)]<sup>+/2+</sup> complexes correlate with the Fe=O and FeO−H stretching vibrations of the reactants and the respective products as determined by infrared photodissociation spectroscopy. Hence, the most reactive [(TPA)FeO(ArIO)]<sup>2+</sup> adduct in the series has the weakest Fe=O bond and forms the strongest FeO−H bond in the HAT reaction.</p><p class="para" id="N65540">The reaction kinetics of H‐atom transfer mediated by iron(IV)oxo complexes with different cis‐ligands can be studied in a modular flow reactor coupled to MS detection. The HAT reactivity correlates with the intrinsic properties of the isolated complexes in the gas phase. A ligand with a larger binding energy forms a more reactive complex for the HAT reactions, has a weaker Fe<sup>I<i>V</i></sup>=O bond, and forms a stronger Fe<sup>III</sup>O−H bond after the HAT reaction.<div class="section"><div class="box" id="N65550"><div class="imageVideo"><img src="/dataresources/secured/content-1766030378989-553d5e2d-ad48-435d-add7-39f99bebc723/assets/ANIE-60-7126-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ruthenium‐Catalyzed Dehydrogenation Through an Intermolecular Hydrogen Atom Transfer Mechanism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030345473-f42da7e5-9c18-48ca-a569-db1abdf9b80a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015837</link>
            <description><![CDATA[<p class="para" id="N65541">The direct dehydrogenation of alkanes is among the most efficient ways to access valuable alkene products. Although several catalysts have been designed to promote this transformation, they have unfortunately found limited applications in fine chemical synthesis. Here, we report a conceptually novel strategy for the catalytic, intermolecular dehydrogenation of alkanes using a ruthenium catalyst. The combination of a redox‐active ligand and a sterically hindered aryl radical intermediate has unleashed this novel strategy. Importantly, mechanistic investigations have been performed to provide a conceptual framework for the further development of this new catalytic dehydrogenation system.</p><p class="para" id="N65540">An approach to the catalytic dehydrogenation of alkanes and heterocycles uses Ru and redox‐active ligands. A wide range of functionalized substrates afforded dehydrogenated products in good yields. Preliminary mechanistic studies suggest that a redox‐active ligand‐assisted intermolecular hydrogen atom transfer is crucial to this process.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030345473-f42da7e5-9c18-48ca-a569-db1abdf9b80a/assets/ANIE-60-7290-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Reduced Nitridogermanates(III) Ca<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] and Sr<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] with Ge−Ge Bonds]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030327506-9142851b-6f16-4768-8166-ddafde939c4b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202017270</link>
            <description><![CDATA[<p class="para" id="N65541">The first nitridogermanates(III) Ca<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] and Sr<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] were synthesized from sodium flux and structurally characterized by powder and single crystal X‐ray diffraction, respectively. They crystallize isostructurally to each other and homeotypic to Ca<sub>6</sub>[Cr<sub>2</sub>N<sub>6</sub>]H in space group <i>R</i>
3‾
. They feature unprecedented, mutually isolated, ethane‐like [Ge<sup>III</sup>
<sub>2</sub>N<sub>6</sub>]<sup>12−</sup> anions in a staggered conformation. The compounds are semiconductors according to resistivity measurements and electronic structure calculations, yielding band gaps of 1.1 eV for Ca<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] and 0.2 eV for Sr<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>].</p><p class="para" id="N65540">The nitridogermanates(III), Ca<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>] and Sr<sub>6</sub>[Ge<sub>2</sub>N<sub>6</sub>], contain the hitherto unknown molecular anion [Ge<sub>2</sub>N<sub>6</sub>]<sup>12−</sup> featuring a Ge−Ge‐bond and thus represent the first members of a novel class of compounds virtually unknown in the nitride chemistry of tetrel elements.<div class="section"><div class="box" id="N65569"><div class="imageVideo"><img src="/dataresources/secured/content-1766030327506-9142851b-6f16-4768-8166-ddafde939c4b/assets/ANIE-60-7691-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cu(OTf)<sub>2</sub>‐Mediated Cross‐Coupling of Nitriles and N‐Heterocycles with Arylboronic Acids to Generate Nitrilium and Pyridinium Products<a href="#anie202016811-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030320286-dbab8bbc-9e28-4174-b4ab-db368fff3555/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016811</link>
            <description><![CDATA[<p class="para" id="N65541">Metal‐catalyzed C–N cross‐coupling generally forms C−N bonds by reductive elimination from metal complexes bearing covalent C‐ and N‐ligands. We have identified a Cu‐mediated C–N cross‐coupling that uses a dative N‐ligand in the bond‐forming event, which, in contrast to conventional methods, generates reactive cationic products. Mechanistic studies suggest the process operates via transmetalation of an aryl organoboron to a Cu<sup>II</sup> complex bearing neutral N‐ligands, such as nitriles or N‐heterocycles. Subsequent generation of a putative Cu<sup>III</sup> complex enables the oxidative C–N coupling to take place, delivering nitrilium intermediates and pyridinium products. The reaction is general for a range of N(sp) and N(sp<sup>2</sup>) precursors and can be applied to drug synthesis and late‐stage N‐arylation, and the limitations in the methodology are mechanistically evidenced.</p><p class="para" id="N65540">Cu(OTf)<sub>2</sub> promotes the oxidative arylation of nitriles and N‐heterocycles to generate ionic products. Mechanistic studies suggest the process operates via reductive elimination from a Cu<sup>III</sup> complex bearing neutral N‐ligands to generate nitrilium and pyridinium products. The reaction is general for a range of N(sp) and N(sp<sup>2</sup>) precursors and can be applied to drug synthesis and late‐stage N‐arylation.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1766030320286-dbab8bbc-9e28-4174-b4ab-db368fff3555/assets/ANIE-60-7935-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Enhanced Concanavalin A Binding to Preorganized Mannose Nanoarrays in Glycodendrimersomes Revealed Multivalent Interactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030307772-2b1e44e2-4adf-40a6-9025-607e500e22fd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202100400</link>
            <description><![CDATA[<p class="para" id="N65541">The effect of the two‐dimensional glycan display on glycan‐lectin recognition remains poorly understood despite the importance of these interactions in a plethora of cellular processes, in (patho)physiology, as well as its potential for advanced therapeutics. Faced with this challenge we utilized glycodendrimersomes, a type of synthetic vesicles whose membrane mimics the surface of a cell and offers a means to probe the carbohydrate biological activity. These single‐component vesicles were formed by the self‐assembly of sequence‐defined mannose‐Janus dendrimers, which serve as surrogates for glycolipids. Using atomic force microscopy and molecular modeling we demonstrated that even mannose, a monosaccharide, was capable of organizing the sugar moieties into periodic nanoarrays without the need of the formation of liquid‐ordered phases as assumed necessary for rafts. Kinetics studies of Concanavalin A binding revealed that those nanoarrays resulted in a new effective ligand yielding a ten‐fold increase in the kinetic and thermodynamic constant of association.</p><p class="para" id="N65540">Multivalent interactions mediated by the cellular glycocalix are ubiquitous in biological processes. We utilized glycodendrimersomes, a type of synthetic cell membrane mimic to probe the carbohydrate biological activity towards lectins. We demonstrated that mannose could organize the sugar moieties into periodic nanoarrays resulting in a new effective ligand yielding a ten‐fold increase in the kinetic and thermodynamic constant of association.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030307772-2b1e44e2-4adf-40a6-9025-607e500e22fd/assets/ANIE-60-8352-g002.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Solid‐State Intramolecular Wittig Reaction Enables Efficient Synthesis of Endofullerenes Including Ne@C<sub>60</sub>, <sup>3</sup>He@C<sub>60</sub>, and HD@C<sub>60</sub>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030300012-3db478f0-9365-4bcc-bf75-3ee93b8e01f3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202100817</link>
            <description><![CDATA[<p class="para" id="N65541">An open‐cage fullerene incorporating phosphorous ylid and carbonyl group moieties on the rim of the orifice can be filled with gases (H<sub>2</sub>, He, Ne) in the solid state, and the cage opening then contracted in situ by raising the temperature to complete an intramolecular Wittig reaction, trapping the atom or molecule inside. Known transformations complete conversion of the product fullerene to C<sub>60</sub> containing the endohedral species. As well as providing an improved synthesis of large quantities of <sup>4</sup>He@C<sub>60</sub>, H<sub>2</sub>@C<sub>60</sub>, and D<sub>2</sub>@C<sub>60</sub>, the method allows the efficient incorporation of expensive gases such as HD and <sup>3</sup>He, to prepare HD@C<sub>60</sub> and <sup>3</sup>He@C<sub>60</sub>. The method also enables the first synthesis of Ne@C<sub>60</sub> by molecular surgery, and its characterization by crystallography and <sup>13</sup>C NMR spectroscopy.</p><p class="para" id="N65540">Solid‐state filling of a stable phosphorus ylid open‐cage fullerene is followed by heating, inducing an in situ intramolecular Wittig reaction to reduce the size of the cage opening and trapping a single gas atom or molecule inside. Expensive gases can be compressed to high pressure, leading to high incorporation of the endohedral species. Cage closure steps allow preparation of gram‐scale endohedral fullerenes including <sup>3</sup>He@C<sub>60</sub>, HD@C<sub>60</sub>, and Ne@C<sub>60</sub>.<div class="section"><div class="box" id="N65554"><div class="imageVideo"><img src="/dataresources/secured/content-1766030300012-3db478f0-9365-4bcc-bf75-3ee93b8e01f3/assets/ANIE-60-8960-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Silver‐Catalyzed Enantioselective Sulfimidation Mediated by Hydrogen Bonding Interactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030290395-c89e0870-eb2a-435c-a820-8a4481bd6540/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016561</link>
            <description><![CDATA[<p class="para" id="N65541">An enantioselective sulfimidation of 3‐thiosubstituted 2‐quinolones and 2‐pyridones was achieved with a stoichiometric nitrene source (PhI=NNs) and a silver‐based catalyst system. Key to the success of the reaction is the use of a chiral phenanthroline ligand with a hydrogen bonding site. The enantioselectivity does not depend on the size of the two substituents at the sulfur atom but only on the binding properties of the heterocyclic lactams. A total of 21 chiral sulfimides were obtained in high yields (44–99 %) and with significant enantiomeric excess (70–99 % <i>ee</i>). The sulfimidation proceeds with high site‐selectivity and can also be employed for the kinetic resolution of chiral sulfoxides. Mechanistic evidence suggests the intermediacy of a heteroleptic silver complex, in which the silver atom is bound to one molecule of the chiral ligand and one molecule of an achiral 1,10‐phenanthroline. Support for the suggested reaction course was obtained by ESI mass spectrometry, DFT calculations, and a Hammett analysis.</p><p class="para" id="N65540">A picky ligand: A chiral phenanthroline ligand allows for the site‐ and enantioselective imidation (Ns=<i>para</i>‐nitrosulfonyl) of a variety of sulfides. Silver acts in concert with an achiral 1,10‐phenanthroline (1,10‐phen) ligand as the catalytically active center.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1766030290395-c89e0870-eb2a-435c-a820-8a4481bd6540/assets/ANIE-60-7920-g012.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mixed Noble‐Gas Compounds of Krypton(II) and Xenon(VI); [F<sub>5</sub>Xe(FKrF)AsF<sub>6</sub>] and [F<sub>5</sub>Xe(FKrF)<sub>2</sub>AsF<sub>6</sub>]]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030284085-07fd18d9-cb2b-49be-9c9c-6a801bba8cc7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014682</link>
            <description><![CDATA[<p class="para" id="N65541">The coordination chemistry of KrF<sub>2</sub> has been limited in contrast with that of XeF<sub>2</sub>, which exhibits a far richer coordination chemistry with main‐group and transition‐metal cations. In the present work, reactions of [XeF<sub>5</sub>][AsF<sub>6</sub>] with KrF<sub>2</sub> in anhydrous HF solvent afforded [F<sub>5</sub>Xe(FKrF)AsF<sub>6</sub>] and [F<sub>5</sub>Xe(FKrF)<sub>2</sub>AsF<sub>6</sub>], the first mixed krypton/xenon compounds. X‐ray crystal structures and Raman spectra show the KrF<sub>2</sub> ligands and [AsF<sub>6</sub>]<sup>−</sup> anions are F‐coordinated to the xenon atoms of the [XeF<sub>5</sub>]<sup>+</sup> cations. Quantum‐chemical calculations are consistent with essentially noncovalent ligand−xenon bonds that may be described in terms of σ‐hole bonding. These complexes significantly extend the XeF<sub>2</sub>–KrF<sub>2</sub> analogy and the limited chemistry of krypton by introducing a new class of coordination compound in which KrF<sub>2</sub> functions as a ligand that coordinates to xenon(VI). The HF solvates, [F<sub>5</sub>Xe(FH)AsF<sub>6</sub>] and [F<sub>5</sub>Xe(FH)SbF<sub>6</sub>], are also characterized in this study and they provide rare examples of HF coordinated to xenon(VI).</p><p class="para" id="N65540">KrF<sub>2</sub> and [XeF<sub>5</sub>][AsF<sub>6</sub>] react in anhydrous HF to form [F<sub>5</sub>Xe(FKrF)AsF<sub>6</sub>] and [F<sub>5</sub>Xe(FKrF)<sub>2</sub>AsF<sub>6</sub>]. The complexes were structurally characterized by low‐temperature single‐crystal X‐ray diffraction and Raman spectroscopy. The KrF<sub>2</sub> ligands interact with xenon(VI) through Xe‐ ‐ ‐FKrF secondary bonds that are shown by computational studies to be noncovalent, electrostatic, σ‐hole interactions. The complexes provide unique examples of mixed noble‐gas compounds.<div class="section"><div class="box" id="N65569"><div class="imageVideo"><img src="/dataresources/secured/content-1766030284085-07fd18d9-cb2b-49be-9c9c-6a801bba8cc7/assets/ANIE-60-8149-g002.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Water Mobility in the Interfacial Liquid Layer of Ice/Clay Nanocomposites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030278149-49802844-51b9-48f3-a7a6-760ac0ae927c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013125</link>
            <description><![CDATA[<p class="para" id="N65541">At solid/ice interfaces, a premelting layer is formed at temperatures below the melting point of bulk water. However, the structural and dynamic properties within the premelting layer have been a topic of intense debate. Herein, we determined the translational diffusion coefficient D<sub>t</sub> of water in ice/clay nanocomposites serving as model systems for permafrost by quasi‐elastic neutron scattering. Below the bulk melting point, a rapid decrease of D<sub>t</sub> is found for charged hydrophilic vermiculite, uncharged hydrophilic kaolin, and more hydrophobic talc, reaching plateau values below −4 °C. At this temperature, D<sub>t</sub> in the premelting layer is reduced up to a factor of two compared to supercooled bulk water. Adjacent to charged vermiculite the lowest water mobility was observed, followed by kaolin and the more hydrophobic talc. Results are explained by the intermolecular water interactions with different clay surfaces and interfacial segregation of the low‐density liquid water (LDL) component.</p><p class="para" id="N65540">Using quasi‐elastic neutron scattering (QENS), the mobility of water molecules confined in the premelting layer of three different ice/clay nanocomposites is quantified. Layers of low‐density liquid water are formed adjacent to ice Ih and clay mineral interfaces. This leads to a reduction of the translational diffusion coefficient within the premelting layer.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030278149-49802844-51b9-48f3-a7a6-760ac0ae927c/assets/ANIE-60-7697-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Photo‐responsive Helical Motion by Light‐Driven Molecular Motors in a Liquid‐Crystal Network]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030266118-1ff959d6-2fe9-4ed9-98e0-fac890d40aa5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016254</link>
            <description><![CDATA[<p class="para" id="N65541">Controlling sophisticated motion by molecular motors is a major goal on the road to future actuators and soft robotics. Taking inspiration from biological motility and mechanical functions common to artificial machines, responsive small molecules have been used to achieve macroscopic effects, however, translating molecular movement along length scales to precisely defined linear, twisting and rotary motions remain particularly challenging. Here, we present the design, synthesis and functioning of liquid‐crystal network (LCN) materials with intrinsic rotary motors that allow the conversion of light energy into reversible helical motion. In this responsive system the photochemical‐driven molecular motor has a dual function operating both as chiral dopant and unidirectional rotor amplifying molecular motion into a controlled and reversible left‐ or right‐handed macroscopic twisting movement. By exploiting the dynamic chirality, directionality of motion and shape change of a single motor embedded in an LC‐network, complex mechanical motions including bending, walking and helical motion, in soft polymer materials are achieved which offers fascinating opportunities toward inherently photo‐responsive materials.</p><p class="para" id="N65540">By exploiting the dynamic chirality, directionality of motion and shape change of a single light‐driven motor embedded in a liquid‐crystal network, complex mechanical motions including bending, walking and helical motion, in soft polymer materials are achieved which offers fascinating opportunities toward inherently photo‐responsive materials.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030266118-1ff959d6-2fe9-4ed9-98e0-fac890d40aa5/assets/ANIE-60-8251-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Protic Ionic Liquid as Reagent, Catalyst, and Solvent: 1‐Methylimidazolium Thiocyanate]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030256032-1e6a8bcb-4521-4ffe-a515-fe5e4a893117/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016593</link>
            <description><![CDATA[<p class="para" id="N65541">We propose a new concept of the triple role of protic ionic liquids with nucleophilic anions: a) a regenerable solvent, b) a Brønsted acid inducing diverse transformations via general acid catalysis, and c) a source of a nucleophile. The efficiency of this strategy was demonstrated using thiocyanate‐based protic ionic liquids for the ring‐opening of donor‐acceptor cyclopropanes. A wide variety of activated cyclopropanes were found to react with 1‐methylimidazolium thiocyanate under mild metal‐free conditions via unusual nitrogen attack of the ambident thiocyanate ion on the electrophilic center of the three‐membered ring affording pyrrolidine‐2‐thiones bearing donor and acceptor substituents at the C(5) and C(3) atoms, respectively, in a single time‐efficient step. The ability of 1‐methylimidazolium thiocyanate to serve as a triplex reagent was exemplarily illustrated by (4+2)‐annulation with 1‐acyl‐2‐(2‐hydroxyphenyl)cyclopropane, epoxide ring‐opening and other organic transformations.</p><p class="para" id="N65540">A resplendent trio: Protic ionic liquids (PILs) with nucleophilic anions served in concert as regenerable reaction medium, Brønsted acid, and a source of nucleophile. Heating of donor–acceptor cyclopropanes with 1‐methylimidazolium thiocyanate (B:⋅HNCS) afforded products of formal (3+2)‐ and (4+2)‐cycloaddition of isothiocyanic acid.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030256032-1e6a8bcb-4521-4ffe-a515-fe5e4a893117/assets/ANIE-60-7927-g001.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Chemically Fueled Volume Phase Transition of Polyacid Microgels]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030213261-5b4c1649-4053-4826-8816-6a1e0c82b1e2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014417</link>
            <description><![CDATA[<p class="para" id="N65541">Microgels are soft colloids that show responsive behavior and are easy to functionalize for applications. They are considered key components for future smart colloidal material systems. However, so far microgel systems have almost exclusively been studied in classical responsive switching settings using external triggers, while internally organized, autonomous control mechanisms as found in supramolecular chemistry and DNA nanotechnology relying on fuel‐driven out‐of‐equilibrium concepts have not been implemented into microgel systems. Here, we introduce chemically fueled transient volume phase transitions (VPTs) for poly(methacrylic acid) (PMAA) microgels, where the collapsed hydrophobic state can be programmed using the fuel concentration in a cyclic reaction network. We discuss details of the system behavior as a function of pH and fuel amount, unravel kinetically trapped regions and showcase transient encapsulation and time‐programmed release as a first application.</p><p class="para" id="N65540">Moving past classical passive responsive behavior, transient volume phase transitions of poly(methacrylic acid) microgels can be achieved through the use of a chemical fuel. The deswelling creates a transient hydrophobic environment with a lifetime tunable via pH and fuel concentration with possible applications for encapsulation/release.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030213261-5b4c1649-4053-4826-8816-6a1e0c82b1e2/assets/ANIE-60-7117-g001.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Enzyme‐Loaded Nanoreactors Enable the Continuous Regeneration of Nicotinamide Adenine Dinucleotide in Artificial Metabolisms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030207271-00681674-62a6-4304-a49a-439dd392394f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012023</link>
            <description><![CDATA[<p class="para" id="N65541">Nicotinamide adenine dinucleotide (NAD) is an essential coenzyme for numerous biocatalytic pathways. While in nature, NAD<sup>+</sup> is continuously regenerated from NADH by enzymes, all synthetic NAD<sup>+</sup> regeneration strategies require a continuous supply of expensive reagents and generate byproducts, making these strategies unattractive. In contrast, we present an artificial enzyme combination that produces NAD<sup>+</sup> from oxygen and water continuously; no additional organic substrates are required once a minimal amount pyruvate is supplied. Three enzymes, i.e., LDH, LOX, and CAT, are covalently encapsulated into a substrate‐permeable silica nanoreactor by a mild fluoride‐catalyzed sol–gel process. The enzymes retain their activity inside of the nanoreactors and are protected against proteolysis and heat. We successfully used NAD<sup>+</sup> from the nanoreactors for the continuous production of NAD<sup>+</sup> i) to sense glucose in artificial glucose metabolism, and ii) to reduce the non‐oxygen binding methemoglobin to oxygen‐binding hemoglobin. This latter conversion might be used for the treatment of <i>Methemoglobinemia</i>. We believe that this versatile tool will allow the design of artificial NAD<sup>+</sup>‐dependent metabolisms or NAD<sup>+</sup>‐mediated redox‐reactions.</p><p class="para" id="N65540">The right combination: An artificial enzyme combination is presented that continuously produces NAD<sup>+</sup> from oxygen and water and a catalytic amount of pyruvate, without additional substrates and without generating byproducts. Three enzymes are covalently encapsulated into a substrate‐permeable silica nanoreactor by a mild fluoride‐catalyzed sol–gel process. NAD<sup>+</sup> from the nanoreactors was successfully used for the continuous production of NAD<sup>+</sup> for sensing glucose and for rapidly reducing the non‐oxygen binding methemoglobin to oxygen‐binding hemoglobin.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1766030207271-00681674-62a6-4304-a49a-439dd392394f/assets/ANIE-60-7728-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Unconventional Photocatalysis in Conductive Polymers: Reversible Modulation of PEDOT:PSS Conductivity by Long‐Lived Poly(Heptazine Imide) Radicals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030137859-1975738f-42bd-46ee-99f5-1959be89749e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014314</link>
            <description><![CDATA[<p class="para" id="N65541">In photocatalysis, small organic molecules are converted into desired products using light responsive materials, electromagnetic radiation, and electron mediators. Substitution of low molecular weight reagents with redox active functional materials may increase the utility of photocatalysis beyond organic synthesis and environmental applications. Guided by the general principles of photocatalysis, we design hybrid nanocomposites composed of n‐type semiconducting potassium poly(heptazine imide) (K‐PHI), and p‐type conducting poly(3,4‐ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) as the redox active substrate. Electrical conductivity of the hybrid nanocomposite, possessing optimal K‐PHI content, is reversibly modulated combining a series of external stimuli ranging from visible light under inert conditions and to dark conditions under an O<sub>2</sub> atmosphere. Using a conductive polymer as the redox active substrate allows study of the photocatalytic processes mediated by semiconducting photocatalysts through electrical conductivity measurements.</p><p class="para" id="N65540">A conductive polymer (PEDOT:PSS) and potassium poly(heptazine imide) (K‐PHI) are combined in one hybrid nanocomposite as electron donor and photocatalyst, respectively. The composite represents an example of unconventional photocatalysis: K‐PHI modulates the physicochemical properties of the conductive polymer upon exposure to light and dark in different environments.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030137859-1975738f-42bd-46ee-99f5-1959be89749e/assets/ANIE-60-7436-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Towards Photoswitchable Contrast Agents for Absolute 3D Temperature MR Imaging]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030097265-5b0f97a6-4d49-4196-b74c-62d1e9f5d5d3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202015851</link>
            <description><![CDATA[<p class="para" id="N65541">Temperature can be used as clinical marker for tissue metabolism and the detection of inflammations or tumors. The use of magnetic resonance imaging (MRI) for monitoring physiological parameters like the temperature noninvasively is steadily increasing. In this study, we present a proof‐of‐principle study of MRI contrast agents (CA) for absolute and concentration independent temperature imaging. These CAs are based on azoimidazole substituted Ni<sup>II</sup> porphyrins, which can undergo Light‐Driven Coordination‐Induced Spin State Switching (LD‐CISSS) in solution. Monitoring the fast first order kinetic of back isomerisation (<i>cis</i> to <i>trans</i>) with standard clinical MR imaging sequences allows the determination of half‐lives, that can be directly translated into absolute temperatures. Different temperature responsive CAs were successfully tested as prototypes in methanol‐based gels and created temperature maps of gradient phantoms with high spatial resolution (0.13×0.13×1.1 mm) and low temperature errors (&lt;0.22 °C). The method is sufficiently fast to record the temperature flow from a heat source as a film.</p><p class="para" id="N65540">Temperature is a clinical marker for tissue metabolism and can be used for the detection of diseases. Besides intrinsic magnetic resonance (MR) methods for relative temperature changes, there are only limited methods for absolute temperature imaging. In this study we present an in vitro method with a photoswitchable contrast agent for absolute and concentration independent 3D temperature imaging.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030097265-5b0f97a6-4d49-4196-b74c-62d1e9f5d5d3/assets/ANIE-60-8220-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Advanced Real‐Time Process Analytics for Multistep Synthesis in Continuous Flow<a href="#anie202016007-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030086985-bfa01b9b-78cb-43cc-a53e-70ddf272d478/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202016007</link>
            <description><![CDATA[<p class="para" id="N65541">In multistep continuous flow chemistry, studying complex reaction mixtures in real time is a significant challenge, but provides an opportunity to enhance reaction understanding and control. We report the integration of four complementary process analytical technology tools (NMR, UV/Vis, IR and UHPLC) in the multistep synthesis of an active pharmaceutical ingredient, mesalazine. This synthetic route exploits flow processing for nitration, high temperature hydrolysis and hydrogenation reactions, as well as three inline separations. Advanced data analysis models were developed (indirect hard modeling, deep learning and partial least squares regression), to quantify the desired products, intermediates and impurities in real time, at multiple points along the synthetic pathway. The capabilities of the system have been demonstrated by operating both steady state and dynamic experiments and represents a significant step forward in data‐driven continuous flow synthesis.</p><p class="para" id="N65540">Process analytical technologies hold tremendous promise in multistep continuous flow synthesis. Here, four orthogonal real‐time analytical tools are employed in a three step synthesis, with phase separations. Advanced data processing techniques, such as indirect hard modeling and deep learning, facilitate quantification of up to 9 process components. These analytical capabilities are demonstrated for both steady state and dynamic experiments.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030086985-bfa01b9b-78cb-43cc-a53e-70ddf272d478/assets/ANIE-60-8139-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient‐Derived Neurons]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030052600-2b9087ea-d67e-4c6b-a0be-1fe6469bfc12/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28365</link>
            <description><![CDATA[<div class="section" id="mds28365-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">VPS35 is part of the retromer complex and is responsible for the trafficking and recycling of proteins implicated in autophagy and lysosomal degradation, but also takes part in the degradation of mitochondrial proteins via mitochondria‐derived vesicles. The p.D620N mutation of <i>VPS35</i> causes an autosomal‐dominant form of Parkinson's disease (PD), clinically representing typical PD.</p></div><div class="section" id="mds28365-sec-0002"><h3 class="BHead" id="nov000-2">Objective</h3><p class="para" id="N65554">Most of the studies on p.D620N VPS35 were performed on human tumor cell lines, rodent models overexpressing mutant VPS35, or in patient‐derived fibroblasts. Here, based on identified target proteins, we investigated the implication of mutant VPS35 in autophagy, lysosomal degradation, and mitochondrial function in induced pluripotent stem cell‐derived neurons from a patient harboring the p.D620N mutation.</p></div><div class="section" id="mds28365-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65560">We reprogrammed fibroblasts from a PD patient carrying the p.D620N mutation in the <i>VPS35</i> gene and from two healthy donors in induced pluripotent stem cells. These were subsequently differentiated into neuronal precursor cells to finally generate midbrain dopaminergic neurons.</p></div><div class="section" id="mds28365-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65569">We observed a decreased autophagic flux and lysosomal mass associated with an accumulation of α‐synuclein in patient‐derived neurons compared to controls. Moreover, patient‐derived neurons presented a mitochondrial dysfunction with decreased membrane potential, impaired mitochondrial respiration, and increased production of reactive oxygen species associated with a defect in mitochondrial quality control via mitophagy.</p></div><div class="section" id="mds28365-sec-0005"><h3 class="BHead" id="nov000-5">Conclusion</h3><p class="para" id="N65575">We describe for the first time the impact of the p.D620N VPS35 mutation on autophago‐lysosome pathway and mitochondrial function in stem cell‐derived neurons from an affected p.D620N carrier and define neuronal phenotypes for future pharmacological interventions. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p></div>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Exclusively Relativistic: Periodic Trends in the Melting and Boiling Points of Group 12]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030008972-f9230621-4d36-4dcf-bb35-b3574f6df1ce/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202100486</link>
            <description><![CDATA[<p class="para" id="N65541">First‐principles simulations can advance our understanding of phase transitions but are often too costly for the heavier elements, which require a relativistic treatment. Addressing this challenge, we recently composed an indirect approach: A precise incremental calculation of absolute Gibbs energies for the solid and liquid with a relativistic Hamiltonian that enables an accurate determination of melting and boiling points (MPs and BPs). Here, we apply this approach to the Group 12 elements Zn, Cd, Hg, and Cn, whose MPs and BPs we calculate with a mean absolute deviation of only 5 % and 1 %, respectively, while we confirm the previously predicted liquid aggregate state of Cn. At a non‐relativistic level of theory, we obtain surprisingly similar MPs and BPs of 650±30 K and 1250±20 K, suggesting that periodic trends in this group are exclusively relativistic in nature. Ultimately, we discuss these results and their implication for Groups 11 and 14.</p><p class="para" id="N65540">Only very recently has it become possible to obtain accurate melting and boiling points from quantum‐chemical simulations. These show that the periodic trends observed for the Group 12 elements are exclusively relativistic in nature, which can be rationalized in terms of the relativistic change in the corresponding cohesive energies.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766030008972-f9230621-4d36-4dcf-bb35-b3574f6df1ce/assets/ANIE-60-7703-g003.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Platinum Dissolution in Realistic Fuel Cell Catalyst Layers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766029955315-af5f2441-9d17-4591-9b31-a6b7709d3900/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014711</link>
            <description><![CDATA[<p class="para" id="N65541">Pt dissolution has already been intensively studied in aqueous model systems and many mechanistic insights have been gained. Nevertheless, transfer of new knowledge to real‐world fuel cell systems is still a significant challenge. To close this gap, we present a novel in situ method combining a gas diffusion electrode (GDE) half‐cell with inductively coupled plasma mass spectrometry (ICP‐MS). With this setup, Pt dissolution in realistic catalyst layers and the transport of dissolved Pt species through Nafion membranes were evaluated directly. We observed that 1) specific Pt dissolution increased significantly with decreasing Pt loading, 2) in comparison to experiments on aqueous model systems with flow cells, the measured dissolution in GDE experiments was considerably lower, and 3) by adding a membrane onto the catalyst layer, Pt dissolution was reduced even further. All these phenomena are attributed to the varying mass transport conditions of dissolved Pt species, influencing re‐deposition and equilibrium potential.</p><p class="para" id="N65540">An in situ technique is presented that closes the gap between catalyst degradation studies in real devices and fundamental electrochemical analyses. The method involves direct measurement of platinum dissolution in realistic catalyst layers and through Nafion membranes. The impact of catalyst loading and electrode–electrolyte interface on platinum dissolution, as well as transport behavior of dissolved Pt species through Nafion membranes, are investigated.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766029955315-af5f2441-9d17-4591-9b31-a6b7709d3900/assets/ANIE-60-8882-g002.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766029936602-ed75dc7c-d3cd-4900-a7ba-652704f65435/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28453</link>
            <description><![CDATA[<div class="section" id="mds28453-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Gait disturbance is an early, disabling feature of Parkinson's disease (PD) that is typically refractory to dopaminergic medication. The cortical cholinergic system, originating in the nucleus basalis of Meynert of the basal forebrain, has been implicated. However, it is not known if degeneration in this region relates to a worsening of disease‐specific gait impairment.</p></div><div class="section" id="mds28453-sec-0002"><h3 class="BHead" id="nov000-2">Objective</h3><p class="para" id="N65551">To evaluate associations between sub‐regional cholinergic basal forebrain volumes and longitudinal progression of gait impairment in PD.</p></div><div class="section" id="mds28453-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">99 PD participants and 47 control participants completed gait assessments via an instrumented walkway during 2 minutes of continuous walking, at baseline and for up to 3 years, from which 16 spatiotemporal characteristics were derived. Sub‐regional cholinergic basal forebrain volumes were measured at baseline via MRI and a regional map derived from post‐mortem histology. Univariate analyses evaluated cross‐sectional associations between sub‐regional volumes and gait. Linear mixed‐effects models assessed whether volumes predicted longitudinal gait changes.</p></div><div class="section" id="mds28453-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">There were no cross‐sectional, age‐independent relationships between sub‐regional volumes and gait. However, nucleus basalis of Meynert volumes predicted longitudinal gait changes unique to PD. Specifically, smaller nucleus basalis of Meynert volume predicted increasing step time variability (<i>P</i> = 0.019) and shortening swing time (<i>P</i> = 0.015); smaller posterior nucleus portions predicted shortening step length (<i>P</i> = 0.007) and increasing step time variability (<i>P</i> = 0.041).</p></div><div class="section" id="mds28453-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65581">This is the first study to demonstrate that degeneration of the cortical cholinergic system predicts longitudinal progression of gait impairments in PD. Measures of this degeneration may therefore provide a novel biomarker for identifying future mobility loss and falls. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p></div><div class="section" id="mds28453-sec-1005"><p class="para" id="N65588">
<div class="section"><div class="box" id="N65590"><div class="imageVideo"><img src="/dataresources/secured/content-1766029936602-ed75dc7c-d3cd-4900-a7ba-652704f65435/assets/MDS-36-611-g003.jpg" alt=""/></div></div></div>
</p></div><p class="para" id="N65540">
<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1766029936602-ed75dc7c-d3cd-4900-a7ba-652704f65435/assets/MDS-36-611-g003.jpg" alt=""/></div></div></div>
</p><p class="para" id="N65552">
March Infographic: Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
</p>]]></description>
            <pubDate><![CDATA[2020-12-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766029909547-59b46bf8-d6bb-45e3-98b0-1f9876e10b8c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.26013</link>
            <description><![CDATA[<div class="section" id="ana26013-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">Diagnosing autoimmune encephalitis (AIE) is difficult in patients with less fulminant diseases such as epilepsy. However, recognition is important, as patients require immunotherapy. This study aims to identify antibodies in patients with focal epilepsy of unknown etiology, and to create a score to preselect patients requiring testing.</p></div><div class="section" id="ana26013-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">In this prospective, multicenter cohort study, adults with focal epilepsy of unknown etiology, without recognized AIE, were included, between December 2014 and December 2017, and followed for 1 year. Serum, and if available cerebrospinal fluid, were analyzed using different laboratory techniques. The ACES score was created using factors favoring an autoimmune etiology of seizures (AES), as determined by multivariate logistic regression. The model was externally validated and evaluated using the Concordance (<i>C</i>) statistic.</p></div><div class="section" id="ana26013-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65558">We included 582 patients, with median epilepsy duration of 8 years (interquartile range = 2–18). Twenty patients (3.4%) had AES, of whom 3 had anti–leucine‐rich glioma inactivated 1, 3 had anti–contactin‐associated protein‐like 2, 1 had anti–N‐methyl‐D‐aspartate receptor, and 13 had anti–glutamic acid decarboxylase 65 (enzyme‐linked immunosorbent assay concentrations &gt;10,000IU/ml). Risk factors for AES were temporal magnetic resonance imaging hyperintensities (odds ratio [OR] = 255.3, 95% confidence interval [CI] = 19.6–3332.2, <i>p</i> &lt; 0.0001), autoimmune diseases (OR = 13.31, 95% CI = 3.1–56.6, <i>p</i> = 0.0005), behavioral changes (OR 12.3, 95% CI = 3.2–49.9, <i>p</i> = 0.0003), autonomic symptoms (OR = 13.3, 95% CI = 3.1–56.6, <i>p</i> = 0.0005), cognitive symptoms (OR = 30.6, 95% CI = 2.4–382.7, <i>p</i> = 0.009), and speech problems (OR = 9.6, 95% CI = 2.0–46.7, <i>p</i> = 0.005). The internally validated <i>C</i> statistic was 0.95, and 0.92 in the validation cohort (n = 128). Assigning each factor 1 point, an antibodies contributing to focal epilepsy signs and symptoms (ACES) score ≥ 2 had a sensitivity of 100% to detect AES, and a specificity of 84.9%.</p></div><div class="section" id="ana26013-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65585">Specific signs point toward AES in focal epilepsy of unknown etiology. The ACES score (cutoff ≥ 2) is useful to select patients requiring antibody testing. ANN NEUROL 2021;89:698–710</p></div>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Closed‐Loop Deep Brain Stimulation for Essential Tremor Based on Thalamic Local Field Potentials]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021597607-0b6c4419-8b52-414b-a985-8f65c7b81b3e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28513</link>
            <description><![CDATA[<div class="section" id="mds28513-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">High‐frequency thalamic stimulation is an effective therapy for essential tremor, which mainly affects voluntary movements and/or sustained postures. However, continuous stimulation may deliver unnecessary current to the brain due to the intermittent nature of the tremor.</p></div><div class="section" id="mds28513-sec-0002"><h3 class="BHead" id="nov000-2">Objective</h3><p class="para" id="N65551">We proposed to close the loop of thalamic stimulation by detecting tremor‐provoking movement states using local field potentials recorded from the same electrodes implanted for stimulation, so that the stimulation is only delivered when necessary.</p></div><div class="section" id="mds28513-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">Eight patients with essential tremor participated in this study. Patient‐specific support vector machine classifiers were first trained using data recorded while the patient performed tremor‐provoking movements. Then, the trained models were applied in real‐time to detect these movements and triggered the delivery of stimulation.</p></div><div class="section" id="mds28513-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">Using the proposed method, stimulation was switched on for 80.37 ± 7.06% of the time when tremor‐evoking movements were present. In comparison, the stimulation was switched on for 12.71 ± 7.06% of the time when the patients were at rest and tremor‐free. Compared with continuous stimulation, a similar amount of tremor suppression was achieved while only delivering 36.62 ± 13.49% of the energy used in continuous stimulation.</p></div><div class="section" id="mds28513-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65569">The results suggest that responsive thalamic stimulation for essential tremor based on tremor‐provoking movement detection can be achieved without any requirement for external sensors or additional electrocorticography strips. Further research is required to investigate whether the decoding model is stable across time and generalizable to the variety of activities patients may engage with in everyday life. © 2021 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2021-02-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Potential‐Dependent Morphology of Copper Catalysts During CO<sub>2</sub> Electroreduction Revealed by In Situ Atomic Force Microscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949043238-1fcb7b10-22d0-4559-9e7b-9e8d1b778129/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010449</link>
            <description><![CDATA[<p class="para" id="N65541">Electrochemical AFM is a powerful tool for the real‐space characterization of catalysts under realistic electrochemical CO<sub>2</sub> reduction (CO<sub>2</sub>RR) conditions. The evolution of structural features ranging from the micrometer to the atomic scale could be resolved during CO<sub>2</sub>RR. Using Cu(100) as model surface, distinct nanoscale surface morphologies and their potential‐dependent transformations from granular to smoothly curved mound‐pit surfaces or structures with rectangular terraces are revealed during CO<sub>2</sub>RR in 0.1 <span style="font-variant: all-small-caps">m</span> KHCO<sub>3</sub>. The density of undercoordinated copper sites during CO<sub>2</sub>RR is shown to increase with decreasing potential. In situ atomic‐scale imaging reveals specific adsorption occurring at distinct cathodic potentials impacting the observed catalyst structure. These results show the complex interrelation of the morphology, structure, defect density, applied potential, and electrolyte in copper CO<sub>2</sub>RR catalysts.</p><p class="para" id="N65540">Copper catalyst for electrochemical CO<sub>2</sub> conversion has been unraveled in situ down to the atomic scale using electrochemical atomic force microscopy under highly gas‐evolving reaction conditions. Oxidized copper surfaces enter different morphological regimes in cathodic potential ranges down to −1.1 V<sub>RHE</sub> coupled with surface reconstructions and varying density of undercoordinated reaction sites.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765949043238-1fcb7b10-22d0-4559-9e7b-9e8d1b778129/assets/ANIE-60-2561-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A phase 1b study of once‐weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949001407-c05f9bda-660f-4faa-93cd-d6bce6cd1270/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ajh.26041</link>
            <description><![CDATA[<p class="para" id="N65541">Twice‐weekly carfilzomib with lenalidomide‐dexamethasone (Rd) is an effective regimen for newly diagnosed multiple myeloma (NDMM). Here we evaluated once‐weekly carfilzomib with Rd (once‐weekly KRd) in NDMM patients. The NDMM patients were enrolled regardless of transplant eligibility. Patients received carfilzomib on days 1, 8, and 15; lenalidomide 25 mg on days 1‐21; and dexamethasone 40 mg on carfilzomib days (also day 22 for cycles 1‐8) for ≤18, 28‐day cycles. Enrollment initiated in a carfilzomib 20/70 mg/m<sup>2</sup> (20 mg/m<sup>2</sup> on cycle one, day 1; 70 mg/m<sup>2</sup> thereafter) NDMM dose‐expansion arm, which was suspended because of serious adverse events. After evaluation of dose‐limiting toxicities in a two‐step‐up dose‐evaluation cohort, an NDMM dose‐expansion arm (carfilzomib 20/56 mg/m<sup>2</sup>) was opened. Fifty‐one NDMM patients were enrolled in dose‐finding and dose‐expansion cohorts. Results are presented for the carfilzomib 56 mg/m<sup>2</sup> NDMM dose‐expansion arm (n = 33). The grade ≥ 3 treatment‐emergent AE (TEAE) rate was 63.6%. Twenty‐five patients underwent stem cell collection; 18 proceeded to auto stem cell transplant, and five resumed KRd on study after autoSCT. The overall response rate (ORR) based on best overall response by cycle four was 97.0% (≥very good partial response [VGPR], 69.7%) in the NDMM 20/56 mg/m<sup>2</sup> cohort. In patients who did not receive autoSCT (n = 15), the median number of cycles was 16.0; ORR was 93.3% (≥VGPR, 80.0%). At a median follow‐up of 8.1 months, median progression‐free survival was not reached. Once‐weekly KRd (carfilzomib 56 mg/m<sup>2</sup>) had a favorable safety profile and promising activity in NDMM, supporting the use of this regimen in this setting.</p>]]></description>
            <pubDate><![CDATA[2020-12-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Autonomous Transient pH Flips Shaped by Layered Compartmentalization of Antagonistic Enzymatic Reactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948766914-de5e8639-d757-47b2-95c3-4a20bb92c3a5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009542</link>
            <description><![CDATA[<p class="para" id="N65541">Transient signaling orchestrates complex spatiotemporal behaviour in living organisms via (bio)chemical reaction networks (CRNs). Compartmentalization of signal processing is an important aspect for controlling such networks. However, artificial CRNs mostly focus on homogeneous solutions to program autonomous self‐assembling systems, which limits their accessible behaviour and tuneability. Here, we introduce layered compartments housing antagonistic pH‐modulating enzymes and demonstrate that transient pH signals in a supernatant solution can be programmed based on spatial delays. This overcomes limitations of activity mismatches of antagonistic enzymes in solution and allows to flexibly program acidic and alkaline pH lifecycles beyond the possibilities of homogeneous solutions. Lag time, lifetime, and the pH minima and maxima can be precisely programmed by adjusting spatial and kinetic conditions. We integrate these spatially controlled pH flips with switchable peptides, furnishing time‐programmed self‐assemblies and hydrogel material system.</p><p class="para" id="N65540">Chemical reaction networks based on antagonistic enzymes can show new behaviour when the enzymes are immobilized into layered compartments to impose spatial diffusive constraints. This allows to overcome mismatches of the enzymatic activities and reduces crosstalk in their pH‐dependent activity when targeting pH‐feedback mechanisms to program self‐assembly lifecycles.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765948766914-de5e8639-d757-47b2-95c3-4a20bb92c3a5/assets/ANIE-60-3619-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural Basis of the Modulation of the Voltage‐Gated Calcium Ion Channel Ca<sub>v</sub>1.1 by Dihydropyridine Compounds<a href="#anie202011793-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948433507-1357f8e4-3cd2-4955-9b03-7afa5cadc392/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011793</link>
            <description><![CDATA[<p class="para" id="N65541">1,4‐Dihydropyridines (DHP), the most commonly used antihypertensives, function by inhibiting the L‐type voltage‐gated Ca<sup>2+</sup> (Ca<sub>v</sub>) channels. DHP compounds exhibit chirality‐specific antagonistic or agonistic effects. The structure of rabbit Ca<sub>v</sub>1.1 bound to an achiral drug nifedipine reveals the general binding mode for DHP drugs, but the molecular basis for chiral specificity remained elusive. Herein, we report five cryo‐EM structures of nanodisc‐embedded Ca<sub>v</sub>1.1 in the presence of the bestselling drug amlodipine, a DHP antagonist (<i>R</i>)‐(+)‐Bay K8644, and a titration of its agonistic enantiomer (<i>S</i>)‐(−)‐Bay K8644 at resolutions of 2.9–3.4 Å. The amlodipine‐bound structure reveals the molecular basis for the high efficacy of the drug. All structures with the addition of the Bay K8644 enantiomers exhibit similar inactivated conformations, suggesting that (<i>S</i>)‐(−)‐Bay K8644, when acting as an agonist, is insufficient to lock the activated state of the channel for a prolonged duration.</p><p class="para" id="N65540">High‐resolution cryo‐EM structures of nanodisc‐embedded Ca<sub>v</sub>1.1 in complex with antagonists Levamlodipine, (<i>R</i>)‐(+)‐Bay K8644, and dual agonist/antagonist (<i>S</i>)‐(−)‐Bay K8644 reveal the molecular basis of the allosteric modulation of the voltage‐gated Ca<sup>2+</sup> channel Ca<sub>v</sub>1.1 by dihydropyridine (DHP) drugs. Advanced structural understanding of the stereo‐selective mode of action of DHP will facilitate drug discovery targeting Ca<sub>v</sub> channels.<div class="section"><div class="box" id="N65560"><div class="imageVideo"><img src="/dataresources/secured/content-1765948433507-1357f8e4-3cd2-4955-9b03-7afa5cadc392/assets/ANIE-60-3131-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Wavelength‐Gated Adaptation of Hydrogel Properties via Photo‐Dynamic Multivalency in Associative Star Polymers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948041524-6bd486ed-5f83-4e57-b542-43fa504fafc2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011592</link>
            <description><![CDATA[<p class="para" id="N65541">Responsive materials, such as switchable hydrogels, have been largely engineered for maximum changes between two states. In contrast, adaptive systems target distinct functional plateaus between these maxima. Here, we demonstrate how the photostationary state (<i>PSS</i>) of an <i>E</i>/<i>Z</i>‐arylazopyrazole photoswitch can be tuned by the incident wavelength across a wide color spectrum, and how this behavior can be exploited to engineer the photo‐dynamic mechanical properties of hydrogels based on multivalent photoswitchable interactions. We show that these hydrogels adapt to the wavelength‐dependent <i>PSS</i> and the number of arylazopyrazole units by programmable relationships. Hence, our material design enables the facile adjustment of the mechanical properties without laborious synthetic efforts. The concept goes beyond the classical switching from state A to B, and demonstrates pathways for a truly wavelength‐gated adaptation of hydrogel properties potentially useful to engineer cell fate or in soft robotics.</p><p class="para" id="N65540">Hydrogels adapt to different colors of light: This study introduces how the mechanical properties of photo‐dynamic hydrogels precisely and reversibly adapt to light of different wavelengths by engineering photo‐switchable multivalency effects in star polymer networks.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765948041524-6bd486ed-5f83-4e57-b542-43fa504fafc2/assets/ANIE-60-4358-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Isolation and Reactivity of an Antiaromatic s‐Block Metal Compound]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765947945508-fea116c5-6360-47a5-a40f-467b2f6510cf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014557</link>
            <description><![CDATA[<p class="para" id="N65541">The concepts of aromaticity and antiaromaticity have a long history, and countless demonstrations of these phenomena have been made with molecules based on elements from the p, d, and f blocks of the periodic table. In contrast, the limited oxidation‐state flexibility of the s‐block metals has long stood in the way of their participation in sophisticated π‐bonding arrangements, and truly antiaromatic systems containing s‐block metals are altogether absent or remain poorly defined. Using spectroscopic, structural, and computational techniques, we present herein the synthesis and authentication of a heterocyclic compound containing the alkaline earth metal beryllium that exhibits significant antiaromaticity, and detail its chemical reduction and Lewis‐base‐coordination chemistry.</p><p class="para" id="N65540">Using spectroscopic, structural, and quantum‐chemical methods, a heterocyclic compound containing the alkaline earth metal beryllium was characterized, which exhibits significant antiaromaticity. This species was subjected to chemical reduction and Lewis base coordination.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765947945508-fea116c5-6360-47a5-a40f-467b2f6510cf/assets/ANIE-60-3812-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Directing the Rate‐Enhancement for Hydronium Ion Catalyzed Dehydration via Organization of Alkanols in Nanoscopic Confinements]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765947876867-af9b7ab9-26e7-4cf6-a7ee-d0ed2339f84c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009835</link>
            <description><![CDATA[<p class="para" id="N65541">Alkanol dehydration rates catalyzed by hydronium ions are enhanced by the dimensions of steric confinements of zeolite pores as well as by intraporous intermolecular interactions with other alkanols. The higher rates with zeolite MFI having pores smaller than those of zeolite BEA for dehydration of secondary alkanols, 3‐heptanol and 2‐methyl‐3‐hexanol, is caused by the lower activation enthalpy in the tighter confinements of MFI that offsets a less positive activation entropy. The higher activity in BEA than in MFI for dehydration of a tertiary alkanol, 2‐methyl‐2‐hexanol, is primarily attributed to the reduction of the activation enthalpy by stabilizing intraporous interactions of the C<sub>β</sub>‐H transition state with surrounding alcohol molecules. Overall, we show that the positive impact of zeolite confinements results from the stabilization of transition state provided by the confinement and intermolecular interaction of alkanols with the transition state, which is impacted by both the size of confinements and the structure of alkanols in the E1 pathway of dehydration.</p><p class="para" id="N65540">The van der Waals stabilization of transition states in smaller‐pore MFI zeolites makes secondary alcohols, 3‐heptanol, and 2‐methyl‐3‐hexanol more reactive toward hydronium ion catalyzed elimination than in the sterically larger pore BEA zeolite. Whereas the stabilization of the C<sub>β</sub>‐H transition state provided by intraporous alcohol for 2‐methyl‐2‐hexanol provides an additional stabilization in the sterically larger pore BEA zeolite, making hydronium ions in BEA more reactive than in MFI.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765947876867-af9b7ab9-26e7-4cf6-a7ee-d0ed2339f84c/assets/ANIE-60-2304-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Protofibril–Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946963699-05c55ec9-ce43-4f2c-8cbc-08f0cd18558b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010098</link>
            <description><![CDATA[<p class="para" id="N65541">Amyloid‐β peptides (Aβ) assemble into both rigid amyloid fibrils and metastable oligomers termed AβO or protofibrils. In Alzheimer's disease, Aβ fibrils constitute the core of senile plaques, but Aβ protofibrils may represent the main toxic species. Aβ protofibrils accumulate at the exterior of senile plaques, yet the protofibril–fibril interplay is not well understood. Applying chemical kinetics and atomic force microscopy to the assembly of Aβ and lysozyme, protofibrils are observed to bind to the lateral surfaces of amyloid fibrils. When utilizing Aβ variants with different critical oligomer concentrations, the interaction inhibits the autocatalytic proliferation of amyloid fibrils by secondary nucleation on the fibril surface. Thus, metastable oligomers antagonize their replacement by amyloid fibrils both by competing for monomers and blocking secondary nucleation sites. The protofibril—fibril interaction governs their temporal evolution and potential to exert specific toxic activities.</p><p class="para" id="N65540">Amyloid fibrils preferentially originate from the surface of existing fibrils, as the fibril surface catalyzes the conversion of monomeric precursors in a process called secondary nucleation. Metastable protofibrils, an alternative, particularly toxic, assembly type of amyloid proteins, bind amyloid fibril surfaces and obstruct secondary nucleation. Protofibrils thereby delay their own replacement by amyloid fibrils.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765946963699-05c55ec9-ce43-4f2c-8cbc-08f0cd18558b/assets/ANIE-60-3016-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[An Unexpected Split‐Merge Pathway in the Assembly of the Symmetric Nonribosomal Peptide Antibiotic Closthioamide]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946921645-ab8af787-b9b7-42a0-8907-907af037ea55/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011741</link>
            <description><![CDATA[<p class="para" id="N65541">Closthioamide (CTA) is a symmetric nonribosomal peptide (NRP) comprised of two diaminopropane‐linked polythioamidated monomers. CTA is biosynthesized by Ruminiclostridium cellulolyticum via an atypical NRP synthetase (NRPS)‐independent biosynthetic pathway. Although the logic for monomer assembly was recently elucidated, the strategy for the biosynthesis and incorporation of the diamine linker remained a mystery. By means of genome editing, synthesis, and in vitro biochemical assays, we demonstrate that the final steps in CTA maturation proceed through a surprising split‐merge pathway involving the dual use of a thiotemplated intermediate. This pathway includes the first examples of an aldo‐keto reductase catalyzing the reductive release of a thiotemplated product, and of a transthioamidating transglutaminase. In addition to clarifying the remaining steps in CTA assembly, our data shed light on largely unexplored pathways for NRPS‐independent peptide biosynthesis.</p><p class="para" id="N65540">Closthioamide is a symmetric perthioamidated nonribosomal peptide (NRP) produced by an atypical NRP‐synthetase‐independent biosynthetic pathway. Using a combination of genome editing and in vitro biochemical assays, we elucidated the last steps of closthioamide biosynthesis and found an unexpected asymmetrical route involving novel enzyme functions for members of the aldo‐keto reductase and transglutaminase protein families.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765946921645-ab8af787-b9b7-42a0-8907-907af037ea55/assets/ANIE-60-4104-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Probing Local Electrostatics of Glycine in Aqueous Solution by THz Spectroscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946833962-cc0991dd-e63b-44f5-b308-284b600209c6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014133</link>
            <description><![CDATA[<p class="para" id="N65541">Based upon precise terahertz (THz) measurements of the solvated amino acid glycine and accompanying ab‐initio molecular‐dynamics simulations, we show that the N‐C‐C‐O open/close mode at 315 cm<sup>−1</sup> serves as a sensitive, label‐free probe for the local protonation of the amide group. Experimentally, we can show that this holds not only for glycine but also for diglycine and valine. The approach is more general, since the changes due to protonation result in intensity changes which can be probed by THz time domain (0–50 cm<sup>−1</sup>) as well as by precise THz‐FT spectroscopy (50–400 cm<sup>−1</sup>). A detailed analysis allows us to directly correlate the titration spectra with p<i>K</i>
<sub>a</sub> values. This demonstrates the potential of THz spectroscopy to probe the charge state of a natural amino acid in water in a label‐free manner.</p><p class="para" id="N65540">Based upon precise terahertz (THz) measurements of the solvated amino acid glycine and accompanying ab‐initio molecular‐dynamics simulations, it is shown that the N‐C‐C‐O open/close mode at 315 cm<sup>−1</sup> serves as a sensitive, label‐free probe for the local protonation of the amide group.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765946833962-cc0991dd-e63b-44f5-b308-284b600209c6/assets/ANIE-60-3768-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Overall Oxygen Electrocatalysis on Nitrogen‐Modified Carbon Catalysts: Identification of Active Sites and In Situ Observation of Reactive Intermediates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946654765-645617e2-17ab-4a80-9f6b-09b153adbc7b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012615</link>
            <description><![CDATA[<p class="para" id="N65541">The recent mechanistic understanding of active sites, adsorbed intermediate products, and rate‐determining steps (RDS) of nitrogen (N)‐modified carbon catalysts in electrocatalytic oxygen reduction (ORR) and oxygen evolution reaction (OER) are still rife with controversy because of the inevitable coexistence of diverse N configurations and the technical limitations for the observation of formed intermediates. Herein, seven kinds of aromatic molecules with designated single N species are used as model structures to investigate the explicit role of each common N group in both ORR and OER. Specifically, dynamic evolution of active sites and key adsorbed intermediate products including O<sub>2</sub> (ads), superoxide anion O<sub>2</sub>
<sup>−</sup>*, and OOH* are monitored with in situ spectroscopy. We propose that the formation of *OOH species from O<sub>2</sub>
<sup>−</sup>* (O<sub>2</sub>
<sup>−</sup>*+H<sub>2</sub>O→OOH*+OH<sup>−</sup>) is a possible RDS during the ORR process, whereas the generation of O<sub>2</sub> from OOH* species is the most likely RDS during the OER process.</p><p class="para" id="N65540">Dynamic evolution of active sites and key oxygen intermediate products during the ORR and OER on N‐doped carbon catalysts are monitored experimentally with in situ ATR‐IR spectra. With the assistance of isotopic labeling, the formation of *OOH species from O<sub>2</sub>
<sup>−</sup>* (O<sub>2</sub>
<sup>−</sup>*+H<sub>2</sub>O→OOH*+OH<sup>−</sup>) is suggested to be a possible RDS during the ORR process, whereas the generation of O<sub>2</sub> from OOH* species is the most possible RDS during the OER process.<div class="section"><div class="box" id="N65563"><div class="imageVideo"><img src="/dataresources/secured/content-1765946654765-645617e2-17ab-4a80-9f6b-09b153adbc7b/assets/ANIE-60-3299-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944284167-6b302f4c-6fc5-4980-b4ac-f5f934fcd1ab/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ajh.26036</link>
            <description><![CDATA[<p class="para" id="N65541">Immune thrombocytopenia (ITP) has a substantial, multifaceted impact on patients' health‐related quality of life (HRQoL). Data describing which aspects of ITP physicians and patients perceive as having the greatest impact are limited. The ITP World Impact Survey (I‐WISh) was a cross‐sectional survey, including 1507 patients and 472 physicians, to establish the impact of ITP on HRQoL and productivity from patient and physician perspectives. Patients reported that ITP reduced their energy levels (85% of patients), capacity to exercise (77%), and limited their ability to perform daily tasks (75%). Eighty percent of physicians reported that ITP symptoms reduced patient HRQoL, with 66% reporting ITP‐related fatigue substantially reduced patient HRQoL. Patients believed ITP had a substantial impact on emotional well‐being (49%) and 63% worried their condition would worsen. Because of ITP, 49% of patients had already reduced, or seriously considered reducing their working hours, and 29% had considered terminating their employment. Thirty‐six percent of patients employed at the time of the survey felt ITP decreased their work productivity, while 51% of patients with high/very high symptom burden reported that ITP affected their productivity. Note, I‐WISh demonstrated substantive impact of ITP on patients' HRQoL both directly for patients and from the viewpoint of their physicians. Patients reported reduced energy levels, expressed fears their condition might worsen, and those who worked experienced reduced productivity. Physicians should be aware not only of platelet counts and bleeding but also the multi‐dimensional impact of ITP on patients' lives as an integral component of disease management.</p>]]></description>
            <pubDate><![CDATA[2020-12-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NHC‐stabilized Parent Arsanylalanes and ‐gallanes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944061527-65bf8462-fdff-4612-a694-80ee8e51abdb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013849</link>
            <description><![CDATA[<p class="para" id="N65541">The synthesis and characterization of the unprecedented compounds IDipp⋅E′H<sub>2</sub>AsH<sub>2</sub> (E′=Al, Ga; IDipp=1,3‐bis(2,6‐diisopropylphenyl)imidazolin‐2‐ylidene) are reported, the first monomeric, parent representatives of an arsanylalane and arsanylgallane, respectively, stabilized only by a LB (LB=Lewis Base). They are prepared by a salt metathesis reaction of KAsH<sub>2</sub> with IDipp⋅E′H<sub>2</sub>Cl (E′=Al, Ga). The H<sub>2</sub>‐elimination pathway through the reaction of AsH<sub>3</sub> with IDipp⋅E′H<sub>3</sub> (E′=Al, Ga) was found to be a possible synthetic route with some disadvantages compared to the salt metathesis reaction. The corresponding organo‐substituted compounds IDipp⋅GaH<sub>2</sub>AsPh<sub>2</sub> (<b>1</b>) and IDipp⋅AlH<sub>2</sub>AsPh<sub>2</sub> (<b>2</b>) were obtained by the reaction of KAsPh<sub>2</sub> with IDipp⋅E′H<sub>2</sub>Cl (E′=Al, Ga). The novel branched parent compounds IDipp⋅E′H(EH<sub>2</sub>)<sub>2</sub> (E′=Al, Ga; E=P, As) were synthesized by salt metathesis reactions starting from IDipp⋅E′HCl<sub>2</sub> (E′=Al, Ga). Supporting DFT computations give insight into the different synthetic pathways and the stability of the products.</p><p class="para" id="N65540">The first parent arsanylalanes and ‐gallanes stabilized only by a Lewis base were synthesized. These compounds are accessible via a salt metathesis reaction of LB⋅E′H<sub>2</sub>Cl and KAsH<sub>2</sub> and a H<sub>2</sub> elimination reaction between LB⋅E′H<sub>3</sub> and AsH<sub>3</sub>, respectively. In addition, the unprecedented branched compounds IDipp⋅E′H(EH<sub>2</sub>)<sub>2</sub> (E′=Al, Ga; E=As, P could be obtained.<div class="section"><div class="box" id="N65563"><div class="imageVideo"><img src="/dataresources/secured/content-1765944061527-65bf8462-fdff-4612-a694-80ee8e51abdb/assets/ANIE-60-3806-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Modular Synthesis of Organoboron Helically Chiral Compounds: Cutouts from Extended Helices]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943872263-78685dbc-94b8-47b7-a0bd-aeb5263acc4b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014138</link>
            <description><![CDATA[<p class="para" id="N65541">Two types of helically chiral compounds bearing one and two boron atoms were synthesized by a modular approach. Formation of the helical scaffolds was executed by the introduction of boron to flexible biaryl and triaryl derived from small achiral building blocks. All‐ortho‐fused azabora[7]helicenes feature exceptional configurational stability, blue or green fluorescence with quantum yields (<i>Φ</i>
<sub>fl</sub>) of 18–24 % in solution, green or yellow solid‐state emission (<i>Φ</i>
<sub>fl</sub> up to 23 %), and strong chiroptical response with large dissymmetry factors of up to 1.12×10<sup>−2</sup>. Azabora[9]helicenes consisting of angularly and linearly fused rings are blue emitters exhibiting <i>Φ</i>
<sub>fl</sub> of up to 47 % in CH<sub>2</sub>Cl<sub>2</sub> and 25 % in the solid state. As revealed by the DFT calculations, their P–M interconversion pathway is more complex than that of <b>H1</b>. Single‐crystal X‐ray analysis shows clear differences in the packing arrangement of methyl and phenyl derivatives. These molecules are proposed as primary structures of extended helices.</p><p class="para" id="N65540">Configurationally stable and flexible organoboron helicenes consisting of either all‐<i>ortho</i>‐fused or a combination of angularly and linearly fused rings were synthesized by a modular approach from small achiral building blocks. A concept towards extended organoboron helices comprising both types of helically chiral compounds as primary substructures is presented.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765943872263-78685dbc-94b8-47b7-a0bd-aeb5263acc4b/assets/ANIE-60-4350-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Metallic Barium: A Versatile and Efficient Hydrogenation Catalyst]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943831275-634c947e-f685-4cab-b0ec-fa7478ffe109/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202014326</link>
            <description><![CDATA[<p class="para" id="N65541">Ba metal was activated by evaporation and cocondensation with heptane. This black powder is a highly active hydrogenation catalyst for the reduction of a variety of unactivated (non‐conjugated) mono‐, di‐ and tri‐substituted alkenes, tetraphenylethylene, benzene, a number of polycyclic aromatic hydrocarbons, aldimines, ketimines and various pyridines. The performance of metallic Ba in hydrogenation catalysis tops that of the hitherto most active molecular group 2 metal catalysts. Depending on the substrate, two different catalytic cycles are proposed. A: a classical metal hydride cycle and B: the Ba metal cycle. The latter is proposed for substrates that are easily reduced by Ba<sup>0</sup>, that is, conjugated alkenes, alkynes, annulated rings, imines and pyridines. In addition, a mechanism in which Ba<sup>0</sup> and BaH<sub>2</sub> are both essential is discussed. DFT calculations on benzene hydrogenation with a simple model system (Ba/BaH<sub>2</sub>) confirm that the presence of metallic Ba has an accelerating effect.</p><p class="para" id="N65540">Just a pinch of Ba metal: Efficient hydrogenation of a wide range of substrates is achieved with metallic barium previously activated by metal vapor synthesis. A mechanism in which Ba<sup>0</sup> and BaH<sub>2</sub> are both essential is discussed.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765943831275-634c947e-f685-4cab-b0ec-fa7478ffe109/assets/ANIE-60-4252-g057.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pathway and Length Control of Supramolecular Polymers in Aqueous Media via a Hydrogen Bonding Lock]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943545065-cfe70c4d-cdd6-47c8-82d0-1205ee2c27ae/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012710</link>
            <description><![CDATA[<p class="para" id="N65541">Programming the organization of π‐conjugated systems into nanostructures of defined dimensions is a requirement for the preparation of functional materials. Herein, we have achieved high‐precision control over the self‐assembly pathways and fiber length of an amphiphilic BODIPY dye in aqueous media by exploiting a programmable hydrogen bonding lock. The presence of a (2‐hydroxyethyl)amide group in the target BODIPY enables different types of intra‐ vs. intermolecular hydrogen bonding, leading to a competition between kinetically controlled discoidal H‐type aggregates and thermodynamically controlled 1D J‐type fibers in water. The high stability of the kinetic state, which is dominated by the hydrophobic effect, is reflected in the slow transformation to the thermodynamic product (several weeks at room temperature). However, this lag time can be suppressed by the addition of seeds from the thermodynamic species, enabling us to obtain supramolecular polymers of tuneable length in water for multiple cycles.</p><p class="para" id="N65540">Length and pathway control of BODIPY‐based supramolecular polymers in aqueous media has been achieved by programmable hydrogen bonding (intra‐ vs. intermolecular) using a new <i>N</i>‐(2‐hydroxyethyl)amide supramolecular synthon as a hydrogen bonding lock. These findings open up new directions in the field of controlled supramolecular polymerization.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765943545065-cfe70c4d-cdd6-47c8-82d0-1205ee2c27ae/assets/ANIE-60-4368-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RNA‐PROTACs: Degraders of RNA‐Binding Proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943532379-1e1fe03c-717a-44f7-a5dc-b8baa9cc29cb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012330</link>
            <description><![CDATA[<p class="para" id="N65541">Defects in the functions of RNA binding proteins (RBPs) are at the origin of many diseases; however, targeting RBPs with conventional drugs has proven difficult. PROTACs are a new class of drugs that mediate selective degradation of a target protein through a cell's ubiquitination machinery. PROTACs comprise a moiety that binds the selected protein, conjugated to a ligand of an E3 ligase. Herein, we introduce RNA‐PROTACs as a new concept in the targeting of RBPs. These chimeric structures employ small RNA mimics as targeting groups that dock the RNA‐binding site of the RBP, whereupon a conjugated E3‐recruiting peptide derived from the HIF‐1α protein directs the RBP for proteasomal degradation. We performed a proof‐of‐concept demonstration with the degradation of two RBPs—a stem cell factor LIN28 and a splicing factor RBFOX1—and showed their use in cancer cell lines. The RNA‐PROTAC approach opens the way to rapid, selective targeting of RBPs in a rational and general fashion.</p><p class="para" id="N65540">RNA‐PROTACs are new chimeric structures that mediate the proteasomal degradation of RNA‐binding proteins (RBP). They comprise an E3‐recruiting peptide conjugated to a short modified RNA, which is iso‐sequential with the native binding element to which the RBP binds in cells. RNA‐PROTACs offer a fast, rational and general approach to target an entire class of protein (RBPs) that has proven difficult until today to target pharmacologically.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765943532379-1e1fe03c-717a-44f7-a5dc-b8baa9cc29cb/assets/ANIE-60-3163-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Discovery and Supramolecular Interactions of Neutral Palladium‐Oxo Clusters Pd<sub>16</sub> and Pd<sub>24</sub>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943292565-3f70173c-e49e-497c-92b0-cdd66aa9fd2e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010690</link>
            <description><![CDATA[<p class="para" id="N65541">We report on the synthesis, structure, and physicochemical characterization of the first three examples of neutral palladium‐oxo clusters (POCs). The 16‐palladium(II)‐oxo cluster [Pd<sub>16</sub>O<sub>24</sub>(OH)<sub>8</sub>((CH<sub>3</sub>)<sub>2</sub>As)<sub>8</sub>] (<b>Pd<sub>16</sub></b>) comprises a cyclic palladium‐oxo unit capped by eight dimethylarsinate groups. The chloro‐derivative [Pd<sub>16</sub>Na<sub>2</sub>O<sub>26</sub>(OH)<sub>3</sub> Cl<sub>3</sub> ((CH<sub>3</sub>)<sub>2</sub> As)<sub>8</sub>] (<b>Pd<sub>16</sub>Cl</b>) was also prepared, which forms a highly stable 3D supramolecular lattice via strong intermolecular interactions. The 24‐palladium(II)‐oxo cluster [Pd<sub>24</sub>O<sub>44</sub>(OH)<sub>8</sub>((CH<sub>3</sub>)<sub>2</sub>As)<sub>16</sub>] (<b>Pd<sub>24</sub></b>) can be considered as a bicapped derivative of <b>Pd<sub>16</sub></b> with a tetra‐palladium‐oxo unit grafted on either side. The three compounds were fully characterized 1) in the solid state by single‐crystal and powder XRD, IR, TGA, and solid‐state <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, 2) in solution by <sup>1</sup>H, <sup>13</sup>C NMR and <sup>1</sup>H DOSY spectroscopic methods, and 3) in the gas phase by electrospray ionization mass spectrometry (ESI‐MS).</p><p class="para" id="N65540">The first three examples of neutral palladium‐oxo clusters (POCs), <b>Pd<sub>16</sub></b>, <b>Pd<sub>16</sub>Cl</b>, and <b>Pd<sub>24</sub></b>, were prepared by simple open‐pot, room‐temperature reactions of palladium(II) salts in sodium dimethylarsinate aqueous solutions. The dimethylarsinate capping groups act as bidentate, monoanionic ligands for the various palladium‐oxo cores. The three POCs were fully characterized in the solid, solution, and gaseous states by a multitude of physicochemical techniques.<div class="section"><div class="box" id="N65558"><div class="imageVideo"><img src="/dataresources/secured/content-1765943292565-3f70173c-e49e-497c-92b0-cdd66aa9fd2e/assets/ANIE-60-3632-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943063809-71c1caf5-efc2-4ced-86e5-64b3ae636820/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ajh.26045</link>
            <description><![CDATA[<p class="para" id="N65541">Immune thrombocytopenia (ITP) is now well‐known to reduce patients' health‐related quality of life. However, data describing which signs and symptoms patients and physicians perceive as having the greatest impact are limited, as is understanding the full effects of ITP treatments. I‐WISh (ITP World Impact Survey) was an exploratory, cross‐sectional survey designed to establish the multifaceted impact of ITP, and its treatments, on patients' lives. It focused on perceptions of 1507 patients and 472 physicians from 13 countries regarding diagnostic pathway, frequency and severity of signs and symptoms, and treatment use. Twenty‐two percent of patients experienced delayed diagnosis (caused by several factors), 73% of whom felt anxious as a result. Patients rated fatigue among the most frequent, severe symptom associated with ITP at diagnosis (58% most frequent; 73% most severe), although physicians assigned it lower priority (30%). Fatigue was one of the few symptoms persisting at survey completion (50% and 65%, respectively) and was the top symptom patients wanted resolved (46%). Participating physicians were experienced at treating ITP, thereby recognizing the need to limit corticosteroid use to newly‐diagnosed or first‐relapse patients and espoused increased use of thrombopoietin receptor agonists and anti‐CD20 after relapse in patients with persistent/chronic disease. Patient and physicians were largely aligned on diagnosis, symptoms, and treatment use. I‐WISh demonstrated that patients and physicians largely align on overall ITP symptom burden, with certain differences, for example, fatigue. Understanding the emotional and clinical toll of ITP on the patient will facilitate shared decision‐management, setting and establishment of treatment goals and disease stage‐appropriate treatment selection.</p>]]></description>
            <pubDate><![CDATA[2020-12-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Fluorescence Assisted Capillary Electrophoresis of Glycans Enabled by the Negatively Charged Auxochromes in 1‐Aminopyrenes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943027643-88c5c4e3-fe42-492a-9c40-2cc7c01d0d5d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013187</link>
            <description><![CDATA[<p class="para" id="N65541">A compact and negatively charged acceptor group, <i>N</i>‐(cyanamino)sulfonyl, is introduced for dye design and its influence on the absorption and emission spectra of the “push–pull” chromophores is demonstrated with 1,3,6‐tris[(cyanamino)sulfonyl]‐8‐aminopyrene. The new sulfonamides, including <i>O</i>‐phosphorylated (3‐hydroxyazetidine)‐<i>N</i>‐sulfonyl, are negatively charged electron acceptors and auxochromes. 1‐Aminopyrenes decorated with the new sulfonamides have three or six negative charges (pH ≥8), low <i>m</i>/<i>z</i> ratios, high mobilities in an electric field, and yellow to orange emission. We labeled maltodextrin oligomers by reductive amination, separated the products by electrophoresis, and demonstrated their high brightness in a commercial DNA analyzer and the distribution of the emission signal among the detection channels.</p><p class="para" id="N65540">Negatively charged electron acceptors and auxochromes? New sulfonamides make it possible! 1‐Aminopyrenes decorated with the new sulfonamides had low <i>m</i>/<i>z</i> ratios and high mobility in an electric field. Their glycoconjugates with reducing sugars were separated and detected at sub‐picomolar concentration by multicolor emission in a DNA analyzer (see picture).<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765943027643-88c5c4e3-fe42-492a-9c40-2cc7c01d0d5d/assets/ANIE-60-3720-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942975204-2c76de54-74a7-483d-940f-ff3e38ce2377/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.25956</link>
            <description><![CDATA[<div class="section" id="ana25956-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">Epilepsy develops in 70 to 90% of children with tuberous sclerosis complex (TSC) and is often resistant to medication. Recently, the concept of preventive antiepileptic treatment to modify the natural history of epilepsy has been proposed. EPISTOP was a clinical trial designed to compare preventive versus conventional antiepileptic treatment in TSC infants.</p></div><div class="section" id="ana25956-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">In this multicenter study, 94 infants with TSC without seizure history were followed with monthly video electroencephalography (EEG), and received vigabatrin either as conventional antiepileptic treatment, started after the first electrographic or clinical seizure, or preventively when epileptiform EEG activity before seizures was detected. At 6 sites, subjects were randomly allocated to treatment in a 1:1 ratio in a randomized controlled trial (RCT). At 4 sites, treatment allocation was fixed; this was denoted an open‐label trial (OLT). Subjects were followed until 2 years of age. The primary endpoint was the time to first clinical seizure.</p></div><div class="section" id="ana25956-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">In 54 subjects, epileptiform EEG abnormalities were identified before seizures. Twenty‐seven were included in the RCT and 27 in the OLT. The time to the first clinical seizure was significantly longer with preventive than conventional treatment [RCT: 364 days (95% confidence interval [CI] = 223–535) vs 124 days (95% CI = 33–149); OLT: 426 days (95% CI = 258–628) vs 106 days (95% CI = 11–149)]. At 24 months, our pooled analysis showed preventive treatment reduced the risk of clinical seizures (odds ratio [OR] = 0.21, <i>p</i> = 0.032), drug‐resistant epilepsy (OR = 0.23, <i>p</i> = 0.022), and infantile spasms (OR = 0, <i>p</i> &lt; 0.001). No adverse events related to preventive treatment were noted.</p></div><div class="section" id="ana25956-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65570">Preventive treatment with vigabatrin was safe and modified the natural history of seizures in TSC, reducing the risk and severity of epilepsy. ANN NEUROL 2021;89:304–314</p></div>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Selective Transformation of Nickel‐Bound Formate to CO or C−C Coupling Products Triggered by Deprotonation and Steered by Alkali‐Metal Ions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942900421-56794aad-1500-4abc-aa76-ff5c5ef84c27/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010180</link>
            <description><![CDATA[<p class="para" id="N65541">The complexes [L<sup><i>t</i>Bu</sup>Ni(OCO‐<i>κ</i>
<sup>2</sup>
<i>O</i>,<i>C</i>)]M<sub>3</sub>[N(SiMe<sub>3</sub>)<sub>2</sub>]<sub>2</sub> (M=Li, Na, K), synthesized by deprotonation of a nickel formate complex [L<sup><i>t</i>Bu</sup>NiOOCH] with the corresponding amides M[N(SiMe<sub>3</sub>)<sub>2</sub>], feature a Ni<sup>II</sup>−CO<sub>2</sub>
<sup>2−</sup> core surrounded by Lewis‐acidic cations (M<sup>+</sup>) and the influence of the latter on the behavior and reactivity was studied. The results point to a decrease of CO<sub>2</sub> activation within the series Li, Na, and K, which is also reflected in the reactivity with Me<sub>3</sub>SiOTf leading to the liberation of CO and formation of a Ni−OSiMe<sub>3</sub> complex. Furthermore, in case of K<sup>+</sup>, the {[K<sub>3</sub>[N(SiMe<sub>3</sub>)<sub>2</sub>]<sub>2</sub>}<sup>+</sup> shell around the Ni−CO<sub>2</sub>
<sup>2−</sup> entity was shown to have a large impact on its stabilization and behavior. If the number of K[N(SiMe<sub>3</sub>)<sub>2</sub>] equivalents used in the reaction with [L<sup><i>t</i>Bu</sup>NiOOCH] is decreased from 3 to 0.5, the deprotonated part of the precursor enters a complex reaction sequence with formation of [L<sup><i>t</i>Bu</sup>Ni<sup>I</sup>(μ‐OOCH)Ni<sup>I</sup>L<sup><i>t</i>Bu</sup>]K and [L<sup><i>t</i>Bu</sup>Ni(C<sub>2</sub>O<sub>4</sub>)NiL<sup><i>t</i>Bu</sup>]. The same reaction at higher concentrations additionally led to the formation of a unique hexanuclear Ni<sup>II</sup> complex containing both oxalate and mesoxalate ([O<sub>2</sub>C‐CO<sub>2</sub>‐CO<sub>2</sub>]<sup>4−</sup>) ligands.</p><p class="para" id="N65540">A deceptively simple proton abstraction from nickel‐bound formate not only prepares the resulting CO<sub>2</sub>
<sup>2−</sup> unit for the release of CO in contact with electrophiles but opens up unique complex reaction schemes including reduction of nickel(II) to nickel(I) and coupling of CO<sub>2</sub> units to give oxalate and mesoxalate. Mesoxalate formation from individual CO<sub>2</sub> units is so far unprecedented.<div class="section"><div class="box" id="N65554"><div class="imageVideo"><img src="/dataresources/secured/content-1765942900421-56794aad-1500-4abc-aa76-ff5c5ef84c27/assets/ANIE-60-2312-g014.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reversibly Photo‐Modulating Mechanical Stiffness and Toughness of Bioengineered Protein Fibers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942690384-ccfb6574-2a07-4279-9482-f8c87c195f91/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012848</link>
            <description><![CDATA[<p class="para" id="N65541">Light‐responsive materials have been extensively studied due to the attractive possibility of manipulating their properties with high spatiotemporal control in a non‐invasive fashion. This stimulated the development of a series of photo‐deformable smart devices. However, it remained a challenge to reversibly modulate the stiffness and toughness of bulk materials. Here, we present bioengineered protein fibers and their optomechanical manipulation by employing electrostatic interactions between supercharged polypeptides (SUPs) and an azobenzene (Azo)‐based surfactant. Photo‐isomerization of the Azo moiety from the <i>E</i>‐ to <i>Z</i>‐form reversibly triggered the modulation of tensile strength, stiffness, and toughness of the bulk protein fiber. Specifically, the photo‐induced rearrangement into the <i>Z</i>‐form of Azo possibly strengthened cation–π interactions within the fiber material, resulting in an around twofold increase in the fiber's mechanical performance. The outstanding mechanical and responsive properties open a path towards the development of SUP‐Azo fibers as smart stimuli‐responsive mechano‐biomaterials.</p><p class="para" id="N65540">Bioengineered protein fibers were prepared through electrostatic complexation of a positively charged polypeptide and a negatively charged azobenzene‐based surfactant. The photo‐isomerization of the azobenzene moiety from <i>E</i>‐ to <i>Z</i>‐isomer reversibly triggered a modulation of the bulk protein fiber's mechanical performance.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765942690384-ccfb6574-2a07-4279-9482-f8c87c195f91/assets/ANIE-60-3222-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Visible‐Light‐Promoted Metal‐Free Synthesis of (Hetero)Aromatic Nitriles from C(sp<sup>3</sup>)−H Bonds<a href="#anie202011815-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942683160-8a607909-d859-4ba7-933d-c4df65c9739f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011815</link>
            <description><![CDATA[<p class="para" id="N65541">The metal‐free activation of C(sp<sup>3</sup>)−H bonds to value‐added products is of paramount importance in organic synthesis. We report the use of the commercially available organic dye 2,4,6‐triphenylpyrylium tetrafluoroborate (TPP) for the conversion of methylarenes to the corresponding aryl nitriles via a photocatalytic process. Applying this methodology, a variety of cyanobenzenes have been synthesized in good to excellent yield under metal‐ and cyanide‐free conditions. We demonstrate the scope of the method with over 50 examples including late‐stage functionalization of drug molecules (celecoxib) and complex structures such as <span style="font-variant: all-small-caps">l</span>‐menthol, amino acids, and cholesterol derivatives. Furthermore, the presented synthetic protocol is applicable for gram‐scale reactions. In addition to methylarenes, selected examples for the cyanation of aldehydes, alcohols and oximes are demonstrated as well. Detailed mechanistic investigations have been carried out using time‐resolved luminescence quenching studies, control experiments, and NMR spectroscopy as well as kinetic studies, all supporting the proposed catalytic cycle.</p><p class="para" id="N65540">C(sp<sup>3</sup>)−H bonds have been converted to cyano derivatives under metal‐ and cyanide‐free condition in the presence of visible light and an organic dye. Potential applications of this method in the late‐stage transformation of complex drug molecules, steroid derivatives, and gram‐scale reactions have been described.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765942683160-8a607909-d859-4ba7-933d-c4df65c9739f/assets/ANIE-60-2439-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Arrested Substrate Binding Resolves Catalytic Intermediates in Higher‐Plant Water Oxidation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942567379-72e0a21f-1a7e-44ef-a4e0-71537205e13b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012304</link>
            <description><![CDATA[<p class="para" id="N65541">Among the intermediate catalytic steps of the water‐oxidizing Mn<sub>4</sub>CaO<sub>5</sub> cluster of photosystem II (PSII), the final metastable S<sub>3</sub> state is critically important because it binds one substrate and precedes O<sub>2</sub> evolution. Herein, we combine X‐ and Q‐band EPR experiments on native and methanol‐treated PSII of <i>Spinacia oleracea</i> and show that methanol‐treated PSII preparations of the S<sub>3</sub> state correspond to a previously uncharacterized high‐spin (<i>S=</i>6) species. This is confirmed as a major component also in intact photosynthetic membranes, coexisting with the previously known intermediate‐spin conformation (<i>S=</i>3). The high‐spin intermediate is assigned to a water‐unbound form, with a Mn<sup>IV</sup>
<sub>3</sub> subunit interacting ferromagnetically via anisotropic exchange with a coordinatively unsaturated Mn<sup>IV</sup> ion. These results resolve and define the structural heterogeneity of the S<sub>3</sub> state, providing constraints on the S<sub>3</sub> to S<sub>4</sub> transition, on substrate identity and delivery pathways, and on the mechanism of O−O bond formation.</p><p class="para" id="N65540">Electron paramagnetic resonance spectroscopy reveals that the final metastable catalytic state (S<sub>3</sub>) in biological water oxidation in higher plants is a mixture of a high‐spin and an intermediate‐spin form. These two forms represent distinct structural components related to water binding and activation on the path towards oxygen evolution.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765942567379-72e0a21f-1a7e-44ef-a4e0-71537205e13b/assets/ANIE-60-3156-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Spin‐Controlled Binding of Carbon Dioxide by an Iron Center: Insights from Ultrafast Mid‐Infrared Spectroscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942560756-6a6a841a-f753-499c-b0e2-2ee7b6a16ce1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012739</link>
            <description><![CDATA[<p class="para" id="N65541">The influence of the spin on the mode of binding between carbon dioxide (CO<sub>2</sub>) and a transition‐metal (TM) center is an entirely open question. Herein, we use an iron(III) oxalato complex with nearly vanishing doublet–sextet gap, and its ultrafast photolysis, to generate TM‐CO<sub>2</sub> bonding patterns and determine their structure in situ by femtosecond mid‐infrared spectroscopy. The formation of the nascent TM‐CO<sub>2</sub> species according to [L<sub>4</sub>Fe<sup>III</sup>(C<sub>2</sub>O<sub>4</sub>)]<sup>+</sup> + <i>hν</i> → [L<sub>4</sub>Fe(CO<sub>2</sub>)]<sup>+</sup> + CO<sub>2</sub>, with L<sub>4</sub>=cyclam, is evidenced by the coincident appearance of the characteristic asymmetric stretching absorption of the CO<sub>2</sub>‐ligand between 1600 cm<sup>−1</sup> and 1800 cm<sup>−1</sup> and that of the free CO<sub>2</sub>‐co‐fragment near 2337 cm<sup>−1</sup>. On the high‐spin surface (<i>S</i>=5/2), the product complex features a bent carbon dioxide radical anion ligand that is O‐“end‐on”‐bound to the metal. In contrast, on the intermediate‐spin and low‐spin surfaces, the product exhibits a “side‐on”‐bound, bent carbon dioxide ligand that has either a partial open‐shell (for <i>S</i>=3/2) or fully closed‐shell character (for <i>S</i>=1/2).</p><p class="para" id="N65540">Snapshots from femtosecond mid‐infrared laser spectroscopy reveal spin‐dependent formation of different binding modes of carbon dioxide to a transition‐metal center. The ultrafast excitation of an iron(III) oxalate precursor complex with ultraviolet pulses releases a neutral carbon dioxide molecule within 500 fs and generates a nascent iron‐CO<sub>2</sub>‐primary complex that isomerizes on a picosecond time scale.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765942560756-6a6a841a-f753-499c-b0e2-2ee7b6a16ce1/assets/ANIE-60-2519-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Stiffness Tomography of Ultra‐Soft Nanogels by Atomic Force Microscopy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942283926-c5cdd939-3c0e-4d22-a463-dfdeb86fe0cb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011615</link>
            <description><![CDATA[<p class="para" id="N65541">The softness of nanohydrogels results in unique properties and recently attracted tremendous interest due to the multi‐functionalization of interfaces. Herein, we study extremely soft temperature‐sensitive ultra‐low cross‐linked (ULC) nanogels adsorbed to the solid/water interface by atomic force microscopy (AFM). The ultra‐soft nanogels seem to disappear in classical imaging modes since a sharp tip fully penetrates these porous networks with very low forces in the range of steric interactions (ca. 100 pN). However, the detailed evaluation of Force Volume mode measurements allows us to resolve their overall shape and at the same time their internal structure in all three dimensions. The nanogels exhibit an extraordinary disk‐like and entirely homogeneous but extremely soft structure—even softer than polymer brushes. Moreover, the temperature‐sensitive nanogels can be switched on demand between the ultra‐soft and a very stiff state.</p><p class="para" id="N65540">Extremely soft temperature‐sensitive nanogels adsorbed to the solid/water interface were studied by atomic force microscopy. The ultra‐soft nanogels disappeared in the classical 2D height image. By detailed analysis of Force Volume data the extraordinary disk‐like and entirely homogeneous but extremely soft structure of the nanogels was resolved.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765942283926-c5cdd939-3c0e-4d22-a463-dfdeb86fe0cb/assets/ANIE-60-2280-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress‐Responsive Activation of PERK Signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765941960075-54287d8e-93c8-4b44-acb7-8b0988ebb57f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013915</link>
            <description><![CDATA[<p class="para" id="N65541">Tau protein aggregates are a recognized neuropathological feature in Alzheimer's disease as well as many other neurodegenerative disorders, known as tauopathies. The development of tau‐targeting therapies is therefore extremely important but efficient strategies or protein targets are still unclear. Here, we performed a cell‐based phenotypic screening under endoplasmic reticulum (ER) stress conditions and identified a small molecule, SB1617, capable of suppressing abnormal tau protein aggregation. By applying label‐free target identification technology, we revealed that the transient enhancement of protein kinase‐like endoplasmic reticulum kinase (PERK) signaling pathway through the inhibition of stress‐responsive SB1617 targets, PDIA3 and DNAJC3, is an effective strategy for regulating proteostasis in tauopathies. The molecular mechanism and the promising efficacy of SB1617 were demonstrated in neuronal cells and a mouse model with traumatic brain injury, a tauopathy known to involve ER stress.</p><p class="para" id="N65540">A novel neuroprotective compound, SB1617, was developed via phenotypic assay by image‐based monitoring of tau protein aggregation. Label‐free target identification study revealed that SB1617 inhibits PDIA3 and DNAJC3, thereby regulates tau proteostasis through the activation of PERK signaling pathway in a stress‐responsive manner. The administration of SB1617 showed neuroprotective effects in mice with tauopathy involving ER stress.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765941960075-54287d8e-93c8-4b44-acb7-8b0988ebb57f/assets/ANIE-60-1831-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765938663347-ac333174-91bd-4111-9964-0e4436290c59/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.25934</link>
            <description><![CDATA[<div class="section" id="ana25934-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">Friedreich ataxia (FA) is a progressive genetic neurodegenerative disorder with no approved treatment. Omaveloxolone, an Nrf2 activator, improves mitochondrial function, restores redox balance, and reduces inflammation in models of FA. We investigated the safety and efficacy of omaveloxolone in patients with FA.</p></div><div class="section" id="ana25934-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">We conducted an international, double‐blind, randomized, placebo‐controlled, parallel‐group, registrational phase 2 trial at 11 institutions in the United States, Europe, and Australia (NCT02255435, EudraCT2015‐002762‐23). Eligible patients, 16 to 40 years of age with genetically confirmed FA and baseline modified Friedreich's Ataxia Rating Scale (mFARS) scores between 20 and 80, were randomized 1:1 to placebo or 150mg per day of omaveloxolone. The primary outcome was change from baseline in the mFARS score in those treated with omaveloxolone compared with those on placebo at 48 weeks.</p></div><div class="section" id="ana25934-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">One hundred fifty‐five patients were screened, and 103 were randomly assigned to receive omaveloxolone (n = 51) or placebo (n = 52), with 40 omaveloxolone patients and 42 placebo patients analyzed in the full analysis set. Changes from baseline in mFARS scores in omaveloxolone (−1.55 ± 0.69) and placebo (0.85 ± 0.64) patients showed a difference between treatment groups of –2.40 ± 0.96 (<i>p</i> = 0.014). Transient reversible increases in aminotransferase levels were observed with omaveloxolone without increases in total bilirubin or other signs of liver injury. Headache, nausea, and fatigue were also more common among patients receiving omaveloxolone.</p></div><div class="section" id="ana25934-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65564">In the MOXIe trial, omaveloxolone significantly improved neurological function compared to placebo and was generally safe and well tolerated. It represents a potential therapeutic agent in FA. ANN NEUROL 2021;89:212–225</p></div>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Interfacial Microcompartmentalization by Kinetic Control of Selective Interfacial Accumulation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935989182-e966cb7d-372b-40ec-bcb7-8658a992b3eb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009701</link>
            <description><![CDATA[<p class="para" id="N65541">Reported here is a 2D, interfacial microcompartmentalization strategy governed by 3D phase separation. In aqueous polyethylene glycol (PEG) solutions doped with biotinylated polymers, the polymers spontaneously accumulate in the interfacial layer between the oil‐surfactant‐water interface and the adjacent polymer phase. In aqueous two‐phase systems, these polymers first accumulated in the interfacial layer separating two polymer solutions and then selectively migrated to the oil‐PEG interfacial layer. By using polymers with varying photopolymerizable groups and crosslinking rates, kinetic control and capture of spatial organisation in a variety of compartmentalized macroscopic structures, without the need of creating barrier layers, was achieved. This selective interfacial accumulation provides an extension of 3D phase separation towards synthetic compartmentalization, and is also relevant for understanding intracellular organisation.</p><p class="para" id="N65540">The phenomenon selective interfacial accumulation (SIA) is reported for an aqueous system. Based on interfacial migration, kinetic control and capture of the spatial organisation in a variety of compartmentalized macroscopic structures, without the need to create barrier layers between compartments, is possible. SIA opens an avenue for 3D phase separation approaches towards synthetic compartmentalized systems, and it is also relevant to understanding and mimicking intracellular organisation.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765935989182-e966cb7d-372b-40ec-bcb7-8658a992b3eb/assets/ANIE-59-23748-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Synthesis and Reactivity of Heteroleptic Ga‐P‐C Allyl Cation Analogues]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935934664-7f82df3c-7861-4be2-8bd1-5cfcc9b5c7e0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012595</link>
            <description><![CDATA[<p class="para" id="N65541">Oxidative addition of cyclic alkyl(amino)carbene‐coordinated phosphinidenes (<sup>Me</sup>cAAC)PX to LGa affords gallium‐coordinated phosphinidenes LGa(X)‐P(<sup>Me</sup>cAAC) (L=HC[C(Me)N(2,6‐<i>i</i>‐Pr<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)]<sub>2</sub>; X=Cl <b>1</b>, Br <b>2</b>), which react with NaBAr<sup>F</sup>
<sub>4</sub> and LiAl(OR<sup>F</sup>)<sub>4</sub> to [LGaP(<sup>Me</sup>cAAC)][An] (An=B(C<sub>6</sub>H<sub>3</sub>(CF<sub>3</sub>)<sub>2</sub>)<sub>4</sub>
<b>3</b>, B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>
<b>4</b>, Al(OC(CF<sub>3</sub>)<sub>3</sub>)<sub>4</sub>
<b>5</b>). The cations in <b>3</b>–<b>5</b> show substantial Ga−P double bond character and represent heteronuclear analogues of allyl cations according to quantum chemical calculations. The reaction of <b>4</b> with 4‐dimethylaminopyridine (dmap) to adduct <b>6</b> confirms the strong electrophilic nature of the gallium center, whereas <b>5</b> reacts with ethyl isocyanate with C−C bond formation to the γ‐C atom of the β‐diketiminate ligand and formation of compound <b>7</b>.</p><p class="para" id="N65540">Halide abstraction of L(X)GaP(<sup>Me</sup>cAAC) yielded [LGaP(<sup>Me</sup>cAAC][An] (An=B{C<sub>6</sub>H<sub>3</sub>(CF<sub>3</sub>)<sub>2</sub>}<sub>4</sub>; B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>; Al{OC(CF<sub>3</sub>)<sub>3</sub>}<sub>4</sub>). The cations not only show substantial Ga−P π‐bonding contribution but can also be regarded as heteroallyl cations according to quantum chemical calculations, since the positive charge is shifted via mesomerism.<div class="section"><div class="box" id="N65581"><div class="imageVideo"><img src="/dataresources/secured/content-1765935934664-7f82df3c-7861-4be2-8bd1-5cfcc9b5c7e0/assets/ANIE-60-1986-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Role of the Subthalamic Nucleus in Sequential Working Memory in <i>De Novo</i> Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935929575-68905403-fb00-4174-a165-dc95498429ea/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28344</link>
            <description><![CDATA[<div class="section" id="mds28344-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Deficits in maintaining and manipulating sequential information online can occur even in patients with mild Parkinson's disease. The subthalamic nucleus may play a modulatory role in the neural system for sequential working memory, which also includes the lateral prefrontal cortex.</p></div><div class="section" id="mds28344-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65551">The objective of this study was to investigate neural markers of sequential working memory deficits in patients with de novo Parkinson's disease.</p></div><div class="section" id="mds28344-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">A total of 50 patients with de novo Parkinson's disease and 50 healthy controls completed a digit ordering task during functional magnetic resonance imaging scanning. The task separated the maintenance (“pure recall”) and manipulation of sequences (“reorder &amp; recall” vs “pure recall”).</p></div><div class="section" id="mds28344-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">In healthy controls, individual participants' task accuracy was predicted by the regional activation and functional connectivity of the subthalamic nucleus. Healthy participants who showed lower subthalamic nucleus activation and stronger subthalamic nucleus connectivity with the putamen performed more accurately in maintaining sequences (“pure recall”). Healthy participants who showed greater ordering‐related subthalamic nucleus activation change exhibited smaller accuracy costs in manipulating sequences (“reorder &amp; recall” vs “pure recall”). Patients performed less accurately than healthy controls, especially in “reorder &amp; recall” trials, accompanied by an overactivation in the subthalamic nucleus and a loss of synchrony between the subthalamic nucleus and putamen. Individual patients' task accuracy was predicted only by the subthalamic nucleus connectivity. The contribution of the subthalamic nucleus activation or activation change was absent. We observed no change in the lateral prefrontal cortex.</p></div><div class="section" id="mds28344-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65569">The overactivation and weakened functional connectivity of the subthalamic nucleus are the neural markers of sequential working memory deficits in de novo Parkinson's disease. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-10-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ligand Protonation Triggers H<sub>2</sub> Release from a Dinickel Dihydride Complex to Give a Doubly “T”‐Shaped Dinickel(I) Metallodiradical]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935906202-30df4269-11e8-442a-8fb8-6e865248fa63/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011494</link>
            <description><![CDATA[<p class="para" id="N65541">The dinickel(II) dihydride complex (<b>1<sup>K</sup></b>) of a pyrazolate‐based compartmental ligand with β‐diketiminato (nacnac) chelate arms (L<sup>−</sup>), providing two pincer‐type {N<sub>3</sub>} binding pockets, has been reported to readily eliminate H<sub>2</sub> and to serve as a masked dinickel(I) species. Discrete dinickel(I) complexes (<b>2<sup>Na</sup></b>, <b>2<sup>K</sup></b>) of L<sup>−</sup> are now synthesized via a direct reduction route. They feature two adjacent T‐shaped metalloradicals that are antiferromagnetically coupled, giving an <i>S</i>=0 ground state. The two singly occupied local dx2-y2
type magnetic orbitals are oriented into the bimetallic cleft, enabling metal–metal cooperative 2 e<sup>−</sup> substrate reductions as shown by the rapid reaction with H<sub>2</sub> or O<sub>2</sub>. X‐ray crystallography reveals distinctly different positions of the K<sup>+</sup> in <b>1<sup>K</sup></b> and <b>2<sup>K</sup></b>, suggesting a stabilizing interaction of K<sup>+</sup> with the dihydride unit in <b>1<sup>K</sup></b>. H<sub>2</sub> release from <b>1<sup>K</sup></b> is triggered by peripheral γ‐C protonation at the nacnac subunits, which DFT calculations show lowers the barrier for reductive H<sub>2</sub> elimination from the bimetallic cleft.</p><p class="para" id="N65540">Highly reactive dinickel(I) complexes with an open cleft between two “T”‐shaped metalloradicals are accessible via H<sub>2</sub> release from a dinickel(II) dihydride complex based on a pyrazolate/β‐diketiminato hybrid ligand. The barrier to intramolecular H<sub>2</sub> elimination is drastically lowered by protonation at the ligand periphery.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765935906202-30df4269-11e8-442a-8fb8-6e865248fa63/assets/ANIE-60-1891-g010.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Biomimetic DNA‐Based Membrane Gate for Protein‐Controlled Transport of Cytotoxic Drugs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935633042-6b8037f9-48c4-45c5-9461-cc8cd4a34616/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011583</link>
            <description><![CDATA[<p class="para" id="N65541">Chemistry is ideally placed to replicate biomolecular structures with tuneable building materials. Of particular interest are molecular nanopores, which transport cargo across membranes, as in DNA sequencing. Advanced nanopores control transport in response to triggers, but this cannot be easily replicated with biogenic proteins. Here we use DNA nanotechnology to build a synthetic molecular gate that opens in response to a specific protein. The gate self‐assembles from six DNA strands to form a bilayer‐spanning pore, and a lid strand comprising a protein‐binding DNA aptamer to block the channel entrance. Addition of the trigger protein, thrombin, selectively opens the gate and enables a 330‐fold increase inw the transport rate of small‐molecule cargo. The molecular gate incorporates in delivery vesicles to controllably release enclosed cytotoxic drugs and kill eukaryotic cells. The generically designed gate may be applied in biomedicine, biosensing or for building synthetic cells.</p><p class="para" id="N65540">DNA nanotechnology can be used to rationally design a molecular gate to control the transport of small‐molecule drugs across bilayer membranes. The DNA pore with a thrombin‐binding aptamer lid opens in the presence of thrombin to increase the transport of the cytotoxic drug topotecan by 330‐fold. The nanodevice could be adapted for a range of different protein triggers with applications in biosensing, research, and biomedicine.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765935633042-6b8037f9-48c4-45c5-9461-cc8cd4a34616/assets/ANIE-60-1903-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935587944-540b7dd2-9904-4791-a3c4-9d60a9c763c9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.25951</link>
            <description><![CDATA[<div class="section" id="ana25951-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">This study was undertaken to determine whether a low residual quantity of dystrophin protein is associated with delayed clinical milestones in patients with <i>DMD</i> mutations.</p></div><div class="section" id="ana25951-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65552">We performed a retrospective multicentric cohort study by using molecular and clinical data from patients with <i>DMD</i> mutations registered in the Universal Mutation Database–DMD France database. Patients with intronic, splice site, or nonsense <i>DMD</i> mutations, with available muscle biopsy Western blot data, were included irrespective of whether they presented with severe Duchenne muscular dystrophy (DMD) or milder Becker muscular dystrophy (BMD). Patients were separated into 3 groups based on dystrophin protein levels. Clinical outcomes were ages at appearance of first symptoms; loss of ambulation; fall in vital capacity and left ventricular ejection fraction; interventions such as spinal fusion, tracheostomy, and noninvasive ventilation; and death.</p></div><div class="section" id="ana25951-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65564">Of 3,880 patients with <i>DMD</i> mutations, 90 with mutations of interest were included. Forty‐two patients expressed no dystrophin (group A), and 31 of 42 (74%) developed DMD. Thirty‐four patients had dystrophin quantities &lt; 5% (group B), and 21 of 34 (61%) developed BMD. Fourteen patients had dystrophin quantities ≥ 5% (group C), and all but 4 who lost ambulation beyond 24 years of age were ambulant. Dystrophin quantities of &lt;5%, as low as &lt;0.5%, were associated with milder phenotype for most of the evaluated clinical outcomes, including age at loss of ambulation (<i>p</i> &lt; 0.001).</p></div><div class="section" id="ana25951-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65576">Very low residual dystrophin protein quantity can cause a shift in disease phenotype from DMD toward BMD. ANN NEUROL 2021;89:280–292</p></div>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Association between Computed Tomographic Biomarkers of Cerebral Small Vessel Diseases and Long‐Term Outcome after Spontaneous Intracerebral Hemorrhage]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935555165-b6e3ecc0-4d93-4ce0-9446-efc21e0c7b41/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.25949</link>
            <description><![CDATA[<div class="section" id="ana25949-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">A study was undertaken to assess whether cerebral small vessel disease (SVD) computed tomographic (CT) biomarkers are associated with long‐term outcome after intracerebral hemorrhage.</p></div><div class="section" id="ana25949-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65549">We performed a prospective, community‐based cohort study of adults diagnosed with spontaneous intracerebral hemorrhage between June 1, 2010 and May 31, 2013. A neuroradiologist rated the diagnostic brain CT for acute intracerebral hemorrhage features and SVD biomarkers. We used severity of white matter lucencies and cerebral atrophy, and the number of lacunes to calculate the CT SVD score. We assessed the association between CT SVD biomarkers and either death, or death or dependence (modified Rankin Scale scores = 4–6) 1 year after first‐ever intracerebral hemorrhage using logistic regression, adjusting for known predictors of outcome.</p></div><div class="section" id="ana25949-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65555">Within 1 year of intracerebral hemorrhage, 224 (56%) of 402 patients died. In separate models, 1‐year death was associated with severe atrophy (adjusted odds ratio [aOR] = 2.54, 95% confidence interval [CI] = 1.44–4.49, <i>p</i> = 0.001) but not lacunes or severe white matter lucencies, and CT SVD sum score ≥ 1 (aOR = 2.50, 95% CI = 1.40–4.45, <i>p</i> = 0.002). Two hundred seventy‐seven (73%) of 378 patients with modified Rankin Scale data were dead or dependent at 1 year. In separate models, 1‐year death or dependence was associated with severe atrophy (aOR = 3.67, 95% CI = 1.71–7.89, <i>p</i> = 0.001) and severe white matter lucencies (aOR = 2.18, 95% CI = 1.06–4.51, <i>p</i> = 0.035) but not lacunes, and CT SVD sum score ≥ 1 (aOR = 2.81, 95% CI = 1.45–5.46, <i>p</i> = 0.002).</p></div><div class="section" id="ana25949-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65576">SVD biomarkers on the diagnostic brain CT are associated with 1‐year death and dependence after intracerebral hemorrhage, independent of known predictors of outcome. ANN NEUROL 2021;89:266–279</p></div>]]></description>
            <pubDate><![CDATA[2020-11-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935541063-76cfdba6-ec23-4a9e-ac1e-95890a1fdf4e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28319</link>
            <description><![CDATA[<div class="section" id="mds28319-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Commentators suggest that patients have unrealistic expectations about the pace of research advances and that such expectations interfere with patient decision‐making.</p></div><div class="section" id="mds28319-sec-0002"><h3 class="BHead" id="nov000-2">Objective</h3><p class="para" id="N65551">The objective of this study was to compare expert expectations about the timing of research milestone attainment with those of patients who follow Parkinson's disease (PD) research.</p></div><div class="section" id="mds28319-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">Patients with PD and experts were asked to provide forecasts about 11 milestones in PD research in an online survey. PD experts were identified from a Michael J. Fox Foundation database, highly ranked neurology centers in the United States and Canada, and corresponding authors of articles on PD in top medical journals. Patients with PD were recruited through the Michael J. Fox Foundation. We tested whether patient forecasts differed on average from expert forecasts. We also tested whether differences between patient forecasts and the average expert forecasts were associated with any demographic factors.</p></div><div class="section" id="mds28319-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">A total of 256 patients and 249 PD experts completed the survey. For 9 of the 11 milestones, patients' forecasts were on average higher than those of experts. Only exercise therapy met our 10% difference threshold for practical significance. Education was the only demographic that predicted patient deviations from expert forecasts on milestone forecasts. Patients offered significantly higher forecasts than experts that the clinical trials used in milestone queries would report positive primary outcomes.</p></div><div class="section" id="mds28319-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65569">Differences between patient and expert expectations about research milestones were generally minor, suggesting that there is little cause for concern that patients who follow PD research are unduly swayed by inaccurate representations of research advancement in the media or elsewhere. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-10-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934882823-8ad60f82-d117-4c45-ae07-d7400a0e23c5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28303</link>
            <description><![CDATA[<div class="section" id="mds28303-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Orthostatic hypotension is common in patients with Parkinson's disease (PD). However, it remains unknown whether orthostatic hypotension is a marker of prodromal PD or more advanced disease. The objectives of this study were to assess whether orthostatic hypotension is a prodromal marker of PD in the general population.</p></div><div class="section" id="mds28303-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65551">This study was embedded in the Rotterdam Study, a large prospective population‐based cohort in the Netherlands. We measured orthostatic hypotension in 6910 participants. First, we determined the relation between prevalent PD and orthostatic hypotension using logistic regression. Second, we followed PD‐free participants for the occurrence of PD until 2016 and studied the association between orthostatic hypotension and the risk of PD using Cox proportional hazards models. All models were adjusted for age and sex.</p></div><div class="section" id="mds28303-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65557">At baseline, the mean age ± standard deviation of the study population was 69.0 ± 8.8 years, and 59.1% were women. Orthostatic hypotension was present in 1245 participants (19.8%), and 62 participants (1.0%) had PD at the time of orthostatic hypotension measurement. Participants with PD were significantly more likely to have orthostatic hypotension (odds ratio, 1.88; 95% confidence interval, 1.09–3.24). During a median (interquartile range) follow‐up of 16.1 years (8.5–22.7 years), 122 participants were diagnosed with incident PD. Orthostatic hypotension at baseline was not associated with an increased risk of PD (hazard ratio, 0.97; 95% confidence interval, 0.59–1.58).</p></div><div class="section" id="mds28303-sec-0004"><h3 class="BHead" id="nov000-4">Conclusions</h3><p class="para" id="N65563">Our study suggests that orthostatic hypotension is common in patients with PD, but that orthostatic hypotension is not associated with an increased risk of PD and thus is not a prodromal marker of PD in the general population. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-09-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural Characterization of N‐Linked Glycans in the Receptor Binding Domain of the SARS‐CoV‐2 Spike Protein and their Interactions with Human Lectins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934807708-00bfbe70-516a-4669-a22c-51d81b189226/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011015</link>
            <description><![CDATA[<p class="para" id="N65541">The glycan structures of the receptor binding domain of the SARS‐CoV2 spike glycoprotein expressed in human HEK293F cells have been studied by using NMR. The different possible interacting epitopes have been deeply analysed and characterized, providing evidence of the presence of glycan structures not found in previous MS‐based analyses. The interaction of the RBD <sup>13</sup>C‐labelled glycans with different human lectins, which are expressed in different organs and tissues that may be affected during the infection process, has also been evaluated by NMR. In particular, <sup>15</sup>N‐labelled galectins (galectins‐3, ‐7 and ‐8 N‐terminal), Siglecs (Siglec‐8, Siglec‐10), and C‐type lectins (DC‐SIGN, MGL) have been employed. Complementary experiments from the glycoprotein perspective or from the lectin's point of view have permitted to disentangle the specific interacting epitopes in each case. Based on these findings, 3D models of the interacting complexes have been proposed.</p><p class="para" id="N65540">Unprecedent structural details of the glycans of the RBD of SARS‐CoV‐2 spike glycoprotein have been revealed by NMR spectroscopy. Unexpected and non‐previously reported glycoepitopes have been detected. The interaction of the RBD glycoprotein with diverse human lectins has been scrutinised by exploiting the NMR signature of the <sup>13</sup>C‐glycans. Our analysis permitted to identify the corresponding glycan epitopes responsible for the interaction with each lectin.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765934807708-00bfbe70-516a-4669-a22c-51d81b189226/assets/ANIE-59-23763-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>TAF1</i> Transcripts and Neurofilament Light Chain as Biomarkers for X‐linked Dystonia‐Parkinsonism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934770538-3eb0a107-14f0-4efa-a6c3-236f19931963/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28305</link>
            <description><![CDATA[<div class="section" id="mds28305-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">X‐linked dystonia‐parkinsonism is a rare neurological disease endemic to the Philippines. Dystonic symptoms appear in males at the mean age of 40 years and progress to parkinsonism with degenerative pathology in the striatum. A retrotransposon inserted in intron 32 of the <i>TAF1</i> gene leads to alternative splicing in the region and a reduction of the full‐length mRNA transcript.</p></div><div class="section" id="mds28305-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65554">The objective of this study was to discover cell‐based and biofluid‐based biomarkers for X‐linked dystonia‐parkinsonism.</p></div><div class="section" id="mds28305-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65560">RNA from patient‐derived neural progenitor cells and their secreted extracellular vesicles were used to screen for dysregulation of <i>TAF1</i> expression. Droplet‐digital polymerase chain reaction was used to quantify the expression of <i>TAF1</i> mRNA fragments 5′ and 3′ to the retrotransposon insertion and the disease‐specific splice variant TAF1‐32i in whole‐blood RNA. Plasma levels of neurofilament light chain were measured using single‐molecule array.</p></div><div class="section" id="mds28305-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65572">In neural progenitor cells and their extracellular vesicles, we confirmed that the <i>TAF1</i>‐3′/5′ ratio was lower in patient samples, whereas <i>TAF1</i>‐32i expression is higher relative to controls. In whole‐blood RNA, both TAF1‐3′/5′ ratio and TAF1‐32i expression can differentiate patient (n = 44) from control samples (n = 18) with high accuracy. Neurofilament light chain plasma levels were significantly elevated in patients (n = 43) compared with both carriers (n = 16) and controls (n = 21), with area under the curve of 0.79.</p></div><div class="section" id="mds28305-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65584">
<i>TAF1</i> dysregulation in blood serves as a disease‐specific biomarker that could be used as a readout for monitoring therapies targeting <i>TAF1</i> splicing. Neurofilament light chain could be used in monitoring neurodegeneration and disease progression in patients. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p></div>]]></description>
            <pubDate><![CDATA[2020-09-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Cobalt@Cucurbit[5]uril Complex as a Highly Efficient Supramolecular Catalyst for Electrochemical and Photoelectrochemical Water Splitting]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934717583-2c157895-47de-448f-8dea-3acba890a9b9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011069</link>
            <description><![CDATA[<p class="para" id="N65541">A host–guest complex self‐assembled through Co<sup>2+</sup> and cucurbit[5]uril (Co@CB[5]) is used as a supramolecular catalyst on the surface of metal oxides including porous indium tin oxide (ITO) and porous BiVO<sub>4</sub> for efficient electrochemical and photoelectrochemical water oxidation. When immobilized on ITO, Co@CB[5] exhibited a turnover frequency (TOF) of 9.9 s<sup>−1</sup> at overpotential <i>η</i>=550 mV in a pH 9.2 borate buffer. Meanwhile, when Co@CB[5] complex was immobilized onto the surface of BiVO<sub>4</sub> semiconductor, the assembled Co@CB[5]/BiVO<sub>4</sub> photoanode exhibited a low onset potential of 0.15 V (vs. RHE) and a high photocurrent of 4.8 mA cm<sup>−2</sup> at 1.23 V (vs. RHE) under 100 mW cm<sup>−2</sup> (AM 1.5) light illumination. Kinetic studies confirmed that Co@CB[5] acts as a supramolecular water oxidation catalyst, and can effectively accelerate interfacial charge transfer between BiVO<sub>4</sub> and electrolyte. Surface charge recombination of BiVO<sub>4</sub> can be also significantly suppressed by Co@CB[5].</p><p class="para" id="N65540">A host–guest complex self‐assembled through Co<sup>2+</sup> and cucurbit[5]uril (Co@CB[5]) is used as a supramolecular catalyst on the surface of metal oxides including porous indium tin oxide (ITO) and porous BiVO<sub>4</sub> for efficient electrochemical and photoelectrochemical water oxidation.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765934717583-2c157895-47de-448f-8dea-3acba890a9b9/assets/ANIE-60-1976-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Efficient Chemical Protein Synthesis using Fmoc‐Masked N‐Terminal Cysteine in Peptide Thioester Segments]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934570792-44f90672-d938-4505-ba9e-d2ad1441679e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202000491</link>
            <description><![CDATA[<p class="para" id="N65541">We report an operationally simple method to facilitate chemical protein synthesis by fully convergent and one‐pot native chemical ligations utilizing the fluorenylmethyloxycarbonyl (Fmoc) moiety as an N‐masking group of the N‐terminal cysteine of the middle peptide thioester segment(s). The Fmoc group is stable to the harsh oxidative conditions frequently used to generate peptide thioesters from peptide hydrazide or <i>o</i>‐aminoanilide. The ready availability of Fmoc‐Cys(Trt)‐OH, which is routinely used in Fmoc solid‐phase peptide synthesis, where the Fmoc group is pre‐installed on cysteine residue, minimizes additional steps required for the temporary protection of the N‐terminal cysteinyl peptides. The Fmoc group is readily removed after ligation by short exposure (&lt;7 min) to 20 % piperidine at pH 11 in aqueous conditions at room temperature. Subsequent native chemical ligation reactions can be performed in presence of piperidine in the same solution at pH 7.</p><p class="para" id="N65540">
<b>All in one</b>: Highly efficient multisegment native chemical ligation (NCL) has been developed by exploiting the Fmoc group to temporarily mask the N‐terminal Cys of the peptide thioester fragments. Fmoc removal and NCL are achieved in the same reaction mixture through pH adjustments in presence of 20 % piperidine. The simplicity and inherent robustness of this method make it an attractive approach for the high‐yielding total synthesis of proteins.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765934570792-44f90672-d938-4505-ba9e-d2ad1441679e/assets/ANIE-59-14796-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-05-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Assembly of Complex 1,4‐Cycloheptadienes by (4+3) Cycloaddition of Rhodium(II) and Gold(I) Non‐Acceptor Carbenes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934517206-d57edbc7-5a12-4a18-bb73-a36d9ad44457/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012092</link>
            <description><![CDATA[<p class="para" id="N65541">The formal (4+3) cycloaddition of 1,3‐dienes with Rh(II) and Au(I) non‐acceptor vinyl carbenes, generated from vinylcycloheptatrienes or alkoxyenynes, respectively, leads to 1,4‐cycloheptadienes featuring complex and diverse substitution patterns, including natural dyctiopterene C′ and a hydroxylated derivative of carota‐1,4‐diene. A complete mechanistic picture is presented, in which Au(I) and Rh(II) non‐acceptor vinyl carbenes were shown to undergo a vinylcyclopropanation/Cope rearrangement or a direct (4+3) cycloaddition that takes place in a non‐concerted manner.</p><p class="para" id="N65540">Metal vinyl carbenes generated by retro‐Buchner reaction or an enyne cycloisomerization cascade react with 1,3‐dienes to afford complex 1,4‐cycloheptadienes in a formal (4+3) cycloaddition process. A combination of experiments and computations provides a full mechanistic picture in which two pathways, a vinylcyclopropanation/Cope rearrangement or a non‐concerted (4+3) cycloaddition, can compete depending on the substitution pattern of the substrate.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765934517206-d57edbc7-5a12-4a18-bb73-a36d9ad44457/assets/ANIE-60-1916-g010.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structure Based Design of Bicyclic Peptide Inhibitors of RbAp48]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934499127-31037dfc-16f6-459a-981d-9cac0d42745a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009749</link>
            <description><![CDATA[<p class="para" id="N65541">The scaffolding protein RbAp48 is part of several epigenetic regulation complexes and is overexpressed in a variety of cancers. In order to develop tool compounds for the study of RbAp48 function, we have developed peptide inhibitors targeting the protein–protein interaction interface between RbAp48 and the scaffold protein MTA1. Based on a MTA1‐derived linear peptide with low micromolar affinity and informed by crystallographic analysis, a bicyclic peptide was developed that inhibits the RbAp48/MTA1 interaction with a very low nanomolar <i>K</i>
<sub>D</sub> value of 8.56 nM, and which showed appreciable stability against cellular proteases. Design included exchange of a polar amide cyclization strategy to hydrophobic aromatic linkers enabling mono‐ and bicyclization by means of cysteine alkylation, which improved affinity by direct interaction of the linkers with a hydrophobic residue on RbAp48. Our results demonstrate that stepwise evolution of a structure‐based design is a suitable strategy for inhibitor development targeting PPIs.</p><p class="para" id="N65540">Potent bicyclic peptide inhibitors of the RbAp48‐MTA1 interaction were developed by structure based stepwise optimization of the cyclization linker. The strategy exemplifies design of peptide derived inhibitors of protein–protein interactions involving large surface areas.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765934499127-31037dfc-16f6-459a-981d-9cac0d42745a/assets/ANIE-60-1813-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Closing the Gap for Electronic Short‐Circuiting: Photosystem I Mixed Monolayers Enable Improved Anisotropic Electron Flow in Biophotovoltaic Devices]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934212282-c2968414-faaa-4cbd-a18b-5a8d07a53513/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202008958</link>
            <description><![CDATA[<p class="para" id="N65541">Well‐defined assemblies of photosynthetic protein complexes are required for an optimal performance of semi‐artificial energy conversion devices, capable of providing unidirectional electron flow when light‐harvesting proteins are interfaced with electrode surfaces. We present mixed photosystem I (PSI) monolayers constituted of native cyanobacterial PSI trimers in combination with isolated PSI monomers from the same organism. The resulting compact arrangement ensures a high density of photoactive protein complexes per unit area, providing the basis to effectively minimize short‐circuiting processes that typically limit the performance of PSI‐based bioelectrodes. The PSI film is further interfaced with redox polymers for optimal electron transfer, enabling highly efficient light‐induced photocurrent generation. Coupling of the photocathode with a [NiFeSe]‐hydrogenase confirms the possibility to realize light‐induced H<sub>2</sub> evolution.</p><p class="para" id="N65540">Towards the development of improved biophotovoltaic devices for solar energy conversion, a mixed monolayer constituted by photosystem I trimers and monomers enables the fabrication of highly efficient biophotoelectrodes by minimizing electronic short‐circuiting processes while at the same time ensuring a high density of photoactive molecules per unit area.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765934212282-c2968414-faaa-4cbd-a18b-5a8d07a53513/assets/ANIE-60-2000-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Serious Transport Accidents in Tourette Syndrome or Chronic Tic Disorder]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934007980-384c34af-0afe-4dd3-b76e-dc75c53de1db/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28301</link>
            <description><![CDATA[<div class="section" id="mds28301-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">It is unknown whether individuals with tic disorders are at increased risk for serious transport accidents.</p></div><div class="section" id="mds28301-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65551">The aim of this study was to investigate the risk for injuries or death caused by transport and motor vehicle accidents in individuals with Tourette syndrome or chronic tic disorder.</p></div><div class="section" id="mds28301-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">This population‐based, sibling‐controlled cohort study included all individuals aged ≥18 years living in Sweden between 1997 and 2013 (N = 6,127,290). A total of 3449 individuals had a registered diagnosis of Tourette syndrome or chronic tic disorder in the Swedish National Patient Register. We also identified 2191 families with full siblings discordant for tic disorders. Cox proportional hazards regression modeling was used to estimate the risk for injuries or deaths as a result of transport accidents in individuals with a lifetime diagnosis of Tourette syndrome or chronic tic disorder compared with unexposed individuals and siblings.</p></div><div class="section" id="mds28301-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">Individuals with tic disorders had a higher risk for transport injuries or death compared with the general population (adjusted hazard ratio, 1.50 [95% confidence interval: 1.33–1.69]) and their unaffected siblings (adjusted hazard ratio, 1.41 [95% confidence interval: 1.18–1.68]). The risks were similar across sexes. The exclusion of most psychiatric comorbidities did not alter the magnitude of the estimates. However, the risks were no longer significant after exclusion of individuals with comorbid attention deficit hyperactivity disorder.</p></div><div class="section" id="mds28301-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65569">The marginally increased risk for serious transport accidents in tic disorders is mainly driven by attention deficit hyperactivity disorder comorbidity. Improved detection and management of attention deficit hyperactivity disorder symptoms in this patient group are warranted. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-09-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Tag‐Free Internal RNA Labeling and Photocaging Based on mRNA Methyltransferases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906199534-57b71c74-2d2d-443e-997b-2ad82c5fb8e2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013936</link>
            <description><![CDATA[<p class="para" id="N65541">The mRNA modification N<sup>6</sup>‐methyladenosine (m<sup>6</sup>A) is associated with multiple roles in cell function and disease. The methyltransferases METTL3‐METTL14 and METTL16 act as “writers” for different target transcripts and sequence motifs. The modification is perceived by dedicated “reader” and “eraser” proteins, but not by polymerases. We report that METTL3‐14 shows remarkable cosubstrate promiscuity, enabling sequence‐specific internal labeling of RNA without additional guide RNAs. The transfer of ortho‐nitrobenzyl and 6‐nitropiperonyl groups allowed enzymatic photocaging of RNA in the consensus motif, which impaired polymerase‐catalyzed primer extension in a reversible manner. METTL16 was less promiscuous but suitable for chemo‐enzymatic labeling using different types of click chemistry. Since both enzymes act on distinct sequence motifs, their combination allowed orthogonal chemo‐enzymatic modification of different sites in a single RNA.</p><p class="para" id="N65540">The <i>N</i>
<sup>6</sup>‐methyladenosine (m<sup>6</sup>A) methyltransferase METTL3‐METTL14 shows remarkable cosubstrate promiscuity, enabling sequence‐specific internal labeling of RNA. The transfer of <i>ortho</i>‐nitrobenzyl and 6‐nitropiperonyl groups allows enzymatic photocaging of RNA. METTL16 is less promiscuous but suitable for chemo‐enzymatic labeling via click chemistry. Since both enzymes act on distinct sequence motifs, their combination enables the modification of different sites in a single RNA.<div class="section"><div class="box" id="N65554"><div class="imageVideo"><img src="/dataresources/secured/content-1765906199534-57b71c74-2d2d-443e-997b-2ad82c5fb8e2/assets/ANIE-60-4098-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hydroxylamine‐Derived Reagent as a Dual Oxidant and Amino Group Donor for the Iron‐Catalyzed Preparation of Unprotected Sulfinamides from Thiols]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765853596383-85289b91-7ede-44bc-a273-f779775dabec/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011138</link>
            <description><![CDATA[<p class="para" id="N65541">An iron catalyzed reaction for the selective transformation of thiols (‐SH) to sulfinamides (‐SONH<sub>2</sub>) by a direct transfer of ‐O and free ‐NH<sub>2</sub> groups has been developed. The reaction operates under mild conditions using a bench stable hydroxylamine derived reagent, exhibits broad functional group tolerance, is scalable and proceeds without the use of any precious metal catalyst or additional oxidant. This novel, practical reaction leads to the formation of two distinct new bonds (S=O and S−N) in a single step to chemoselectively form valuable, unprotected sulfinamide products. Preliminary mechanistic studies implicate the role of the alcoholic solvent as an oxygen atom donor.</p><p class="para" id="N65540">Readily available thiols are chemoselectively converted to valuable unprotected sulfinamides using an inexpensive iron catalyst through the formation of two distinct new bonds (S=O and S−N) in a single step. A hydroxylamine‐derived reagent acts as dual oxidant and amino group donor for the synthesis of structurally and functionally complex sulfinamides.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765853596383-85289b91-7ede-44bc-a273-f779775dabec/assets/ANIE-60-758-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Solvation Effects on the Structure and Stability of Alkali Metal Carbenoids]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765853550204-957a9345-8e38-41e9-bbd9-0264836885e2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011278</link>
            <description><![CDATA[<p class="para" id="N65541">s‐Block metal carbenoids are carbene synthons and applied in a myriad of organic transformations. They exhibit a strong structure–activity relationship, but this is only poorly understood due to the challenging high reactivity and sensitivity of these reagents. Here, we report on systematic VT and DOSY NMR studies, XRD analyses as well as DFT calculations on a sulfoximinoyl‐substituted model system to explain the pronounced solvent dependency of the carbenoid stability. While the sodium and potassium chloride carbenoids showed high stabilities independent of the solvent, the lithium carbenoid was stable at room temperature in THF but decomposed at −10 °C in toluene. These divergent stabilities could be explained by the different structures formed in solution. In contrast to simple organolithium reagents, the monomeric THF‐solvate was found to be more stable than the dimer in toluene, since the latter more readily forms direct Li/Cl interactions which facilitate decomposition via α‐elimination.</p><p class="para" id="N65540">Whereas in conventional organolithium chemistry unsolvated dimers are generally more stable than solvated monomers and their sodium and potassium analogues are less stable still, curiously this trend seems to be reversed in carbenoid systems. DOSY‐NMR, SC‐XRD analyses and computational studies on a chiral test system show dramatic changes in the stability depending on the solvent and the formed structures.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765853550204-957a9345-8e38-41e9-bbd9-0264836885e2/assets/ANIE-60-493-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Isomerization Reactions in Anionic Mesoionic Carbene‐Borates and Control of Properties and Reactivities in the Resulting Co<sup>II</sup> Complexes through Agostic Interactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852796580-d2c6c01e-ab85-4d87-a6cc-372c7e25a307/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013376</link>
            <description><![CDATA[<p class="para" id="N65541">We present herein anionic borate‐based bi‐mesoionic carbene compounds of the 1,2,3‐triazol‐4‐ylidene type that undergo C−N isomerization reactions. The isomerized compounds are excellent ligands for Co<sup>II</sup> centers. Strong agostic interactions with the “C−H”‐groups of the cyclohexyl substituents result in an unusual low‐spin square planar Co<sup>II</sup> complex, which is unreactive towards external substrates. Such agostic interactions are absent in the complex with phenyl substituents on the borate backbone. This complex displays a high‐spin tetrahedral Co<sup>II</sup> center, which is reactive towards external substrates including dioxygen. To the best of our knowledge, this is also the first investigation of agostic interactions through single‐crystal EPR spectroscopy. We conclusively show here that the structure and properties of these Co<sup>II</sup> complexes can be strongly influenced through interactions in the secondary coordination sphere. Additionally, we unravel a unique ligand rearrangement for these classes of anionic mesoionic carbene‐based ligands.</p><p class="para" id="N65540">C−N isomerization reactions on borate‐based anionic bi‐mesoionic carbene ligands are reported. The Co<sup>II</sup> complexes with these ligands display geometries, spin states, and reactivities that are controlled by agostic interactions in the secondary coordination sphere.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765852796580-d2c6c01e-ab85-4d87-a6cc-372c7e25a307/assets/ANIE-60-499-g013.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Synthetic Biology Driven Biosynthesis of Unnatural Tropolone Sesquiterpenoids]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852128011-e2c87b87-2ea6-4f96-9917-c79732300c6b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009914</link>
            <description><![CDATA[<p class="para" id="N65541">Tropolone sesquiterpenoids (TS) are an intriguing family of biologically active fungal meroterpenoids that arise through a unique intermolecular hetero Diels–Alder (hDA) reaction between humulene and tropolones. Here, we report on the combinatorial biosynthesis of a series of unprecedented analogs of the TS pycnidione <b>1</b> and xenovulene A <b>2</b>. In a systematic synthetic biology driven approach, we recombined genes from three TS biosynthetic gene clusters (pycnidione <b>1,</b> xenovulene A <b>2</b> and eupenifeldin <b>3</b>) in the fungal host <i>Aspergillus oryzae</i> NSAR1. Rational design of the reconstituted pathways granted control over the number of hDA reactions taking place, the chemical nature of the fused polyketide moiety (tropolono‐ vs. monobenzo‐pyranyl) and the degree of hydroxylation. Formation of unexpected monobenzopyranyl sesquiterpenoids was investigated using isotope‐feeding studies to reveal a new and highly unusual oxidative ring contraction rearrangement.</p><p class="para" id="N65540">New bis‐ and mono‐ tropolono‐ and benzo‐pyranyl humulene meroterpenoids, priviledged structures with diverse potent bioactivities, were synthesised using a rational synthetic biology platform based on the heterologous expression of genes from three different natural product pathways in the fungal host <i>Aspergillus oryzae</i>. Control over number of additions to humulene, ring contractions and humulene hydroxylation was achieved.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765852128011-e2c87b87-2ea6-4f96-9917-c79732300c6b/assets/ANIE-59-23870-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852064286-ab457370-254e-446a-843e-173c05aa0a31/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28220</link>
            <description><![CDATA[<div class="section" id="mds28220-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Multiple system atrophy (MSA) is a rare neurodegenerative disorder, and its parkinsonian variant can be difficult to delineate from Parkinson's disease (PD). Despite laryngeal dysfunction being associated with decreased life expectancy and quality of life, systematic assessments of laryngeal dysfunction in large cohorts are missing.</p></div><div class="section" id="mds28220-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65551">The objective of this study was to systematically assess laryngeal dysfunction in MSA and PD and identify laryngeal symptoms that allow for differentiating MSA from PD.</p></div><div class="section" id="mds28220-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">Patients with probable or possible MSA underwent flexible endoscopic evaluation of swallowing performing a systematic task protocol. Findings were compared with an age‐matched PD cohort.</p></div><div class="section" id="mds28220-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65563">A total of 57 patients with MSA (64 [59–71] years; 35 women) were included, and task assessments during endoscopic examination compared with 57 patients with PD (67 [60–73]; 28 women). Patients with MSA had a shorter disease duration (4 [3–5] years vs 7 [5–10]; <i>P</i> &lt; 0.0001) and higher disease severity (Hoehn &amp; Yahr stage 4 [3–4] vs 3 [2–4]; <i>P</i> &lt; 0.0001). Of the patients with MSA, 43.9% showed clinically overt laryngeal dysfunction with inspiratory stridor. During endoscopic task assessment, however, 93% of patients with MSA demonstrated laryngeal dysfunction in contrast with only 1.8% of patients with PD (<i>P</i> &lt; 0.0001). Irregular arytenoid cartilages movements were present in 91.2% of patients with MSA, but in no patients with PD (<i>P</i> &lt; 0.0001). Further findings included vocal fold motion impairment (75.4%), paradoxical vocal fold motion (33.3%), and vocal fold fixation (19.3%). One patient with PD showed vocal fold motion impairment.</p></div><div class="section" id="mds28220-sec-0005"><h3 class="BHead" id="nov000-5">Conclusion</h3><p class="para" id="N65581">Laryngeal movement disorders are highly prevalent in patients with MSA when assessed by a specific task protocol despite the lack of overt clinical symptoms. Our data suggest that irregular arytenoid cartilage movements could be used as a clinical marker to delineate MSA from PD with a specificity of 1.0 and sensitivity 0.9. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-08-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Carbon‐Carbon Coupling on Inert Surfaces by Deposition of En Route Generated Aryl Radicals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765851903296-d882167d-e3e8-4ca6-a391-e6d6c778b08a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010833</link>
            <description><![CDATA[<p class="para" id="N65541">To facilitate C−C coupling in on‐surface synthesis on inert surfaces, we devised a radical deposition source (RDS) for the direct deposition of aryl radicals onto arbitrary substrates. Its core piece is a heated reactive drift tube through which halogenated precursors are deposited and en route converted into radicals. For the proof of concept we study 4,4′′‐diiodo‐<i>p</i>‐terphenyl (DITP) precursors on iodine‐passivated metal surfaces. Deposition with the RDS at room temperature results in highly regular structures comprised of mostly monomeric (terphenyl) or dimeric (sexiphenyl) biradicals. Mild heating activates progressive C−C coupling into more extended molecular wires. These structures are distinctly different from the self‐assemblies observed upon conventional deposition of intact DITP. Direct deposition of radicals renders substrate reactivity unnecessary, thereby paving the road for synthesis on application‐relevant inert surfaces.</p><p class="para" id="N65540">Terphenyl biradicals are generated from iodinated precursors en route by deposition through the reactive drift tube of a newly devised radical deposition source. Upon deposition onto iodine‐passivated metal surfaces, the terphenyl radicals self‐assemble into ordered structures but remain active for C−C coupling into dimers and extended oligomers.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765851903296-d882167d-e3e8-4ca6-a391-e6d6c778b08a/assets/ANIE-59-22785-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Diels–Alder Polymer Networks with Temperature‐Reversible Cross‐Linking‐Induced Emission]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765851062789-3639bb54-cd5f-4776-b41e-461bf1fdd1b6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013183</link>
            <description><![CDATA[<p class="para" id="N65541">A novel synthetic strategy gives reversible cross‐linked polymeric materials with tunable fluorescence properties. Dimaleimide‐substituted tetraphenylethene (TPE‐2MI), which is non‐emissive owing to the photo‐induced electron transfer (PET) between maleimide (MI) and tetraphenylethene (TPE) groups, was used to cross‐link random copolymers of methyl (MM), decyl (DM) or lauryl (LM) methacrylate with furfuryl methacrylate (FM). The mixture of copolymer and TPE‐2MI in DMF showed reversible fluorescence with “on/off” behavior depending on the Diels–Alder (DA)/retro‐DA process, which is easily adjusted by temperature. At high temperatures, the retro‐DA reaction is dominant, and the fluorescence is quenched by the photo‐induced electron transfer (PET) mechanism. In contrast, at low temperatures, the emission recovers as the DA reaction takes over. A transparent PMFM/TPE‐2MI polymer film was prepared which shows an accurate response to the external temperature and exhibited tunable fluorescent “turn on/off” behavior. These results suggest the possible application in areas including information security and transmission. An example of invisible/visible writing is given.</p><p class="para" id="N65540">Novel Diels–Alder polymer networks with tunable aggregation‐induced emission (AIE) behavior, constructed from non‐emission dimaleimide‐substituted tetraphenylethene and linear furan‐based copolymers, have a tunable fluorescent “turn on/off” property, which shows an accurate response to temperature.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765851062789-3639bb54-cd5f-4776-b41e-461bf1fdd1b6/assets/ANIE-60-331-g011.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847974855-26860038-195e-49ae-8edf-464b1d09cb16/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011370</link>
            <description><![CDATA[<p class="para" id="N65541">We report the extension of the class of organotetrel sulfide clusters with further examples of the still rare silicon‐based species, synthesized from RSiCl<sub>3</sub> with R=phenyl (Ph, <b>I</b>), naphthyl (Np, <b>II</b>), and styryl (Sty, <b>III</b>) with Na<sub>2</sub>S. Besides known [(PhSi)<sub>4</sub>S<sub>6</sub>] (<b>IV</b>), new compounds [(NpSi)<sub>4</sub>S<sub>6</sub>] (<b>1</b>) and [(StySi)<sub>4</sub>S<sub>6</sub>] (<b>2</b>) were obtained, the first two of which underwent reactions with [AuCl(PPh<sub>3</sub>)] to form ternary complexes. DFT studies of cluster dimers helped us understand the differences between the habit of {Si<sub>4</sub>S<sub>6</sub>}‐ and {Sn<sub>4</sub>S<sub>6</sub>}‐based compounds. Crystalline <b>1</b> showed a pronounced nonlinear optical response, while for intrinsically amorphous <b>2</b>, the chemical damage threshold seems to inhibit a corresponding observation. Calculations within the independent particle approximation served to rationalize and compare electronic and optical excitations of [(RSi)<sub>4</sub>S<sub>6</sub>] clusters (R=Ph, Np). The calculations reproduced the measured data and allowed for the interpretation of the main spectroscopic features.</p><p class="para" id="N65540">To gain insight into the nonlinear optical properties and reactivity of organotetrel chalcogenide clusters, we studied the silicon homologues, [(RSi)<sub>4</sub>S<sub>6</sub>] (R=Ph, Np, Sty), and their products upon reaction with [AuCl(PPh<sub>3</sub>)], [{RSi(μ‐S)}<sub>2</sub>{AuPPh<sub>3</sub>(μ‐S)}<sub>2</sub>]. Quantum chemical studies of cluster dimers elucidated the differences in the habit of silicon and tin compounds, and DFT calculations of crystalline models confirmed the applicability of these methods.<div class="section"><div class="box" id="N65560"><div class="imageVideo"><img src="/dataresources/secured/content-1765847974855-26860038-195e-49ae-8edf-464b1d09cb16/assets/ANIE-60-1176-g018.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Electrochemical B−H Nitrogenation: Access to Amino Acid and BODIPY‐Labeled <i>nido</i>‐Carboranes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847876892-51e443fc-f36e-4547-a73a-c2374ecac9af/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012105</link>
            <description><![CDATA[<p class="para" id="N65541">Electrocatalyzed oxidative B−H nitrogenations of <i>nido</i>‐carborane (<i>nido</i>‐7,8‐C<sub>2</sub>B<sub>9</sub>H<sub>12</sub>
<sup>−</sup>) with N‐heterocycles have been established, enabling the preparation of various N‐substituted <i>nido</i>‐carboranes without chemical oxidants or metal catalyst under ambient conditions. The electrolysis manifold occurred with high levels of efficiency as well as chemo‐ and position‐ selectivity, employing sustainable electricity as the sole oxidant. The strategy set the stage for a user‐friendly access to novel amino acid and fluorogenic boron‐dipyrrin (BODIPY)‐labeled <i>nido</i>‐carborane hybrids.</p><p class="para" id="N65540">Metal‐free electrocatalyzed B−H nitrogenation is used to synthesize various N‐heterocyclic <i>nido</i>‐carboranes.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765847876892-51e443fc-f36e-4547-a73a-c2374ecac9af/assets/ANIE-60-1482-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847649290-bb2ff8b2-2e15-4973-949b-8763e8035933/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ana.25681</link>
            <description><![CDATA[<div class="section" id="ana25681-sec-0001"><h3 class="BHead" id="nov000-1">Objective</h3><p class="para" id="N65543">To determine the clinical and molecular features in patients with amyotrophic lateral sclerosis 4 (ALS4) due to mutations in the senataxin (<i>SETX</i>) gene and to develop tools for evaluating <i>SETX</i> variants.</p></div><div class="section" id="ana25681-sec-0002"><h3 class="BHead" id="nov000-2">Methods</h3><p class="para" id="N65555">Our study involved 32 patients, including 31 with mutation in <i>SETX</i> at c.1166 T&gt;C (p.Leu389Ser) and 1 with mutation at c.1153 G&gt;A (p.Glu385Lys). Clinical characterization of the patients included neurological examination, blood tests, magnetic resonance imaging (MRI), and dual‐energy x‐ray absorptiometry (DEXA). Fibroblasts and motor neurons were obtained to model the disease and characterize the molecular alteration in senataxin function.</p></div><div class="section" id="ana25681-sec-0003"><h3 class="BHead" id="nov000-3">Results</h3><p class="para" id="N65564">We report key clinical features of ALS4. Laboratory analysis showed alteration of serum creatine kinase and creatinine in the Leu389Ser ALS4 cohort. MRI showed increased muscle fat fraction in the lower extremities, which correlates with disease duration (thigh fat fraction <i>R</i>
<sup>2</sup> = 0.35, <i>p</i> = 0.01; lower leg fat fraction <i>R</i>
<sup>2</sup> = 0.49, <i>p</i> &lt; 0.01). DEXA measurements showed lower extremities are more affected than upper extremities (average fat <i>z</i> scores of 2.1 and 0.6, respectively). A cellular assay for SETX function confirmed that like the Leu389Ser mutation, the Glu385Lys variant leads to a decrease in R loops, likely from a gain of function.</p></div><div class="section" id="ana25681-sec-0004"><h3 class="BHead" id="nov000-4">Interpretation</h3><p class="para" id="N65591">We identified clinical laboratory and radiological features of ALS4, and hence they should be monitored for disease progression. The molecular characterization of R‐loop levels in patient‐derived cells provides insight into the disease pathology and assays to evaluate the pathogenicity of candidate mutations in the <i>SETX</i> gene. <b>ANN NEUROL 2020;87:547–555</b>
</p></div>]]></description>
            <pubDate><![CDATA[2020-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Effect of Particle Wettability and Particle Concentration on the Enzymatic Dehydration of <i>n</i>‐Octanaloxime in Pickering Emulsions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847622882-b86dff10-b583-4e93-a00d-00897d31e03a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202013171</link>
            <description><![CDATA[<p class="para" id="N65541">Pickering emulsion systems have emerged as platforms for the synthesis of organic molecules in biphasic biocatalysis. Herein, the catalytic performance was evaluated for biotransformation using whole cells exemplified for the dehydration of <i>n</i>‐octanaloxime to <i>n</i>‐octanenitrile catalysed by an aldoxime dehydratase (OxdB) overexpressed in <i>E. coli</i>. This study was carried out in Pickering emulsions stabilised solely with silica particles of different hydrophobicity. We correlate, for the first time, the properties of the emulsions with the conversion of the reaction, thus gaining an insight into the impact of the particle wettability and particle concentration. When comparing two emulsions of different type with similar stability and droplet diameter, the oil‐in‐water (o/w) system displayed a higher conversion than the water‐in‐oil (w/o) system, despite the conversion in both cases being higher than that in a “classic” two‐phase system. Furthermore, an increase in particle concentration prior to emulsification resulted in an increase of the interfacial area and hence a higher conversion.</p><p class="para" id="N65540">The dehydration of <i>n</i>‐octanaloxime to <i>n</i>‐octanenitrile catalysed by an aldoxime dehydratase (OxdB) overexpressed in <i>E. coli</i> is carried out in Pickering emulsions stabilised solely with silica particles of different hydrophobicity. The effects of particle wettability and particle concentration are evaluated with respect to the conversion of the reaction.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1765847622882-b86dff10-b583-4e93-a00d-00897d31e03a/assets/ANIE-60-1450-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[In‐Cell NMR Spectroscopy of Functional Riboswitch Aptamers in Eukaryotic Cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847414118-aea2f97b-4e77-4630-a695-a72184a6db14/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202007184</link>
            <description><![CDATA[<p class="para" id="N65541">We report here the in‐cell NMR‐spectroscopic observation of the binding of the cognate ligand 2′‐deoxyguanosine to the aptamer domain of the bacterial 2′‐deoxyguanosine‐sensing riboswitch in eukaryotic cells, namely Xenopus laevis oocytes and in human HeLa cells. The riboswitch is sufficiently stable in both cell types to allow for detection of binding of the ligand to the riboswitch. Most importantly, we show that the binding mode established by in vitro characterization of this prokaryotic riboswitch is maintained in eukaryotic cellular environment. Our data also bring important methodological insights: Thus far, in‐cell NMR studies on RNA in mammalian cells have been limited to investigations of short (&lt;15 nt) RNA fragments that were extensively modified by protecting groups to limit their degradation in the intracellular space. Here, we show that the in‐cell NMR setup can be adjusted for characterization of much larger (≈70 nt) functional and chemically non‐modified RNA.</p><p class="para" id="N65540">RNA aptamers find increasing application in synthetic biology as exogenous gene control elements, but high‐resolution structural characterization in vivo is challenging. We report here the NMR‐spectroscopic observation of ligand binding by the 2′‐deoxyguanosine riboswitch aptamer in eukaryotic cells and show that the binding mode established by in vitro characterization of this aptamer is maintained in eukaryotic cellular environment.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765847414118-aea2f97b-4e77-4630-a695-a72184a6db14/assets/ANIE-60-865-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Azo bond formation on metal surfaces]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847128378-fcbf09f6-88d4-4472-a581-65092e1b4eea/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011858</link>
            <description><![CDATA[<p class="para" id="N65541">The formation of azo compounds via redox cross‐coupling of nitroarenes and arylamines, challenging in solution phase chemistry, is achieved by on‐surface chemistry. Reaction products are analyzed with a cryogenic scanning tunneling microscope (STM) and X‐ray photoelectron spectroscopy (XPS). By using well‐designed precursors containing both an amino and a nitro functionality, azo polymers are prepared on surface via highly efficient nitro‐amino cross‐coupling. Experiments conducted on other substrates and surface orientations reveal that the metal surface has a significant effect on the reaction efficiency. The reaction was further found to proceed from partially oxidized/reduced precursors in dimerization reactions, shedding light on the mechanism that was studied by DFT calculations.</p><p class="para" id="N65540">Herein we disclose the on‐surface redox coupling of arylamines and nitroarenes on Ag(111). Starting from well‐designed monomeric precursors, the cross‐coupling yielding azo bridged polyphenylenes was investigated by STM and XPS. Further, first steps toward copolymerization were performed with two comonomers. Mechanistic studies and supportive DFT calculations are provided.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765847128378-fcbf09f6-88d4-4472-a581-65092e1b4eea/assets/ANIE-60-1458-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nanoscale Anatomy of Iron‐Silica Self‐Organized Membranes: Implications for Prebiotic Chemistry]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765846905864-ed2e7492-0bdb-4d6b-a40b-760140b951a0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012059</link>
            <description><![CDATA[<p class="para" id="N65541">Iron‐silica self‐organized membranes, so‐called chemical gardens, behave as fuel cells and catalyze the formation of amino/carboxylic acids and RNA nucleobases from organics that were available on early Earth. Despite their relevance for prebiotic chemistry, little is known about their structure and mineralogy at the nanoscale. Studied here are focused ion beam milled sections of iron‐silica membranes, grown from synthetic and natural, alkaline, serpentinization‐derived fluids thought to be widespread on early Earth. Electron microscopy shows they comprise amorphous silica and iron nanoparticles of large surface areas and inter/intraparticle porosities. Their construction resembles that of a heterogeneous catalyst, but they can also exhibit a bilayer structure. Surface‐area measurements suggest that membranes grown from natural waters have even higher catalytic potential. Considering their geochemically plausible precipitation in the early hydrothermal systems where abiotic organics were produced, iron‐silica membranes might have assisted the generation and organization of the first biologically relevant organics.</p><p class="para" id="N65540">Iron‐silica membranes grown from laboratory and natural solutions are made of iron nanoparticles over amorphous silica, similar to a heterogeneous catalyst, and under geochemically plausible conditions they show a bilayer structure. These results provide a mineralogical/structural explanation for their remarkable catalytic behavior, while relating them to a natural setting relevant for early Earth geochemistry and prebiotic chemistry.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765846905864-ed2e7492-0bdb-4d6b-a40b-760140b951a0/assets/ANIE-60-1396-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[H<sub>2</sub>‐Free Re‐Based Catalytic Dehydroxylation of Aldaric Acid to Muconic and Adipic Acid Esters]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765841982553-13a683f1-3a38-43d3-bdbe-d0b2adac81d1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010035</link>
            <description><![CDATA[<p class="para" id="N65541">As one of the most demanded dicarboxylic acids, adipic acid can be directly produced from renewable sources. Hexoses from (hemi)cellulose are oxidized to aldaric acids and subsequently catalytically dehydroxylated. Hitherto performed homogeneously, we present the first heterogeneous catalytic process for converting an aldaric acid into muconic and adipic acid. The contribution of leached Re from the solid pre‐reduced catalyst was also investigated with hot‐filtration test and found to be inactive for dehydroxylation. Corrosive or hazardous (HBr/H<sub>2</sub>) reagents are avoided and simple alcohols and solid Re/C catalysts in an inert atmosphere are used. At 120 °C, the carboxylic groups are protected by esterification, which prevents lactonization in the absence of water or acidic sites. Dehydroxylation and partial hydrogenation yield monohexenoates (93 %). For complete hydrogenation to adipate, a 16 % higher activation barrier necessitates higher temperatures.</p><p class="para" id="N65540">In the present work, the conversion of bio‐based aldaric acids into muconic and adipic acid through a heterogeneous catalytic process, in the absence of corrosive reagents or gaseous H<sub>2</sub> is reported. The mechanism of the selective removal of adjacent OH* groups on Re/C catalysts and the role of (m)ethanol in carboxylic group protection and hydrogen transfer in a slurry reactor are elucidated by DFT calculations and XPS, chemisorption, and HR‐TEM.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765841982553-13a683f1-3a38-43d3-bdbe-d0b2adac81d1/assets/ANIE-60-1244-g009.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Engineered SAM Synthetases for Enzymatic Generation of AdoMet Analogs with Photocaging Groups and Reversible DNA Modification in Cascade Reactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765841895981-ed520dd4-78b9-4b19-9a37-7a97757cdd13/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012623</link>
            <description><![CDATA[<p class="para" id="N65541">Methylation and demethylation of DNA, RNA and proteins has emerged as a major regulatory mechanism. Studying the function of these modifications would benefit from tools for their site‐specific inhibition and timed removal. <i>S</i>‐Adenosyl‐L‐methionine (AdoMet) analogs in combination with methyltransferases (MTases) have proven useful to map or block and release MTase target sites, however their enzymatic generation has been limited to aliphatic groups at the sulfur atom. We engineered a SAM synthetase from <i>Cryptosporidium hominis</i> (PC‐ChMAT) for efficient generation of AdoMet analogs with photocaging groups that are not accepted by any WT MAT reported to date. The crystal structure of PC‐ChMAT at 1.87 Å revealed how the photocaged AdoMet analog is accommodated and guided engineering of a thermostable MAT from <i>Methanocaldococcus jannaschii</i>. PC‐MATs were compatible with DNA‐ and RNA‐MTases, enabling sequence‐specific modification (“writing”) of plasmid DNA and light‐triggered removal (“erasing”).</p><p class="para" id="N65540">
<i>S</i>‐Adenosyl‐L‐methionine (AdoMet) analogs provide a way to study and control methyltransferase target sites. Their enzymatic generation has been limited to aliphatic groups at the sulfur atom. We engineered and crystallized the first SAM synthetases (PC‐MATs) able to generate AdoMet analogs with photocaging groups. In combination with DNA‐MTases, sequence‐specific modification (“writing”) of plasmid DNA and light‐triggered removal (“erasing”) is demonstrated.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765841895981-ed520dd4-78b9-4b19-9a37-7a97757cdd13/assets/ANIE-60-480-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Next Generation of Zinc Bisguanidine Polymerization Catalysts towards Highly Crystalline, Biodegradable Polyesters]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765841458110-f3132c24-4aa0-4bfc-93aa-e706e2fd6a54/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202008473</link>
            <description><![CDATA[<p class="para" id="N65541">Polylactide and polycaprolactone are both biodegradable polymers produced through metal‐catalyzed ring‐opening polymerization. For a truly sustainable lifecycle of these polymers it is essential to replace the industrially used cytotoxic catalyst tin(II) bis(2‐ethylhexanoate) [Sn(Oct)<sub>2</sub>] with non‐toxic alternatives. Here, we report the fastest known robust catalyst in the polymerization of lactide and ϵ‐caprolactone. This zinc guanidine catalyst can polymerize non‐purified technical <i>rac</i>‐lactide and ϵ‐caprolactone in the melt at different [M]/[I] ratios with fast rate constants, high molar masses, and high yields in a short time, leading to colorless, transparent polymer. Moreover, we report that polylactide and polycaprolactone produced by zinc‐guanidine complexes have favorably high crystallinities. In fact, the obtained polylactide shows a more robust degradation profile than its Sn(Oct)<sub>2</sub>‐catalysed equivalent due to a higher degree of crystallinity.</p><p class="para" id="N65540">A highly active and robust zinc guanidine catalyst for the polymerization of lactide and ϵ‐caprolactone was investigated. The catalyst not only has a faster catalytic activity in bulk for the ring‐opening polymerization of lactide than the industrially used Sn(Oct)<sub>2</sub> catalyst but also leads to a higher degree of crystallinity in the polymer then Sn(Oct)<sub>2</sub>, progressing towards a more robust degradation profile.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765841458110-f3132c24-4aa0-4bfc-93aa-e706e2fd6a54/assets/ANIE-59-21778-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hydrogen Bonding Enhances the Electrochemical Hydrogenation of Benzaldehyde in the Aqueous Phase]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765841369534-e2188f91-194e-4edd-b296-19a10f2fe907/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202008178</link>
            <description><![CDATA[<p class="para" id="N65541">The hydrogenation of benzaldehyde to benzyl alcohol on carbon‐supported metals in water, enabled by an external potential, is markedly promoted by polarization of the functional groups. The presence of polar co‐adsorbates, such as substituted phenols, enhances the hydrogenation rate of the aldehyde by two effects, that is, polarizing the carbonyl group and increasing the probability of forming a transition state for H addition. These two effects enable a hydrogenation route, in which phenol acts as a conduit for proton addition, with a higher rate than the direct proton transfer from hydronium ions. The fast hydrogenation enabled by the presence of phenol and applied potential overcompensates for the decrease in coverage of benzaldehyde caused by competitive adsorption. A higher acid strength of the co‐adsorbate increases the intensity of interactions and the rates of selective carbonyl reduction.</p><p class="para" id="N65540">Electrocatalytic hydrogenation of benzaldehyde to benzyl alcohol on carbon‐supported metals proceeds through proton‐coupled electron transfer. The presence of polar co‐adsorbates such as phenols enhances the hydrogenation rate of the aldehyde by the polarization of the carbonyl group because of the formation of a hydrogen bond. Increasing either the concentration or acidity of the co‐adsorbate increases the rates of selective carbonyl reduction.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765841369534-e2188f91-194e-4edd-b296-19a10f2fe907/assets/ANIE-60-290-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Shear Stress‐Responsive Polymersome Nanoreactors Inspired by the Marine Bioluminescence of Dinoflagellates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765840241375-b151495f-9993-4165-ba65-10ccaf209310/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010099</link>
            <description><![CDATA[<p class="para" id="N65541">Some marine plankton called dinoflagellates emit light in response to the movement of surrounding water, resulting in a phenomenon called milky seas or sea sparkle. The underlying concept, a shear‐stress induced permeabilisation of biocatalytic reaction compartments, is transferred to polymer‐based nanoreactors. Amphiphilic block copolymers that carry nucleobases in their hydrophobic block are self‐assembled into polymersomes. The membrane of the vesicles can be transiently switched between an impermeable and a semipermeable state by shear forces occurring in flow or during turbulent mixing of polymersome dispersions. Nucleobase pairs in the hydrophobic leaflet separate when mechanical force is applied, exposing their hydrogen bonding motifs and therefore making the membrane less hydrophobic and more permeable for water soluble compounds. This polarity switch is used to release payload of the polymersomes on demand, and to activate biocatalytic reactions in the interior of the polymersomes.</p><p class="para" id="N65540">Polymersomes with nucleobase pairs in their membrane become transiently permeable for substrates when shear forces are applied. These force‐responsive polymersomes allow to switch on enzymatic reactions by turbulent mixing of vesicle dispersions, which is demonstrated with colorimetric and chemoluminescent reactions, as well as the curing of hydrogels.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765840241375-b151495f-9993-4165-ba65-10ccaf209310/assets/ANIE-60-904-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Stabilization of Pentaphospholes as η<sup>5</sup>‐Coordinating Ligands]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838627574-d9c1e591-ca70-4a0c-8cd9-f2696e58718e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011571</link>
            <description><![CDATA[<p class="para" id="N65541">Electrophilic functionalisation of [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>)] (<b>1</b>) yields the first transition‐metal complexes of pentaphospholes (cyclo‐P<sub>5</sub>R). Silylation of <b>1</b> with [(Et<sub>3</sub>Si)<sub>2</sub>(μ‐H)][B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>] leads to the ionic species [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>SiEt<sub>3</sub>)][B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>] (<b>2</b>), whose subsequent reaction with H<sub>2</sub>O yields the parent compound [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>H)][B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>] (<b>3</b>). The synthesis of a carbon‐substituted derivative [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>Me)][X] ([X]<sup>−</sup>=[FB(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub>]<sup>−</sup> (<b>4 a</b>), [B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>]<sup>−</sup> (<b>4 b</b>)) is achieved by methylation of <b>1</b> employing [Me<sub>3</sub>O][BF<sub>4</sub>] and B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub> or a combination of MeOTf and [Li(OEt<sub>2</sub>)<sub>2</sub>][B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>]. The structural characterisation of these compounds reveals a slight envelope structure for the cyclo‐P<sub>5</sub>R ligand. Detailed NMR‐spectroscopic studies suggest a highly dynamic behaviour and thus a distinct lability for <b>2</b> and <b>3</b> in solution. DFT calculations shed light on the electronic structure and bonding situation of this unprecedented class of compounds.</p><p class="para" id="N65540">The reaction of pentaphosphaferrocene [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>)] with cationic electrophiles results in the formation of the complexes [Cp*Fe(η<sup>5</sup>‐P<sub>5</sub>R)][B(C<sub>6</sub>F<sub>5</sub>)<sub>4</sub>] (R=SiEt<sub>3</sub>, H, Me). These compounds represent the first structurally characterised coordination complexes bearing elusive pentaphospholes (<i>cyclo</i>‐P<sub>5</sub>R) as ligands, including the parent <i>cyclo</i>‐P<sub>5</sub>H.<div class="section"><div class="box" id="N65578"><div class="imageVideo"><img src="/dataresources/secured/content-1765838627574-d9c1e591-ca70-4a0c-8cd9-f2696e58718e/assets/ANIE-59-23879-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Controlling Intramolecular Förster Resonance Energy Transfer and Singlet Fission in a Subporphyrazine–Pentacene Conjugate by Solvent Polarity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838370159-ba889810-9235-4fa9-bfa1-a11f3fd091f3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011197</link>
            <description><![CDATA[<p class="para" id="N65541">Due its complementary absorptions in the range of 450 and 600 nm, an energy‐donating hexaaryl‐subporphyrazine has been linked to a pentacene dimer, which acts primarily as an energy acceptor and secondarily as a singlet fission enabler. In the corresponding conjugate, efficient intramolecular Förster resonance energy transfer (i‐FRET) is the modus operandi to transfer energy from the subporphyrazine to the pentacene dimer. Upon energy transfer, the pentacene dimer undergoes intramolecular singlet fission (i‐SF), that is, converting the singlet excited state, via an intermediate state, into a pair of correlated triplet excited states. Solvatochromic fluorescence of the subporphyrazine is a key feature of this system and features a red‐shift as large as 20 nm in polar media. Solvent is thus used to modulate spectral overlap between the fluorescence of subporphyrazine and absorption of the pentacene dimer, which controls the Förster rate constant, on one hand, and the triplet quantum yield, on the other hand. The optimum spectral overlap is realized in xylene, leading to Förster rate constant of 3.52×10<sup>11</sup> s<sup>−1</sup> and a triplet quantum yield of 171 % ±10 %. In short, the solvent polarity dependence, which is a unique feature of subporphyrazines, is decisive in terms of adjusting spectral overlap, ensuring a sizable Förster rate constant, and maximizing triplet quantum yields. Uniquely, this optimization can be achieved without a need for synthetic modification of the subporphyrazine donor.</p><p class="para" id="N65540">The solvatochromic fluorescence properties of a subporphyrazine are used to control the rate of intramolecular Förster resonance energy transfer (i‐FRET) in a subporphyrazine–pentacene conjugate (<b>SubPzPnc<sub>2</sub></b>) that undergoes intramolecular singlet fission (i‐SF). A simple selection of solvent serves to optimize the triplet quantum yield by enhancing the spectral overlap between the fluorescence of the SubPz and the absorption of the Pnc dimer.<div class="section"><div class="box" id="N65547"><div class="imageVideo"><img src="/dataresources/secured/content-1765838370159-ba889810-9235-4fa9-bfa1-a11f3fd091f3/assets/ANIE-60-1474-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cationic Group VI Metal Imido Alkylidene <i>N</i>‐Heterocyclic Carbene Nitrile Complexes: Bench‐Stable, Functional‐Group‐Tolerant Olefin Metathesis Catalysts]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838271585-a81212be-065e-4926-b1c8-fe7d183ab1aa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011666</link>
            <description><![CDATA[<p class="para" id="N65541">Despite their excellent selectivities and activities, Mo‐and W‐based catalysts for olefin metathesis have not gained the same widespread use as Ru‐based systems, mainly due to their inherent air sensitivity. Herein, we describe the synthesis of air‐stable cationic‐at‐metal molybdenum and tungsten imido alkylidene NHC nitrile complexes. They catalyze olefin metathesis reactions of substrates containing functional groups such as (thio‐) esters, (thio‐) ethers and alcohols without the need for prior activation, for example, by a Lewis acid. The presence of a nitrile ligand was found to be essential for their stability towards air, while no decrease in activity and productivity could be observed upon coordination of a nitrile. Variations of the imido and anionic ligand revealed that alkoxide complexes with electron‐withdrawing imido ligands offer the highest reactivities and excellent stability compared to analogous triflate and halide complexes.</p><p class="para" id="N65540">The presence of a nitrile ligand renders cationic group VI metal imido alkylidene NHC complexes air‐stable, functional‐group‐tolerant, and olefin metathesis‐active. No pre‐activation is required and no loss of activity, productivity, or selectivity in olefin metathesis is observed due to the presence of a nitrile ligand.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765838271585-a81212be-065e-4926-b1c8-fe7d183ab1aa/assets/ANIE-60-1374-g014.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Design, Identification, and Evolution of a Surface Ruthenium(II/III) Single Site for CO Activation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765837351133-55816efd-9798-4b19-954a-9e67aead3496/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202008370</link>
            <description><![CDATA[<p class="para" id="N65541">Ru<sup>II</sup> compounds are widely used in catalysis, photocatalysis, and medical applications. They are usually obtained in a reductive environment as molecular O<sub>2</sub> can oxidize Ru<sup>II</sup> to Ru<sup>III</sup> and Ru<sup>IV</sup>. Here we report the design, identification and evolution of an air‐stable surface [bipy‐Ru<sup>II</sup>(CO)<sub>2</sub>Cl<sub>2</sub>] site that is covalently mounted onto a polyphenylene framework. Such a Ru<sup>II</sup> site was obtained by reduction of [bipy‐Ru<sup>III</sup>Cl<sub>4</sub>]<sup>−</sup> with simultaneous ligand exchange from Cl<sup>−</sup> to CO. This structural evolution was witnessed by a combination of in situ X‐ray and infrared spectroscopy studies. The [bipy‐Ru<sup>II</sup>(CO)<sub>2</sub>Cl<sub>2</sub>] site enables oxidation of CO with a turnover frequency of 0.73×10<sup>−2</sup> s<sup>−1</sup> at 462 K, while the Ru<sup>III</sup> site is completely inert. This work contributes to the study of structure–activity relationship by demonstrating a practical control over both geometric and electronic structures of single‐site catalysts at molecular level.</p><p class="para" id="N65540">An air‐stable surface [bipy‐Ru<sup>II</sup>(CO)<sub>2</sub>Cl<sub>2</sub>] single site is designed towards CO oxidation, while all other Ru<sup>III</sup> single sites are not active. The methodology is further extended to nine transition‐metal single‐site systems, enabling the use of surface coordination chemistry in heterogeneous catalysis.<div class="section"><div class="box" id="N65554"><div class="imageVideo"><img src="/dataresources/secured/content-1765837351133-55816efd-9798-4b19-954a-9e67aead3496/assets/ANIE-60-1212-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Interlayer Engineering of α‐MoO<sub>3</sub> Modulates Selective Hydronium Intercalation in Neutral Aqueous Electrolyte]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765836209162-3b27978a-b100-455d-b6d0-80a08edd67bd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010073</link>
            <description><![CDATA[<p class="para" id="N65541">Among various charge‐carrier ions for aqueous batteries, non‐metal hydronium (H<sub>3</sub>O<sup>+</sup>) with small ionic size and fast diffusion kinetics empowers H<sub>3</sub>O<sup>+</sup>‐intercalation electrodes with high rate performance and fast‐charging capability. However, pure H<sub>3</sub>O<sup>+</sup> charge carriers for inorganic electrode materials have only been observed in corrosive acidic electrolytes, rather than in mild neutral electrolytes. Herein, we report how selective H<sub>3</sub>O<sup>+</sup> intercalation in a neutral ZnCl<sub>2</sub> electrolyte can be achieved for water‐proton co‐intercalated α‐MoO<sub>3</sub> (denoted WP‐MoO<sub>3</sub>). H<sub>2</sub>O molecules located between MoO<sub>3</sub> interlayers block Zn<sup>2+</sup> intercalation pathways while allowing smooth H<sub>3</sub>O<sup>+</sup> intercalation/diffusion through a Grotthuss proton‐conduction mechanism. Compared to α‐MoO<sub>3</sub> with a Zn<sup>2+</sup>‐intercalation mechanism, WP‐MoO<sub>3</sub> delivers the substantially enhanced specific capacity (356.8 vs. 184.0 mA h g<sup>−1</sup>), rate capability (77.5 % vs. 42.2 % from 0.4 to 4.8 A g<sup>−1</sup>), and cycling stability (83 % vs. 13 % over 1000 cycles). This work demonstrates the possibility of modulating electrochemical intercalating ions by interlayer engineering, to construct high‐rate and long‐life electrodes for aqueous batteries.</p><p class="para" id="N65540">Selective H<sub>3</sub>O<sup>+</sup> intercalation is demonstrated for a water‐proton co‐intercalated α‐MoO<sub>3</sub> cathode in a neutral ZnCl<sub>2</sub> electrolyte, thus providing substantially enhanced specific capacity, rate capability, and cycling stability. H<sub>2</sub>O molecules between the α‐MoO<sub>3</sub> interlayers are uncovered to block Zn<sup>2+</sup> intercalation pathways, while allowing smooth H<sub>3</sub>O<sup>+</sup> intercalation/diffusion through a Grotthuss proton conduction mechanism.<div class="section"><div class="box" id="N65569"><div class="imageVideo"><img src="/dataresources/secured/content-1765836209162-3b27978a-b100-455d-b6d0-80a08edd67bd/assets/ANIE-60-896-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Solvent‐Activated Hafnium‐Containing Zeolites Enable Selective and Continuous Glucose–Fructose Isomerisation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765834040509-19793b8d-2c6e-4d42-ac78-ab1d79049fc6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202006718</link>
            <description><![CDATA[<p class="para" id="N65541">The isomerisation of glucose to fructose is a critical step towards manufacturing petroleum‐free chemicals from lignocellulosic biomass. Herein we show that Hf‐containing zeolites are unique catalysts for this reaction, enabling true thermodynamic equilibrium to be achieved in a single step during intensified continuous operation, which no chemical or biological catalyst has yet been able to achieve. Unprecedented single‐pass yields of 58 % are observed at a fructose selectivity of 94 %, and continuous operation for over 100 hours is demonstrated. The unexpected performance of the catalyst is realised following a period of activation within the reactor, during which time interaction with the solvent generates a state of activity that is absent in the synthesised catalyst. Mechanistic studies by X‐ray absorption spectroscopy, chemisorption FTIR, <i>operando</i> UV/Vis and <sup>1</sup>H–<sup>13</sup>C HSQC NMR spectroscopy indicate that activity arises from isolated Hf<sup>IV</sup> atoms with monofunctional acidic properties.</p><p class="para" id="N65540">Hafnium zeolites are shown to catalyse glucose–fructose isomerisation to thermodynamic equilibrium during continuous operation, which no chemical catalyst has yet been able to achieve. Fructose yields of 58 % are observed at a selectivity of 94 %. Structure–activity relationships are developed with X‐ray absorption spectroscopy, chemisorption FTIR, operando UV/Vis and HSQC NMR spectroscopy.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765834040509-19793b8d-2c6e-4d42-ac78-ab1d79049fc6/assets/ANIE-59-20017-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-08-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Photo‐Effect on Ion Transport in Mixed Cation and Halide Perovskites and Implications for Photo‐Demixing<a href="#anie202005853-note-1001">**</a>
]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765832949723-28800fd4-fca0-4d73-86a9-5f1a19603226/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202005853</link>
            <description><![CDATA[<p class="para" id="N65541">Lead halide perovskites are considered to be most promising photovoltaic materials. Highest efficiency and improved stability of perovskite solar cells have been achieved by using cation and anion mixtures. Experimental information on electronic and ionic charge carriers is key to evaluate device performance, as well as processes of photo‐decomposition and photo‐demixing which are observed in these materials. Here, we measure ionic and electronic transport properties and investigate various cation and anion substitutions with a special eye on their photo‐ionic effect, following our previous study on CH<sub>3</sub>NH<sub>3</sub>PbI<sub>3</sub>, where we found that light enhances not only electronic but also ionic conductivities. We find that this phenomenon is very sensitive to the nature of the halide, while the cationic substitutions are less relevant. Based on the observation that the ionic conductivity enhancement found for iodide perovskites is significantly weakened by bromide substitution, we provide a chemical rationale for the photo‐demixing in mixed halide compositions.</p><p class="para" id="N65540">The photo‐effect on ion conduction in mixed cation and halide perovskites is studied. Unlike A‐site substitution, anion replacement is of great influence. In I‐Br mixtures the differences in hole localization and defect formation favor (reversible) photo‐demixing (the situation in the right part is simplified as the interstitial neutral iodine is further stabilized by ionic rearrangement, and the hole in the bromide is delocalized over several regular anions).<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765832949723-28800fd4-fca0-4d73-86a9-5f1a19603226/assets/ANIE-60-820-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The “Hidden” Reductive [2+2+1]‐Cycloaddition Chemistry of 2‐Phosphaethynolate Revealed by Reduction of a Th‐OCP Linkage]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765832644600-50aeeea9-bfda-4004-bc02-2317334d1b86/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012506</link>
            <description><![CDATA[<p class="para" id="N65541">The reduction chemistry of the newly emerging 2‐phosphaethynolate (OCP)<sup>−</sup> is not well explored, and many unanswered questions remain about this ligand in this context. We report that reduction of [Th(Tren<sup>TIPS</sup>)(OCP)] (<b>2</b>, Tren<sup>TIPS</sup>=[N(CH<sub>2</sub>CH<sub>2</sub>NSiPr<sup>i</sup>
<sub>3</sub>)]<sup>3−</sup>), with RbC<sub>8</sub> via [2+2+1] cycloaddition, produces an unprecedented hexathorium complex [{Th(Tren<sup>TIPS</sup>)}<sub>6</sub>(μ‐OC<sub>2</sub>P<sub>3</sub>)<sub>2</sub>(μ‐OC<sub>2</sub>P<sub>3</sub>H)<sub>2</sub>Rb<sub>4</sub>] (<b>5</b>) featuring four five‐membered [C<sub>2</sub>P<sub>3</sub>] phosphorus heterocycles, which can be converted to a rare oxo complex [{Th(Tren<sup>TIPS</sup>)(μ‐ORb)}<sub>2</sub>] (<b>6</b>) and the known cyclometallated complex [Th{N(CH<sub>2</sub>CH<sub>2</sub>NSiPr<sup>i</sup>
<sub>3</sub>)<sub>2</sub>(CH<sub>2</sub>CH<sub>2</sub>SiPr<sup>i</sup>
<sub>2</sub>CHMeCH<sub>2</sub>)}] (<b>4</b>) by thermolysis; thereby, providing an unprecedented example of reductive cycloaddition reactivity in the chemistry of 2‐phosphaethynolate. This has permitted us to isolate intermediates that might normally remain unseen. We have debunked an erroneous assumption of a concerted fragmentation process for (OCP)<sup>−</sup>, rather than cycloaddition products that then decompose with [Th(Tren<sup>TIPS</sup>)O]<sup>−</sup> essentially acting as a protecting then leaving group. In contrast, when KC<sub>8</sub> or CsC<sub>8</sub> were used the phosphinidiide C−H bond activation product [{Th(Tren<sup>TIPS</sup>)}Th{N(CH<sub>2</sub>CH<sub>2</sub>NSiPr<sup>i</sup>
<sub>3</sub>)<sub>2</sub>[CH<sub>2</sub>CH<sub>2</sub>SiPr<sup>i</sup>
<sub>2</sub>CH(Me)CH<sub>2</sub>C(O)μ‐P]}] (<b>3</b>) and the oxo complex [{Th(Tren<sup>TIPS</sup>)(μ‐OCs)}<sub>2</sub>] (<b>7</b>) were isolated.</p><p class="para" id="N65540">A reaction with the overall appearance of (OCP)<sup>−</sup> concerted cleavage is revealed to proceed through a [2+2+1]‐cycloaddition reaction intermediate, introducing an unprecedented example of (OCP)<sup>−</sup> cycloaddition under reducing conditions to the established neutral and oxidative cycloaddition classes of (OCP)<sup>−</sup> reactivity.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1765832644600-50aeeea9-bfda-4004-bc02-2317334d1b86/assets/ANIE-60-1197-g004.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824771209-03f79bef-c1bb-42b9-91e6-992ee0d18a2b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28222</link>
            <description><![CDATA[<div class="section" id="mds28222-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Huntington's disease (HD) develops in individuals with extended cytosine‐adenine‐guanine (CAG) repeats within the huntingtin (<i>HTT</i>) gene, causing neurodegeneration and progressive motor and cognitive symptoms. The inclusion of mutant <i>HTT</i> carriers in whom overt symptoms are not yet fully manifest in therapeutic trials would enable the development of treatments that delay or halt the accumulation of significant disability.</p></div><div class="section" id="mds28222-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65557">The present analyses assess whether screening prediagnosis (preHD) individuals based on a normalized prognostic index (PIN) score would enable the selection of prodromal preHD subjects in whom longitudinal changes in established outcome measures might provide robust signals. It also compares the relative statistical effect size of longitudinal change for these measures.</p></div><div class="section" id="mds28222-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65563">Individual participant data from 2 studies were used to develop mixed effect linear models to assess longitudinal changes in clinical metrics for participants with preHD and PIN‐stratified subcohorts. Relative effect sizes were calculated in 5 preHD studies and internally normalized to evaluate the strength and consistency of each metric across cohorts.</p></div><div class="section" id="mds28222-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65569">Longitudinal modeling data demonstrate the amplification of effect sizes when preHD subcohorts were selected by PIN score thresholds of &gt;0.0 and &gt;0.4. These models and relative effect sizes across 5 studies consistently indicate that the Unified Huntington's Disease Rating Scale total motor score exhibits the greatest change in preHD.</p></div><div class="section" id="mds28222-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65575">These analyses suggest that the employment of PIN scores to homogenize and stratify preHD cohorts could improve the efficiency of current outcome measures, the most robust of which is the total motor score. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society</p></div>]]></description>
            <pubDate><![CDATA[2020-07-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Configurational Entropy Driven High‐Pressure Behaviour of a Flexible Metal–Organic Framework (MOF)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765823049433-8c92196d-293c-4385-95fb-624dcea682a9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011004</link>
            <description><![CDATA[<p class="para" id="N65541">Flexible metal–organic frameworks (MOFs) show large structural flexibility as a function of temperature or (gas)pressure variation, a fascinating property of high technological and scientific relevance. The targeted design of flexible MOFs demands control over the macroscopic thermodynamics as determined by microscopic chemical interactions and remains an open challenge. Herein we apply high‐pressure powder X‐ray diffraction and molecular dynamics simulations to gain insight into the microscopic chemical factors that determine the high‐pressure macroscopic thermodynamics of two flexible pillared‐layer MOFs. For the first time we identify configurational entropy that originates from side‐chain modifications of the linker as the key factor determining the thermodynamics in a flexible MOF. The study shows that configurational entropy is an important yet largely overlooked parameter, providing an intriguing perspective of how to chemically access the underlying free energy landscape in MOFs.</p><p class="para" id="N65540">By combining high‐pressure powder X‐ray diffraction and molecular dynamics simulation we gain insight into the microscopic chemical factors that determine the high‐pressure macroscopic thermodynamics of two flexible pillared‐layer MOFs, identifying configurational entropy as originating from side‐chain modifications as the determining factor of the macroscopic thermodynamics.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765823049433-8c92196d-293c-4385-95fb-624dcea682a9/assets/ANIE-60-787-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NIR‐Sensitized Cationic and Hybrid Radical/Cationic Polymerization and Crosslinking]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822613862-ebfc82b1-e981-40d8-8305-57549bf99d98/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010746</link>
            <description><![CDATA[<p class="para" id="N65541">NIR‐sensitized cationic polymerization proceeded with good efficiency, as was demonstrated with epoxides, vinyl ether, and oxetane. A heptacyanine functioned as sensitizer while iodonium salt served as coinitiator. The anion adopts a special function in a series selected from fluorinated phosphates (<b>a</b>: [PF<sub>6</sub>]<sup>−</sup>, <b>b</b>: [PF<sub>3</sub>(C<sub>2</sub>F<sub>5</sub>)<sub>3</sub>]<sup>−</sup>, <b>c</b>: [PF<sub>3</sub>(<i>n</i>‐C<sub>4</sub>F<sub>9</sub>)<sub>3</sub>]<sup>−</sup>), aluminates (<b>d</b>: [Al(O‐<i>t</i>‐C<sub>4</sub>F<sub>9</sub>)<sub>4</sub>]<sup>−</sup>, <b>e</b>: [Al(O(C<sub>3</sub>F<sub>6</sub>)CH<sub>3</sub>)<sub>4</sub>]<sup>−</sup>), and methide [C(O‐SO<sub>2</sub>CF<sub>3</sub>)<sub>3</sub>]<sup>−</sup> (<b>f</b>). Vinyl ether showed the best cationic polymerization efficiency followed by oxetanes and oxiranes. DFT calculations provided a rough pattern regarding the electrostatic potential of each anion where <b>d</b> showed a better reactivity than <b>e</b> and <b>b</b>. Formation of interpenetrating polymer networks (IPNs) using trimethylpropane triacrylate and epoxides proceeded in the case of NIR‐sensitized polymerization where anion <b>d</b> served as counter ion in the initiator system. No IPN was formed by UV‐LED initiation using the same monomers but thioxanthone/iodonium salt as photoinitiator. Exposure was carried out with new NIR‐LED devices emitting at either 805 or 870 nm.</p><p class="para" id="N65540">Change of the excitation wavelength enables formation of interpenetrating polymer networks based on radical and cationic photopolymerization where heptamethines and iodonium salts served as initiating system also for photopolymerization of epoxides, oxetanes and vinyl ether. Engineering of the anion marked the tetra(nonafluoro‐<i>t</i>‐butoxy)aluminate as best candidate.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765822613862-ebfc82b1-e981-40d8-8305-57549bf99d98/assets/ANIE-60-1465-g010.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Gold Nanoparticle Nanonuclease Relying on a Zn(II) Mononuclear Complex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822518437-102dc52a-a623-4d0a-8790-aba970890b02/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012513</link>
            <description><![CDATA[<p class="para" id="N65541">Similarly to enzymes, functionalized gold nanoparticles efficiently catalyze chemical reactions, hence the term nanozymes. Herein, we present our results showing how surface‐passivated gold nanoparticles behave as synthetic nanonucleases, able to cleave pBR322 plasmid DNA with the highest efficiency reported so far for catalysts based on a single metal ion mechanism. Experimental and computational data indicate that we have been successful in creating a catalytic site precisely mimicking that suggested for natural metallonucleases relying on a single metal ion for their activity. It comprises one Zn(II) ion to which a phosphate diester of DNA is coordinated. Importantly, as in nucleic acids‐processing enzymes, a positively charged arginine plays a key role by assisting with transition state stabilization and by reducing the p<i>K</i>
<sub>a</sub> of the nucleophilic alcohol of a serine. Our results also show how designing a catalyst for a model substrate (bis‐<i>p</i>‐nitrophenylphosphate) may provide wrong indications as for its efficiency when it is tested against the real target (plasmid DNA).</p><p class="para" id="N65540">Gold nanoparticles passivated with Zn(II) complexes and short peptides were transformed into nanozymes able to very efficiently cleave plasmid DNA with a mechanism not much different from that of mononuclear nucleases.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765822518437-102dc52a-a623-4d0a-8790-aba970890b02/assets/ANIE-60-1423-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Light‐Controlled Cell‐Cycle Arrest and Apoptosis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822402663-c00a82af-6ace-4eac-9d14-28da64dd871c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202008267</link>
            <description><![CDATA[<p class="para" id="N65541">Cell‐cycle interference by small molecules has widely been used to study fundamental biological mechanisms and to treat a great variety of diseases, most notably cancer. However, at present only limited possibilities exist for spatio‐temporal control of the cell cycle. Here we report on a photocaging strategy to reversibly arrest the cell cycle at metaphase or induce apoptosis using blue‐light irradiation. The versatile proteasome inhibitor MG132 is photocaged directly at the reactive aldehyde function effectively masking its biological activity. Upon irradiation reversible cell‐cycle arrest in the metaphase is demonstrated to take place <i>in vivo</i>. Similarly, apoptosis can efficiently be induced by irradiation of human cancer cells. With the developed photopharmacological approach spatio‐temporal control of the cell cycle is thus enabled with very high modulation, as caged MG132 shows no effect on proliferation in the dark. In addition, full compatibility of photo‐controlled uncaging with dynamic microscopy techniques <i>in vivo</i> is demonstrated. This visible‐light responsive tool should be of great value for biological as well as medicinal approaches in need of high‐precision targeting of the proteasome and thereby the cell cycle and apoptosis.</p><p class="para" id="N65540">Blue‐light control of the proteasome is achieved using a new photocaging approach. Photolabile protection of the versatile proteasome inhibitor MG132 at the reactive aldehyde function abolished proteasome binding. After irradiation MG132 activity is restored resulting in cell‐cycle arrest at metaphase or apoptosis. This visible‐light‐responsive tool opens up new avenues for spatiotemporal control of the proteasome in basic and medicinal research.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765822402663-c00a82af-6ace-4eac-9d14-28da64dd871c/assets/ANIE-60-1187-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Host–Guest Exchange of Viologen Guests in Porphyrin Cage Compounds as Studied by Selective Exchange Spectroscopy (1D EXSY) NMR]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765821413356-0c0d5ded-e4fa-4da1-a5b2-e83ff3f03c18/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010335</link>
            <description><![CDATA[<p class="para" id="N65541">Dynamics in complexes of porphyrin cage compounds and viologen‐derived guest molecules are investigated by selective exchange NMR spectroscopy (1D EXSY). Exchange rates were found to be independent of excess guest concentration, revealing a dissociative exchange mechanism, which is accompanied by negative activation entropies, indicating significant reorganization of the host–guest complex during dissociation. Nonsymmetric viologen guests with bulky head groups had more unidirectional binding and slower exchange rates than guests with less‐bulky head groups. Thermodynamic and kinetic studies revealed that the exchange process is primarily driven by the thermodynamics of binding and that guest binding can be influenced by introducing steric and electronic groups on the host . Exchange studies with guests bearing a polymer chain revealed that both slippage and full dissociation takes place and the rate constants for both processes were determined. The slippage rate constant revealed that for smaller guests exchange takes place nearly exclusively under thermodynamic control.</p><p class="para" id="N65540">Dynamics in complexes of porphyrin cage compounds and viologen‐derived guest molecules are investigated by selective exchange NMR spectroscopy (1D EXSY). These studies explore the mechanism of host–guest exchange, how steric and electronic properties influence the rate of exchange, and whether the exchange process is governed by kinetic or thermodynamic factors.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765821413356-0c0d5ded-e4fa-4da1-a5b2-e83ff3f03c18/assets/ANIE-60-1254-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A General and Highly Selective Palladium‐Catalyzed Hydroamidation of 1,3‐Diynes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820637387-7e810198-a558-4dfe-a55b-fed34b378329/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010768</link>
            <description><![CDATA[<p class="para" id="N65541">A chemo‐, regio‐, and stereoselective mono‐hydroamidation of (un)symmetrical 1,3‐diynes is described. Key for the success of this novel transformation is the utilization of an advanced palladium catalyst system with the specific ligand Neolephos. The synthetic value of this general approach to synthetically useful α‐alkynyl‐α, β‐unsaturated amides is showcased by diversification of several structurally complex molecules and marketed drugs. Control experiments and density‐functional theory (M06L‐SMD) computations also suggest the crucial role of the substrate in controlling the regioselectivity of unsymmetrical 1,3‐diynes.</p><p class="para" id="N65540">The advanced Pd catalyst system with Neolephos as a ligand enables highly selective hydroamidation of unbiased (un)symmetrical 1,3‐diynes. In this way, a wide range of synthetically useful α‐alkynyl‐α,β‐unsaturated amides are afforded in good to high yields with excellent chemo‐, regio‐, and stereoselectivities.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765820637387-7e810198-a558-4dfe-a55b-fed34b378329/assets/ANIE-60-371-g011.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Formation of Nucleophilic Allylboranes from Molecular Hydrogen and Allenes Catalyzed by a Pyridonate Borane that Displays Frustrated Lewis Pair Reactivity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820326423-c79b07d8-3163-4435-918a-b98287fad629/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011790</link>
            <description><![CDATA[<p class="para" id="N65541">Here we report the in situ generation of nucleophilic allylboranes from H<sub>2</sub> and allenes mediated by a pyridonate borane that displays frustrated‐Lewis‐pair reactivity. Experimental and computational mechanistic investigations reveal that upon H<sub>2</sub> activation, the covalently bound pyridonate substituent becomes a datively bound pyridone ligand. Dissociation of the formed pyridone borane complex liberates Piers borane and enables a hydroboration of the allene. The allylboranes generated in this way are reactive towards nitriles. A catalytic protocol for the formation of allylboranes from H<sub>2</sub> and allenes and the allylation of nitriles has been devised. This catalytic reaction is a conceptually new way to use molecular H<sub>2</sub> in organic synthesis.</p><p class="para" id="N65540">The in situ formation of nucleophilic allylboranes from H<sub>2</sub> and allenes is reported. The reaction is catalyzed by pyridonate borane that displays frustrated‐Lewis‐pair reactivity. The allylboranes that are generated in this way are reactive towards nitriles. Mechanistic investigations show that a change in the binding mode of the pyridonate substituent upon hydrogen activation is essential for the formation of the allylboranes.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765820326423-c79b07d8-3163-4435-918a-b98287fad629/assets/ANIE-59-23885-g014.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Synthesis of 2D Germanane (GeH): a New, Fast, and Facile Approach]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820074932-3ec67210-db9b-404c-a6fa-894bd7020b83/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010404</link>
            <description><![CDATA[<p class="para" id="N65541">Germanane (GeH), a germanium analogue of graphane, has recently attracted considerable interest because its remarkable combination of properties makes it an extremely suitable candidate to be used as 2D material for field effect devices, photovoltaics, and photocatalysis. Up to now, the synthesis of GeH has been conducted by substituting Ca by H in a β‐CaGe<sub>2</sub> layered Zintl phase through topochemical deintercalation in aqueous HCl. This reaction is generally slow and takes place over 6 to 14 days. The new and facile protocol presented here allows to synthesize GeH at room temperature in a significantly shorter time (a few minutes), which renders this method highly attractive for technological applications. The GeH produced with this method is highly pure and has a band gap (<i>E</i>
<sub>g</sub>) close to 1.4 eV, a lower value than that reported for germanane synthesized using HCl, which is promising for incorporation of GeH in solar cells.</p><p class="para" id="N65540">Germanane was synthesized by topotatic deintercalation of β‐CaGe2 in aqueous HF solution at room temperature under stirring for 2‐3 minutes. In order to remove the residual CaF<sub>2</sub> the material was treated with a saturated aqueous solution of EDTA.<div class="section"><div class="box" id="N65545"><div class="imageVideo"><img src="/dataresources/secured/content-1765820074932-3ec67210-db9b-404c-a6fa-894bd7020b83/assets/ANIE-60-360-g005.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765818442684-04c9a2ec-fecd-401d-968a-10a3bb8467b5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202009663</link>
            <description><![CDATA[<p class="para" id="N65541">Matching of symmetry at interfaces is a fundamental obstacle in molecular assembly. Virus‐like particles (VLPs) are important vaccine platforms against pathogenic threats, including Covid‐19. However, symmetry mismatch can prohibit vaccine nanoassembly. We established an approach for coupling VLPs to diverse antigen symmetries. SpyCatcher003 enabled efficient VLP conjugation and extreme thermal resilience. Many people had pre‐existing antibodies to SpyTag:SpyCatcher but less to the 003 variants. We coupled the computer‐designed VLP not only to monomers (SARS‐CoV‐2) but also to cyclic dimers (Newcastle disease, Lyme disease), trimers (influenza hemagglutinins), and tetramers (influenza neuraminidases). Even an antigen with dihedral symmetry could be displayed. For the global challenge of influenza, SpyTag‐mediated display of trimer and tetramer antigens strongly induced neutralizing antibodies. SpyCatcher003 conjugation enables nanodisplay of diverse symmetries towards generation of potent vaccines.</p><p class="para" id="N65540">Nanoassembly can play a key role in generating effective vaccines for emerging (SARS‐CoV‐2) and established (influenza) pandemic threats. SpyTag‐mediated display was used to adapt the nanocage to the challenge of bacterial or viral antigens with diverse cyclic and dihedral symmetries. Establishing display of both trimeric and tetrameric antigens may lead to an influenza vaccine with broader protection.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765818442684-04c9a2ec-fecd-401d-968a-10a3bb8467b5/assets/ANIE-60-321-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Formosalides: Structure Determination by Total Synthesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799926469-d2b01506-971f-408b-86bf-a6723a54b2b5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011472</link>
            <description><![CDATA[<p class="para" id="N65541">Total synthesis allowed the constitution of the cytotoxic marine macrolides of the formosalide family to be confirmed and their previously unknown stereostructure to be assigned with confidence. The underlying blueprint was inherently modular to ensure that each conceivable isomer could be reached. This flexibility derived from the use of strictly catalyst controlled transformations to set the stereocenters, except for the anomeric position, which is under thermodynamic control; as an extra safety measure, all stereogenic centers were set prior to ring closure to preclude any interference of the conformation adopted by the macrolactone rings of the different diastereomers. Late‐stage macrocyclization by ring‐closing alkyne metathesis was followed by a platinum‐catalyzed transannular 6‐exo‐dig hydroalkoxylation/ketalization to craft the polycyclic frame. The side chain featuring a very labile unsaturation pattern was finally attached to the core by Stille coupling.</p><p class="para" id="N65540">Total synthesis allowed the identification of the most likely stereostructure of the cytotoxic marine macrolides of the formosalide family (see structure) from eight possibilities. The successful route was based upon an inherently flexible blueprint that builds all stereogenic centers by strictly catalyst controlled transformations prior to formation of the polycyclic framework by late‐stage alkyne metathesis followed by a π‐acid‐catalyzed transannular cyclization<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799926469-d2b01506-971f-408b-86bf-a6723a54b2b5/assets/ANIE-60-446-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Unusual Magnetic Field Responsive Circularly Polarized Luminescence Probes with Highly Emissive Chiral Europium(III) Complexes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799833199-e14ee65f-fbe5-4001-8e86-f35be4307f4b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012133</link>
            <description><![CDATA[<p class="para" id="N65541">Chirality is ubiquitous within biological systems where many of the roles and functions are still undetermined. Given this, there is a clear need to design and develop sensitive chiral optical probes that can function within a biological setting. Here we report the design and synthesis of magnetically responsive Circularly Polarized Luminescence (CPL) complexes displaying exceptional photophysical properties (quantum yield up to 31 % and |g<sub>lum</sub>| up to 0.240) by introducing chiral substituents onto the macrocyclic scaffolds. Magnetic CPL responses are observed in these chiral Eu<sup>III</sup> complexes, promoting an exciting development to the field of magneto‐optics. The |g<sub>lum</sub>| of the <sup>5</sup>D<sub>0</sub> → <sup>7</sup>F<sub>1</sub> transition increases by 20 % from 0.222 (0 T) to 0.266 (1.4 T) displaying a linear relationship between the Δg<sub>lum</sub> and the magnetic field strength. These Eu<sup>III</sup> complexes with magnetic CPL responses, provides potential development to be used in CPL imaging applications due to improved sensitivity and resolution.</p><p class="para" id="N65540">A series of chiral, water‐soluble, DO3A‐based Eu<sup>III</sup> complexes was designed and synthesized. The chiral substituents introduced onto the macrocyclic scaffolds enhanced the photophysical properties with quantum yields up to 31 % and |g<sub>lum</sub>| up to 0.240. The |g<sub>lum</sub>| value increased by 20 % from 0.222 to 0.267 under external magnetic field showing a linear response.<div class="section"><div class="box" id="N65551"><div class="imageVideo"><img src="/dataresources/secured/content-1765799833199-e14ee65f-fbe5-4001-8e86-f35be4307f4b/assets/ANIE-60-1004-g006.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799824901-ac40e16a-c97d-494a-9fa1-58fb619e4cc6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28124</link>
            <description><![CDATA[<div class="section" id="mds28124-sec-0001"><h3 class="BHead" id="nov000-1">Background</h3><p class="para" id="N65545">Numerous studies indicate an association between neurodegenerative and metabolic diseases. Although still a matter of debate, growing evidence from epidemiological and animal studies indicate that preexisting diabetes increases the risk to develop Parkinson's disease. However, the mechanisms of such an association are unknown.</p></div><div class="section" id="mds28124-sec-0002"><h3 class="BHead" id="nov000-2">Objectives</h3><p class="para" id="N65551">We investigated whether diabetes alters striatal dopamine neurotransmission and assessed the vulnerability of nigrostriatal neurons to neurodegeneration.</p></div><div class="section" id="mds28124-sec-0003"><h3 class="BHead" id="nov000-3">Methods</h3><p class="para" id="N65557">We used streptozotocin‐treated and genetically diabetic <i>db/db</i> mice. Expression of oxidative stress and nigrostriatal neuronal markers and levels of dopamine and its metabolites were monitored. Dopamine release and uptake were assessed using fast‐scan cyclic voltammetry. 6‐Hydroxydopamine was unilaterally injected into the striatum using stereotaxic surgery. Motor performance was scored using specific tests.</p></div><div class="section" id="mds28124-sec-0004"><h3 class="BHead" id="nov000-4">Results</h3><p class="para" id="N65566">Diabetes resulted in oxidative stress and decreased levels of dopamine and its metabolites in the striatum. Levels of proteins regulating dopamine release and uptake, including the dopamine transporter, the Girk2 potassium channel, the vesicular monoamine transporter 2, and the presynaptic vesicle protein synaptobrevin‐2, were decreased in diabetic mice. Electrically evoked levels of extracellular dopamine in the striatum were enhanced, and altered dopamine uptake was observed. Striatal microinjections of a subthreshold dose of the neurotoxin 6‐hydroxydopamine in diabetic mice, insufficient to cause motor alterations in nondiabetic animals, resulted in motor impairment, higher loss of striatal dopaminergic axons, and decreased neuronal cell bodies in the substantia nigra.</p></div><div class="section" id="mds28124-sec-0005"><h3 class="BHead" id="nov000-5">Conclusions</h3><p class="para" id="N65572">Our results indicate that diabetes promotes striatal oxidative stress, alters dopamine neurotransmission, and increases vulnerability to neurodegenerative damage leading to motor impairment. © 2020 The Authors. <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p></div>]]></description>
            <pubDate><![CDATA[2020-07-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[En Route Towards the Control of Luminescent, Optically‐Active 3D Architectures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799787692-a0132e24-9b77-44b9-ac66-deefd512a974/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011368</link>
            <description><![CDATA[<p class="para" id="N65541">π‐Extended systems are key components for the development of future organic electronic technologies. While conceiving molecules with improved properties is fundamental for the evolution of materials science, keeping control over the 3D arrangement of molecules represents an ever‐expanding challenge. Herein, a synthetic protocol to replace carbon atoms of π‐systems by dissymmetric phosphorus atoms is reported; in particular, it allowed for conceiving new fused phosphapyrene derivatives with improved properties. The presence of dissymmetric phosphorus atoms precluded the formation of excimers. X‐ray diffraction revealed that, meanwhile, strong intermolecular interactions are taking place in the solid state. The phosphapyrenes photoluminesce in the visible region with high quantum yields; importantly, they are CD‐active. In addition, the unique non‐planar features of phosphorus atoms allowed for the control of the 3D arrangement of molecules, rendering lemniscate‐like structures. Based on our discoveries, we envisage the possibility to construct higher‐order, chiral 3D architectures from larger phosphorus‐containing π‐systems.</p><p class="para" id="N65540">A synthetic method to replace carbon atoms of π‐extended systems by dissymmetric phosphorus centers was developed. It allowed to conceive optically active, luminescent phosphapyrenes whose dissymmetric phosphorus atoms could be employed as cornerstone to keep control over the 3D arrangement of molecules<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799787692-a0132e24-9b77-44b9-ac66-deefd512a974/assets/ANIE-60-766-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Size‐Accelerated Kinetic Resolution of Secondary Alcohols]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799664266-a7e8b3e7-8561-46b9-9127-718513adac97/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011687</link>
            <description><![CDATA[<p class="para" id="N65541">The factors responsible for the kinetic resolution of alcohols by chiral pyridine derivatives have been elucidated by measurements of relative rates for a set of substrates with systematically growing aromatic side chains using accurate competitive linear regression analysis. Increasing the side chain size from phenyl to pyrenyl results in a rate acceleration of more than 40 for the major enantiomer. Based on this observation a new catalyst with increased steric bulk has been designed that gives enantioselectivity values of up to s=250. Extensive conformational analysis of the relevant transition states indicates that alcohol attack to the more crowded side of the acyl‐catalyst intermediate is favoured due to stabilizing CH‐π‐stacking interactions. Experimental and theoretical results imply that enantioselectivity enhancements result from accelerating the transformation of the major enantiomer through attractive non‐covalent interactions (NCIs) rather than retarding the transformation of the minor isomer through repulsive steric forces.</p><p class="para" id="N65540">The kinetic resolution of secondary alcohols by fluxionally chiral pyridine catalysts is increasingly selective with increasingly bulky substrates. Detailed kinetic and computational studies show that this is mainly caused by a selective reaction rate acceleration for the major isomer through non‐covalent interactions. More bulky catalysts further increase reaction rate and selectivity.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799664266-a7e8b3e7-8561-46b9-9127-718513adac97/assets/ANIE-60-774-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[London Dispersion in Alkane Solvents]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799658034-8e08f5ee-9c82-44b1-a8f6-35ff9a6b3c80/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202012094</link>
            <description><![CDATA[<p class="para" id="N65541">The importance of London dispersion interactions in solution is an ongoing debate. Although the significance of dispersion for structure and stability is widely accepted, the degree of its attenuation in solution is still not properly understood. Quantitative evaluations are derived mostly from computations. Experimental data provide guidelines to include London dispersion in solution phase design. Herein, dispersive interactions were examined with an azobenzene probe. Alkyl substituents in <i>meta</i> positions of the azobenzene core were systematically varied and the effect on the half‐lives for the thermally induced <i>Z</i> to <i>E</i> isomerization in several alkane solvents was determined. The results show that intramolecular dispersion is only marginally influenced. In solvents with low surface tension, reduced destabilizing solvent‐solvent interactions increase the half‐life up to 20 %. Specific individual interactions between alkyl chains on the azobenzene and those of the solvent lead to additional fluctuations of the half‐lives. These presumably result from structural changes of the conformer ensemble.</p><p class="para" id="N65540">The degree of attenuation of London dispersion in solution is evaluated. Dispersive interactions were examined with azobenzene probes. The effect on half‐lives for the thermally induced <i>Z</i> to <i>E</i> isomerization in several alkane solvents was determined. The results show only a marginally influence on intramolecular dispersion. In solvents with low surface tension, reduced destabilizing solvent‐solvent interactions increase the half‐life up to 20 %.<div class="section"><div class="box" id="N65548"><div class="imageVideo"><img src="/dataresources/secured/content-1765799658034-8e08f5ee-9c82-44b1-a8f6-35ff9a6b3c80/assets/ANIE-60-779-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reactivity–Stereoselectivity Mapping for the Assembly of <i>Mycobacterium marinum</i> Lipooligosaccharides]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799497036-2f11ada2-f216-4e5e-baa4-d3ba94e5ac78/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202010280</link>
            <description><![CDATA[<p class="para" id="N65541">The assembly of complex bacterial glycans presenting rare structural motifs and <i>cis</i>‐glycosidic linkages is significantly obstructed by the lack of knowledge of the reactivity of the constituting building blocks and the stereoselectivity of the reactions in which they partake. We here report a strategy to map the reactivity of carbohydrate building blocks and apply it to understand the reactivity of the bacterial sugar, caryophyllose, a rare C12‐monosaccharide, containing a characteristic tetrasubstituted stereocenter. We mapped reactivity–stereoselectivity relationships for caryophyllose donor and acceptor glycosides by a systematic series of glycosylations in combination with the detection and characterization of different reactive intermediates using experimental and computational techniques. The insights garnered from these studies enabled the rational design of building blocks with the required properties to assemble mycobacterial lipooligosaccharide fragments of <i>M. marinum</i>.</p><p class="para" id="N65540">A joint experimental and computational approach was used to assess reactivity–stereoselectivity relationships of the bacterial sugar caryophyllose, a rare C12‐monosaccharide, containing a characteristic tetrasubstituted stereocenter. The fundamental insights gained guided the rational design of building blocks for the effective and stereoselective assembly of mycobacterial lipooligosaccharide fragments.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799497036-2f11ada2-f216-4e5e-baa4-d3ba94e5ac78/assets/ANIE-60-937-g016.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Predicting Nitrogen‐Based Families of Compounds: Transition‐Metal Guanidinates <i>T</i>CN<sub>3</sub> (<i>T</i>=V, Nb, Ta) and Ortho‐Nitrido Carbonates <i>T′</i>
<sub>2</sub>CN<sub>4</sub> (<i>T′</i>=Ti, Zr, Hf)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799281311-cc39327b-5e23-4c6a-a9ae-6e238e4f9103/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202011196</link>
            <description><![CDATA[<p class="para" id="N65541">Due to its unsurpassed capability to engage in various sp hybridizations or orbital mixings, carbon may contribute in expanding solid‐state nitrogen chemistry by allowing for different complex anions, such as the known NCN<sup>2−</sup> carbodiimide unit, the so far unknown CN<sub>3</sub>
<sup>5−</sup> guanidinate anion, and the likewise unknown CN<sub>4</sub>
<sup>8−</sup> ortho‐nitrido carbonate (<i>onc</i>) entity. Because the latter two complex anions have never been observed before, we have chemically designed them using first‐principles structural searches, and we here predict the first hydrogen‐free guanidinates <i>T</i>CN<sub>3</sub> (<i>T</i>=V, Nb, Ta) and ortho‐nitrido carbonates <i>T′</i>
<sub>2</sub>CN<sub>4</sub> (<i>T′</i>=Ti, Zr, Hf) being mechanically stable at normal pressure; the latter should coexist as solid solutions with the stoichiometrically identical nitride carbodiimides and nitride guanidinates. We also suggest favorable exothermic reactions as useful signposts for eventual synthesis, and we trust that the decay of the novel compounds is unlikely due to presumably large kinetic activation barriers (C−N bond breaking) and quite substantial Madelung energies stabilizing the highly charged complex anions. While chemical‐bonding analysis reveals the novel CN<sub>4</sub>
<sup>8−</sup> to be more covalent compared to NCN<sup>2−</sup> and CN<sub>3</sub>
<sup>5−</sup> within related compounds, further electronic‐structure data of <i>onc</i> phases hint at their physicochemical potential in terms of photoelectrochemical water splitting and nonlinear optics.</p><p class="para" id="N65540">Structural searches from first principles have led to the prediction of solid‐state carbodiimides, guanidinates, and ortho‐nitrido carbonates, the latter introducing the diamond motif into condensed‐matter nitrogen chemistry by high pressure. Some of these novel phases are expected to show potential in terms of photoelectrochemical water splitting and nonlinear optics.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799281311-cc39327b-5e23-4c6a-a9ae-6e238e4f9103/assets/ANIE-60-486-g008.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Singlet Heterofission in Tetracene–Pentacene Thin‐Film Blends]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799268102-7a4ccd38-30cf-4abd-8a71-bf394d263a2c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/anie.202007412</link>
            <description><![CDATA[<p class="para" id="N65541">Heterofission is a photophysical process of fundamental and applied interest whereby an excited singlet state is converted into two triplets on chemically distinct chromophores. The potential of this process lies in the tuning of both the optical band gap and the splitting between singlet and triplet energies. Herein, we report the time‐domain observation of heterofission in mixed thin films of the prototypical singlet fission chromophores pentacene and tetracene using excitation wavelengths above and below the tetracene band gap. We found a time constant of 26 ps for endothermic heterofission of a singlet exciton on pentacene in blends with low pentacene fractions, which was outcompeted by pentacene homofission for increasing pentacene concentrations. Direct excitation of tetracene lead to fast energy transfer to pentacene and subsequent singlet fission, which prevented homo‐ or heterofission of a singlet exciton on tetracene.</p><p class="para" id="N65540">A study of mixed thin films of pentacene and tetracene using ultrafast optical spectroscopy revealed spontaneous fission of a singlet exciton on pentacene, resulting in triplets on both chromophores, with a time constant of 26 ps. In blends containing pentacene fractions exceeding 5 %, the pentacene homofission process outcompetes heterofission because of the endothermicity of the latter.<div class="section"><div class="box" id="N65542"><div class="imageVideo"><img src="/dataresources/secured/content-1765799268102-7a4ccd38-30cf-4abd-8a71-bf394d263a2c/assets/ANIE-59-19966-g007.jpg" alt=""/></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-09-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765799214914-291ac5b1-36f9-457d-ba5b-81a1fdbb08fe/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/ajh.25958</link>
            <description><![CDATA[<p class="para" id="N65541">Patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) have poor outcomes and hematopoietic cell transplantation (HCT) is the only curative treatment. New targeted therapies improved survival in select patients with specific mutations, however management of patients without these molecular alterations is an unmet need. We conducted a phase one study of lenalidomide in combination with cytarabine/idarubicin salvage chemotherapy in patients with R/R AML and high‐risk myelodysplastic syndromes. A total of 33 patients were enrolled in the study (30 AML, 3 MDS), and treated at three dose levels with 3 + 3 design. Dose‐limiting toxicity (DLT) was seen in eight patients, including four hematologic DLTs. The most commonly observed non‐hematologic serious adverse events were febrile neutropenia, rash, sepsis and renal injury. Dose level −1, consisting of 25 mg/d lenalidomide D1‐21, 1 g/m<sup>2</sup> cytarabine D5‐8, and 8 mg/m<sup>2</sup> idarubicin D5‐7 was determined to be the maximum tolerated dose. Note, 15/33 (45%) of patients were able to receive pre‐planned 21 days of lenalidomide. Overall, 18 patients achieved complete remission (CR) (n = 14) or CR with incomplete count recovery (CRi) (n = 4) with total CR/CRi rate of 56%. The 1‐year and 2‐year overall survival (OS) were 24% and 10%, respectively. Among responders, 10/18 underwent allogeneic HCT and had a 1‐year OS of 40%. There was no molecular pattern associated with response. These data demonstrate that the combination had clinical activity in R/R AML. This regimen should be further investigated for patients who relapsed after HCT, and as a bridge therapy to HCT. (ClinicalTrials.gov identifier: NCT01132586).</p>]]></description>
            <pubDate><![CDATA[2020-09-19T00:00]]></pubDate>
        </item>
    </channel>
</rss>